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Abstract 
Our work has been concerned with the synthesis of azasteroid ring systems, utilising 
acyl radical cascade reactions. Chapter 1 comprises an overview of published work 
relevant to our studies: an analysis of steroid biosynthesis and synthesis; a review of 
the use of azasteroids, their biological activity and current synthetic techniques in 
azasteroid formation. This initial chapter also includes an introduction to published 
work in the area of nitrogen heterocycle synthesis using radical reactions and finally 
the use of acyl radicals in synthesis, particularly cascade reactions. 
Chapter 2 starts by describing the requirements of a reaction system for use in acyl 
radical cascades and then discusses the relevance of this to the synthesis of ring 
junction azasteroids. OUf attempts to synthesise ring junction azasteroids and the 
problems that we encountered are then discussed. 
Subsequent sections describe the disconnection of azasteroids where nitrogen is part of 
the body of the ring and the synthetic work that we performed in this area. Using 
cyclohexenyl enamides as the terminal electrophore in cascade reactions we were able 
to synthesise a 12-aza-D-homosteroid in nine steps. The final step was a cascade 
reaction involving three consecutive 6-elldo-trig cyclisations starting from an acyl 
radical and terminating on an cycIohexenyl enamide electrophore. An extensive, 
though unsuccessful, study attempting to use linear enamides in cascade reactions is 
described showing routes towards the synthesis of steroid models. 
Finally we reveal the work that was performed in the use of highly stabilised enamides 
as radical acceptors. This work resulted in the formation of a bicycIo[S.3.0]tridecene 
after a lO-endo-trig, 5-exo-trig cascade from a linear precursor designed to form a 7-
azaandrostane skeleton. 
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1. INTRODUCTION 
1 
1.1 STEROIDS 
1.1.1 Biosynthesis of Steroids 
Investigation into the biosynthesis of terpenoids and steroids has been a continuing 
theme in the chemical literature and this work has been reviewed extensively. I 
Revealing the full details of the story uncovering the mechanisms behind the 
remarkable biosynthesis of steroids, from squalene, has involved the work of many 
researchers. In 1953, Woodward and Bloch combined the groundbreaking work of 
Bloch,2 Channon,3 and Robinson 4 to hypothesise that squalene 1 was converted into 
lanosterol 2 as the key step in the cholesterol 3 biosynthetic pathway (Scheme 1). 5 
In 1955, Stork and Eschenmoser proposed that a prearranged squalene molecule could 
undergo an uninterrupted stereochemically controlled cascade cyclisation followed by 
1,2-migrations to give lanosterol, as the key step in steroid biosynthesis.6•7 Direct 
evidence for these proposals was uncovered by Bloch and Cornforth during their 
incorporation experiments, where deuterium and carbon-14 labelled malonates were 
fed to liver enzymes during the study of the biosynthesis of steroids. 8.9 Corey 10 and 
van Tamelen II demonstrated the intermediacy of 2,3-oxidosqualene in lanosterol 2 
biosynthesis and Barton 12 verified that only (3S)-2,3-oxidosqualene 4 was accepted as 
a substrate by eukaryotic oxidosqualene cyclases. This led to the accepted cascade 
via the "chair-boat-chair" conformation of (3S)-2,3-oxidosquaJene 5 initiated by an 
acid catalysed epoxide ring opening, with an anti-Markovnikov cyclisation in the 
formation of the C-ring to give the cationic intermediate tetracycle 6. From 6, 1,2-
2 
methyl and 1,2-hydrogen migrations yielded lanosterol 2 to complete the biosynthesis 
of the steroidal core (Scheme 2), 
HO 
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11 
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However, when 2,3-oxidosqualene 4 was submitted to non-enzymic cyclisation 
conditions the 6,6,5 fused tricyclic products, 7 and 8, were isolated, resulting from the 
more favourable Markovnikov addition during the formation of the C-ring. 13 Further 
investigation into steroid biosynthesis, using 18,19-dihydro-2,3-oxidosqualene 9 as 
the enzyme substrate, resulted in the formation of the 6,6,5 fused tricycle 10 and 
highlighted the possibility of alternative sequences in the cascade leading to steroid 
formation (Scheme 3).14,15 
HO 
7 
9 
HO 
enzyme mediated 
.. 
cascade 
Scheme 3 
8 
HO 
10 
A recent in-depth reinvestigation of steroid biosynthesis, combining the ever 
developing arsenal of tools from chemistry, biochemistry and biological chemistry, 
has shown new and unexpected aspects of the cascade cyclisation. Corey and co-
workers used 20-oxa-2,3-oxidosqualene 11 as a substrate in the enzyme catalysed 
cascade. They were able to trap the intermediate cation 12 which they isolated as the 
5 
ketone 13 (Scheme 4).16 Stereochemical comparison to synthetic material revealed 
that the C-17 sidechain was in the ~ - c o n f i g u r a t i o n n and not the a-configuration as 
previously assumed in the intermediate 6.6•7 
HO 
HO 
HO 
11 I enzyme catalysed t cascade 
13 
Scheme 4 
14 
6 
In the previously proposed biosynthesis (Scheme 2) the transformation from 6 into 2 
involved a 120 0 bond rotation about the C-17/C-20 bond·, which maintained the 
stereochemical integrity at C-20. However, with the C-17 side chain in the ~ ~
orientation in intermediate 12 the required C-17 / C ~ 2 0 0 bond rotation was reduced to 
60 0 • This change in the proposed pathway would lower the energy boundaries for the 
transformation. When this investigation was repeated on a larger scale small 
quantities of the 6,6,5,4 tetracycle 14 were isolated)7 Trapping of the tetracycle 14 
with its 5-membered C-ring pointed towards a Markovnikov cyclisation, which is 
favoured on steric grounds, rather than the previously proposed anti-Markovnikov 
cyclisation with its high steric constraints. This led to the hypothesis that the cationic 
cascade proceeded via a stepwise cyclisation pathway rather than a concerted cascade. 
Therefore, formation of the steroid ring system via this pathway would involve a ring 
expansion of a five membered C-ring, to the six membered ring found in steroids, 
from a discrete intermediate cation in the cyclisation pathway. 
HO 
15 
HO 
16 
Further investigation by the Corey group also showed that the synthetic mimic 15 of 
the intermediate cation 16 did not block sterol biosynthesis implying that both the 
conformation of oxidosqualene and the shape of the enzyme site change during the 
7 
cyclisation. 18 Using the truncated analogue 17 of 2,3-oxidosqualene 4 Corey and 
Cheng were also able to show that the interrupted cascade of this substrate led entirely 
to the 6,6,5 tricyclic structures 19,20 and 21 (Scheme 5).19 The culmination of this 
work is a revised cationic cascade, with the intermediate tricyclic cation 22 
undergoing ring expansion to form the cation 23. The cascade continues, resulting 
initially in the formation of the tetracyclic system 16, where 1,2-hydrogen and 1,2-
methyl migrations on the protosterol 16 finally results in the biosynthesis of 
lanosterol 2 (Scheme 6).18 
17 
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1.1.2 Biomimetic Steroid Synthesis 
Many synthetic approaches to steroids have been employed by chemists over the past 
six decades. These range from the synthetic modification of abundant steroid systems 
to their less abundant cousins20 and annulation reactions,21 such as the Diels-Alder 
and Robinson annulations for sequential ring formation. Perhaps one of the most 
elegant approaches is in the form of biomimetic cascade reactions. The synthesis of 
the tetracyclic ring system in one step in a fully stereoselective manner from 
polyolefinic precursors was the goal of these synthetic efforts. Ground-breaking work 
in this area was performed by the group of the late W. S. Johnson and has been 
extensively reviewed in recent Iiterature.22 
The stereoelectronic rationalisation of cationic cascades by Stork and Eschenmoser6·7 
led to a series of biomimetic synthetic approaches to steroids. A major advancement 
in this area was made with the introduction of acetals as initiators for the cationic 
cascades. Work by Johnson and co-workers23 showed that bicyclic products 25 and 
27 were formed in high yield and with high stereoselectivity under relatively mild 
conditions from the olefinic acetals 22 and 24 respectively, thus adhering to the Stork 
and Eschenmoser hypothesis (Scheme 7) . 
.. 
H O ~ O O
24 25; 80 % 
Scheme 7 
10 
)III 
26 
Reagents: i, SnCI4, CH3N02, O·C. 
Scheme 7 
The work was developed further for the formation of tetracyclic systems from 
tetraene acetals. Thus, cyc1isation of the tetraene acetal 28, under Lewis acidic 
conditions, led to the tetracycle 29 in 30 % yield and with high stereoselectivity 
(Scheme 8).24 This was the first synthesis of a steroid ring system in one step from a 
linear precursor. 
)III 
H O ~ O O
28 29; 30 % 
Reagents: i, SnCI4, pentane, O·C. 
Scheme 8 
With the use of chiral acetals, the work has undergone a further metamorphosis, 
alIowing the use of this methodology in the enantioselective synthesis of steroids.25 
For example, the fluorine substituted trieneyne acetal 30 underwent a Lewis acid 
initiated cascade to give the steroid 31 in 38 % yield and 93 %de (Scheme 9).26 The 
use of cationic cascades in the synthesis of natural and unnatural steroids represents 
one of the most impressive stories in organic synthesis. 
11 
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Reagents: i, SnCI4, (Me3SihO, -7SoC. 
Scheme 9 
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1.2 AZASTEROIDS 
Azasteroids are a group of natural and unnatural products that contain nitrogen either 
in the tetracyclic steroidal core (nuclear azasteroids), or as part of an extra ring system 
or sidechain, apart from the tetracyclic core (extranuclear azasteroids), which show a 
wide and interesting variety of biological activity.27 One of the few examples of a 
nuclear azasteroid natural product is A25822B 32, a 15-azasteroid, where nitrogen is 
incorporated as part of an a,p-unsaturated imine in a homo-D-ring. An example of 
the more common class of extranuclear azasteroid natural products is the hexacyclic 
androstane-tomatidine 33, isolated from tomato plants, where the nitrogen atom is 
incorporated as part of a spirofused hemiaminal. Extensive research as been 
conducted into nuclear azasteroids during the exploration of the biological activity of 
these functionally flexible molecules. Therefore, unnatural nuclear azasteroids 
predominate in the literature in this area and an example of this type of molecule is 
the neuromuscular blocking agent chandonium iodide 34, where the nitrogen 
containing functionality is a quaternary iodide salt in the homo-D-ring. 
HO 
H H 
32; A25822B 33; tomatidine 
13 
34; chandonium iodide 
1.2.1 A25822 
The range of natural products known as A25822 were isolated by chemists working at 
Eli Lilly in 1975 from the mould Geotriclzum flavo-brunneum. 28 This mixture was 
subsequently identified as seven diverse structures all related to a central D-homo-15-
azasteroidal ring structure.29 These compounds became known as factors A 35, B 32, 
D 36, H, L 37, M 38, N 39, where the factor A25822H was unstable and had an 
undefinable structure. 
HO 
H 
35; A25822A 32; A25822B 
HO HO 
H H 
36; A25822D 37; A25822L 
14 
o 
H AcO H 
38; A25822M 39; A25822N 
An investigation into their biosynthesis showed that increasing the amount of L-
tryptophan in the fungal broth increased the yield of the azasteroids, but that racemic 
and D-tryptophan were not as active, implying this amino acid is the source of 
nitrogen during the biosynthesis. 30 Also it was shown that squalene and iso-valeric 
acid increased the yield of the azasteroids implying that the squalene oxide cascade is 
performed, unusually, in the bacterial cells,3o Subsequent investigation into the 
biological activity of these compounds showed that A25822B 32, by far the most 
abundant metabolite, also possessed the strongest antifungal activity,31 A25822B 32 
was shown to deactivate fungal cell proliferation by blocking ergosterol 41 synthesis 
at the NADP-H mediated A14-15 reductase stage from the triene 40 (Scheme 10),32 It 
has been shown that treatment of fungal systems with A25822B 32 results in a build-
up of the A14-15 precursor 40 in the fungal broth and loss of ergosterol 41, consumed 
during cell proliferation. 
HO 
H HO 
40 41; ergosterol 
Scheme 10 
15 
It has been proposed that the conjugate acid of A25822B, 46, binds competitively to 
the NADP-H site in the reductase enzyme, thus inhibiting this pathway by blocking 
the availability of these sites to the natural enzyme substrate 40. There is clear 
congruence between the intermediate of reduction 43 in the biosynthetic pathway and 
the conjugate acids 46 and 47 (Scheme 11),34 A25822B 32 has also been seen to be a 
potent plant growth regulator, again by blocking phytosterol biosynthesis at the A14-
15 reduction stage.35 
R R 
NADP-H 
"'1:; 
42 43 44 
R R R 
... ... 
45 
Scheme 11 
This powerful and broad ranging ill vivo biological activity has naturally spawned 
many partial and total synthetic efforts from the chemical community. In 1983 
Barton et al.36 synthesised derivatives of A25822B 32 using ergosterol 41 as the 
starting material. Conversion of 41 into the known ketone 49 progressed via 
literature procedures.37 Generation of an oxime and then Beckmann rearrangement 
followed by reduction installed the imine into the homo-D-ring of 51. 
Dehydrogenation of the steroid using DDQ afforded the A25822B analogue 50 and 
other unsaturated products 52 and 53 (Scheme 12). 
16 
HO AcO 
48 H 49 
H. m.;v! 
A 
v 
... 
HO HO 
H 50 
Reagents: i, reference 37; ii, CINHOH, pyridine, MeOH, reflux; iii, p-toluenesulfonyl 
chloride, pyridine then HCI, MeOH; iv, LiAIH4' THF, reflux; v, DDQ, C6H6, reflux. 
Scheme 12 
A 
H 52 
HO HO 
I I " : ~ ~
A = "Jv. I 
Workers at Smith-Kline and French undertook the total synthesis of A25822A 35, 
again starting from a suitable steroid, in this case the diene ( 3 ~ , , 22E)-4,4-dimethyl 
ergosta-5,7,2-trien-3-ol 54.38•39 Isomerisation of 54 followed by oxidative ring 
opening and protection of the resulting functional groups gave the tricycle 55. The 
side chain was removed by ozonolyisis and then replaced to give the key intermediate 
17 
57. Highlighting the method used for the formation of the azasteroidal core, 
cyclisation of the tricycle 57 using an aza-Wittig protocol proceeded smoothly via the 
intermediate azide 58, installed using a Mitsunobu reaction.40 This sequence of 
reactions gave the azasteroid ring system 56 which was converted to A25822A 35 
using a Wittig olefination reaction (Scheme 13). These workers progressed to 
synthesise a number of analogues of A25822A and A25822B. They employed the 
Beckmann rearrangement strategy, previously used by Barton,36 to install the imine in 
the D-ring, again starting from steroidal starting materials.41 
HO 
iiC 
54 
56; x=o 
35;X=CH2 
)It 
X 
)It 
AcO 
HO 
11 
C 57;X=OH i. a 58; X=N3 
Reagents: i. a) DPPA. DEAD. PPh3. THF; b) PPh3. 
70·C; ii. Ph3PMeBr. KOC(MehEt. toluene. 60·C. 
Scheme 13 
18 
OAe 
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Workers from ICI Agrochemicals at lealott's Hill were- also interested in the 
fungicidal properties of the A25822 series of compounds and undertook the synthesis 
of an acetate protected version of A25822B using the same ring formation 
methodology as Dolle and Kruse.38,42 However, they started from Cholic acid 
deri vati ves such as 59 and introduced the side chain using Grignard methodology, via 
an acid chloride, resulting in a synthesis of the ketone 60. This was then converted 
into the protected version of A25822B 61 (Scheme 14). 
~ ~
OMe 
AcO'\' 
H 59 
AcO'\' 
AcO 
H 61 
Reagents: i, LiOH. MeOH, H20; ii. AC20. pyridine. CH2CI2; 
(COCI)2 toluene; i-PrMgCI. CuCN. THF; iii. reference 38. 
19 
Scheme 14 
Back and co-workers became interested in the synthesis of the A25822 class of 
compounds and developed new methodology for both the synthesis of the side chains 
and the ring system. Introduction of a side chain was achieved using a stereoselective 
conjugate addition to an a,fJ-unsaturated epoxide. Subsequent Baeyer-Villiger ring 
expansion and introduction of nitrogen gave the unnatural product 62.43 This 
methodology was then used in the first total synthesis of the natural product A25822B 
32. 
HO 
H 
62 
Following literature procedures they synthesised the a,fJ-unsaturated epoxide 64 from 
epiandrostane 63.44 A highly stereoselective addition of an organocuprate to the a,fJ 
unsaturated epoxide introduced the side chain in the form of the acetal 66.44c Again, 
a Baeyer-Villiger ring expansion generated a six membered D-ring and subsequent 
functional group manipulations gave the key iodoketone 65. Amination and acid 
catalysed cyclisation gave the natural product 32 (Scheme 15).45 
Interest continues in this range of natural products with recent work being published 
by chemists from lealott's Hill on the synthesis of C,D-ring analogues of A25822B.46 
These authors investigated a range of compounds with various side chains at C-17, 
also exploring the effects on biological activity of heteroatom substitutions into the 
20 
ring system. A number of different systems have been synthesised, but no data about 
the effect on the biological activity have been published. 
HO 
H 
H 
63 
65 
iii. iv 1 
32 
o 
steps 
.. 
TBSO 
H 
64 
OH 
66 
Reagems: i, reference 44; ii, (CH3hCHC(OCH2CH20)CH2CH2I, r-BuLi, EtlO, -7SoC; 
CuCN, Et20, -7SoC; 64. Et20, -7SoC; iii, NH3' MeOH, NH4Cl; iv, H30+, THF. 
Scheme 15 
21 
1.2.2 Neuromuscular Blocking Agents 
Following the discovery of the steroidal alkaloid maiouetine 67 and synthesis of some 
of its stereoisomers, which exhibit potent neuromuscular blocking activity, many 
other steroidal based bisonium compounds have been synthesised.47•48 The rigid 
skeleton of the steroidal system allows the prediction of the interonium distance, 
which is a very important aspect of neuromuscular blocking activity,49 and has led to 
successful development of pharmaceutical products based on these compounds. 
M e ~ ~
H 
67; malouetine 
Synthetic work by the group of Singh resulted in the discovery of chandonium iodide 
34 as a potent and selective neuromuscular blocking agent with minor ganglion 
blocking activity and little effect on blood presure. 50 The synthesis of chandonium 
iodide 34 started from the dione-D-homo-17a-azasteroid 68 which had previously 
been prepared by Reagan and Hayes.51 Condensation with pyrrolidine led to the 
enamine 69 and subsequent reduction of the enamine and amide gave the diamine 70. 
Methylation followed by conversion into the dimethiodide derivative realised the 
target 34 (Scheme 16). Continuation of synthetic studies in this area by Singh and co-
workers failed to uncover a more potent agent than chandonium iodide which has 
been marketed as an effective nondepolarizing neuromuscular blocking agent.52•53 
22 
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34 70 
Reagents: i, pyrrolidine. MeOH. reflux; ii. NaBH4. MeOH. reflux; iii. Na. 
II-pentanol. reflux; iv. formic acid. formalin. reflux; v, Mel, ethanol, reflux. 
Scheme 16 
o 
This work has been developed in the area of extranuclear azasteroids by Akzo Nobel. 
Using maloutine 67 as a lead compound in a pharmaceutical study, they were able to 
develop three therapeutic agents as neuromuscular blocking agents for use in surgery. 
These are pancuronium bromide, vecuronium bromide 71, a hexacyclic steroid with a 
single quaternized nitrogen and rocurnium bromide 72, a structurally related 
compound.54.55 
23 
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71; vercuronium bromide 72; rocurnium bromide 
1.2.3 Sa-Reductase Inhibitors 
Numerous 4 and 6-azasteroids have shown activity as 5a-reductase inhibitors. This 
important area of research has been driven by the implication of 5a-
dihydrotestosterone 74 as an intracellular androgenic in a number of conditions such 
as acne, benign prostatic hyperplasia and male pattern baldness.56 Many 4 and 6-
azasteroids have been shown to block both type I, expressed in the skin, and type II, 
expressed in the prostate, 5a-reductases and thus, the biosynthesis of 5a-
dihydrotestosterone 74 from testosterone 73 (Scheme 17). 
OH 
a 
73; testosterone 
5a-reductase 
.. 
Scheme 17 
OH 
a 
H 
74; 5a-dihydrotestosterone 
Rasmusson and co-workers have had a deep interest in the use of 4-azasteroids as 5a-
reductase inhibitors and have synthesised a wide range of these compounds for 
biological testing on rat, dog and human 5a-reductase enzymes.56 Starting from 
24 
suitably substituted ~ 4 - a n d r o s t a n - 3 - o n e s s 75, oxidative ring opening yielded 76. A 
range of 4-aza-androstanes 78 were synthesised by condensation with a selection of 
amines. Hydrogenation of the /::.5 bond, in the case where R'=H, and then oxidation in 
the /::.1 position, using benzene selenic anhydride, led to a series of highly active 
reductase inhibitors 77 (Scheme 18).57 Further modification of 77 and 78 gave a 
selection of structurally diverse steroids which were used for testing against 5-a 
reductases. A key lead compound, on which this study was based, was the 4-aza-
androstane (4-MA) 79, which showed high activity against rat and human 5a-
reductase.56c.58 Merck have since taken finasteride (MK-906) 80, a compound from 
these studies, onto clinical trials although the results did not show the expected 
therapeutic activity.59 A related series of compounds have also been synthesised by 
Labrie et al. and their biological activity has been assessed against both Type I and 
Type II Human 5a-reductases.60 
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Back and co-workers have published much work on azasteroids and they synthesised 
a range of N-chloro derivatives containing the a,p-unsaturated amide found in MK-
90680.61 Treatment of the azasteroid 81 with trichloroisocyanuric acid (TelA) gave 
the target N-chloro compounds 82 in excellent yields (Scheme 19).6Ia It has been 
hypothesised that these compounds may be irreversible inhibitors of 5a-reductases, 
with displacement of chloride resulting in covalent bond formation between the 
nitrogen and a cystine residue. 
.. 
o o 
81 82 
Reagellfs: i. TelA. CHCI3. reflux. 
Scheme 19 
There has also been extensive interest in 6-azasteroids as 5a-reductase inhibitors and 
a range of these molecules have undergone ill vivo testing by a group from Glaxo.62.63 
Synthesis of the key steroid nucleus followed a nine step route based on the original 
work performed by Lettre and co-workers.64 Thus, starting from the known 
androstane 83,56c oxidative ring opening followed by acyl chloride formation gave the 
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tricyclic compound 84. Introduction of azide and silica catalysed Curtius 
rearrangement generated the key aza-B-ring in 86. Functional group manipulation 
gave structural variations at the C-20 position which led to a range of 6-aza-
androstanes 85. These were further modified to give a huge variety of compounds for 
biological evaluation. Results from this investigation highlighted a number of 
compounds such as the azasteroids 87 and 88 with good in vivo efficacy and 
pharmacokinetics. 
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1.2.4 Other Biological Uses 
Aside from the three main areas of biological activity already highlighted, azasteroids 
have been used for a range of other functions. 4-Azasteroids showed potency as 
antimicrobial agents in a study performed by Doorenbos and co-workers.65 They 
synthesised a variety of 4-azasteroids using Curti us rearrangement methodology 
resulting in the identification of the androstane 89 and the methyl derivative 90 as 
having antimicrobial activity against Gram-positive bacteria, yeasts and moulds. 
Azasteroids have also been used as probes for the mechanisms of cholesterol 
metabolism,66 as antifertility compounds in a study on rats,67 and in various synthetic 
studies investigating a number of biological areas.68 
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1.2.5 Total Synthesis of Azasteroids 
The review above demonstrates that nuclear azasteroids exhibit a wide range of 
biological activity representing a variety of applications. This has led the 
development of a number of synthetic efforts in this area. However, most of this 
work concentrates on partial syntheses starting from readily available steroid 
materials and there have only been a few reported total synthesis of azasteroids.27.69 
We have seen that this is in contrast to carbocyclic steroids where biomimetic 
cascades are a major area of research. The main use of azasteroid total synthesis is in 
the incorporation of nitrogen into a ring junction position in the tetracyclic nucleus. 
This method has been exemplified by the work of Speckamp and co-workers who 
have specialised in pseudo-biomimetic acyl iminum ion cyclisations to give 13-
azasteroids.7o Synthesis of the precursor 92 started from benzyl bromide. Wurtz 
coupling with propargyl magnesium bromide followed by alkylation with ethylene 
oxide gave the key intermediate 91. Sodium/ammonia reduction and introduction of 
succinimide using a Mitsunobu coupling yielded 93. Subsequent reduction gave the 
desired precursor 92 (Scheme 21). Treatment of the precursor 92 with formic acid 
resulted in a highly stereoselective cyclisation to yield the 13-azasteroid 94 in 89 % 
yield (Scheme 22). This methodology has been used recently in the synthesis of 10-
chloro-13-azasteroids for investigation into their biological activity.71 
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1.3 THE USE OF NITROGEN ELECTROPHORES IN 
HETEROCYCLE SYNTHESIS 
The synthesis of ring systems via radical mediated cyclisation reactions is an ever 
expanding area in organic chemistry. Many carbon ring systems have been 
synthesised over the past decades and this research has been applied to natural 
product total synthesis.72 Until recently however, the use of radical cyclisations in 
the synthesis of nitrogen heterocycles was a relatively under explored area, but there 
has now been an explosion of work investigating the possibilities of this 
methodology,73 Two strategies towards nitrogen heterocycles have been developed, 
the use of nitrogen containing electrophores and the use of nitrogen centred radicals. 
For example, the generation of aminyl radicals from many different precursors has 
been explored by a number of researchers.74 Iminyl radicals have also been used to 
good effect in the synthesis of heterocycles by Zard.74d.75 Nitrogen can be 
incorporated into many different functional groups containing unsaturation suitable 
for accepting radical additions. The combination of these groups and the different 
nitrogen centred radicals has allowed researchers to explore many different avenues 
in the synthesis of heterocycles. 
1.3.1 Azides 
Azides, as well as being used as precursors to aminyl radicals via their reaction with 
tributyltin hydride, have been used widely as radical acceptors. In this case TTMSS 
has to be used as the initiator in the reactions, homolytically cleaving a halide-carbon 
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bond to generate radicals in the presence of azides. Kim and co-workers76 have 
developed the use of azides as radical acceptors in the formation of 5 membered 
rings. For example, generation of an alkyl radical by TTMSS from the iodide 9S 
followed by two 5-exo-trig cyclisations resulted in the formation of the fused 
THF/pyrrolidinone 96 in 56 % yield (Scheme 23). The initial ring closure generated 
the tetrahydrofuran and subsequent cyclisation onto the azide, with loss of nitrogen, 
gave the product 96 after tosylation. 
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i, ii 
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I 
9S 96 
Reagellts: i, (TMS}JSiH, AIBN, C6H6, 80·C; ii, tosylation 
Scheme 23 
Murphy and co-workers77 have used'azides as radical acceptors in the key step of a 
synthetic approach towards aspidospermidine 97. The tetracyclic core 99 was 
synthesised from the aryl iodide 98 with high diastereoselectivity and in an excellent 
yield of 95 % after TTMSS induced radical generation followed by two 5-exo-trig 
cyclisations, the second one terminating on the azide (Scheme 24). 
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Reagents: i. (TMS}JSiH. AIBN. C6H6. SO·C; ii. H20. 
Scheme 24 
1.3.2 Oximes 
Oxime ethers are the most explored of the unsaturated nitrogen containing 
electrophores and they were the first system to be developed for synthesis. Even 
though they have not been applied to the synthesis of nitrogen containing 
heterocycles, this work represents an historically important development in radical 
chemistry. A large number of systems have been explored for many different 
purposes and the work has been extensively reviewed in the recent literature)3 One 
of the first uses of this functional group was by Corey in 1983.18 Generation of the 
trimethylsilyl protected ketyl radical 101 from the ketone 100, followed by a 5-exo-
trig cyclisation onto the oxime resulted in the formation of the bicyclic system 102 
(Scheme 25). 
.. ~ N O M . - - - - ~ " . . ~ H O M M• 
C02Me 
100 101 102 
Reagents: i. Zn. TMSCI. lutidine. THE reflux. 
Scheme 25 
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More recent work by Pattenden and co-workers has shown some of the flexibility that 
oximes exhibit.79 The discovery of a novel double ring expansion cyclisation process 
led to the synthesis of the bicyc1ic system 106 in 70 % yield from the cycIobutane 
oxime 103. Thus, 103 was subjected to radical generating conditions, viz: TTMSS, 
hexane, 50°C, hv; which resulted in 'the formation of the vinyl radical 104. Upon 6-
exo-trig cyc1isation the resulting nitrogen centred radical 105 underwent ~ - f i s s i o n n to 
leave the 8 membered ring 108. Transannulation of this radical 108 followed by 3-
exo-trig cyclisation gave another nitrogen centred radical 107, which also underwent 
~ - f i s s i o n n and elimination of the silyl group to yield the bicyclic compound 106 
(Scheme 26). 
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Scheme 26 
This work was then taken to an extra dimension with the synthesis of the angular 
fused triquinane 111 from the vinyl bromide 109.80 Thus, generation of the vinyl 
radical 110, which underwent a similar cyclisation/fragmentation sequence to the one 
which resulted in the formation of the eight membered ring 108 from 104, led to the 
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intermediate radical 112. This radical 112 then transannulated and underwent a 5-
exo-trig cyclisation to give the triquinane 111 in 38 % as a 1: 1 mixture of 
diastereoisomers (Scheme 27). 
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Scheme 27 
Recently Alsono and Noya used oximes as radical acceptors in their synthetic 
approaches towards the puffer fish toxin tetrodotoxin 113.81 Choosing the oxime 
ether containing anhydromannose derivative 114 as a precursor and treating it with 
BU3SnClINaBH3CN (an in situ generator of BU3SnH) and AIBN in tert-butanol at 
80°C, they found that it underwent a 5-exo-trig cyclisation reaction to give the desired 
tricycle l1S in a modest 29 % yield (Scheme 28). 
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1.3.3 Hydrazones 
Radical reactions of hydrazones have not been explored to the same extent as oximes. 
Kim and co-workers have performed numerous studies into hydrazones as radical 
acceptors and generators but they have not used them in the synthesis of nitrogen 
heterocycles.82 This work was extended by a variety of other authors who 
investigated hydrazones as radical acceptors and as radical clocks.s3 However, it was 
left to the group of Belletire to use hydrazones in the synthesis of heterocycles, albeit 
in a reaction designed to give a different product from the one isolated.84 Taking the 
a-bromoacylphenyl hydrazone 116 and submitting it to standard radical conditions 
they were able to isolate pyrazolidinone 120 instead of the anticipated ~ - l a c t a m m
product 118. The authors proposed that the intermediate radical 117 underwent a 4-
exo-trig cyclisation to give the intermediate radical 119. Rearrangement of 119 gave 
radical 121 which was then quenched to give the isolated product 120 in 96 % yield, 
though a 5-endo-trig cyclisation would leave the same material (Scheme 29). 
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1.3.4 Azo systems 
In contrast to oximes, azo containing precursors have been used in the synthesis of 
nitrogen heterocycles. As part of a kinetic study into radical cyclisations Warkentin 
et at. 85 synthesised the aryl radical precursor 122 and measured rate constants for the 
intramolecular reactions of the corresponding radical 123. They found that the radical 
species 123 underwent both 5-exo and 6-endo-trig cyclisation to yield the two 
products, 124 and 125, respectively (Scheme 30). The ratio of the products depended 
on the concentration of tributyltin hydride in the reaction mixture. 
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1.3.5 Imines 
During the 1990s imines have been investigated as radical acceptors and used to 
perform monocyclisations and as part of cascade sequences. In 1990, Takano 
reported a radical cyclisation onto an aryl imine as the key step in the synthesis of 
cryptostyline I 126.86 Generation of the aryl radical 128 from the bromide 127 
resulted in a predominantly 6-endo-trig cyclisation to give the tetrahydro-iso-
quinoline 130 in 56 % yield. The dihydroindole 129 was also isolated in 10 % yield 
following 5-exo-trig cyclisation from 128. 
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Bowman and co-workers have concentrated their work in the area of alkyl radical 
cyclisation onto alkyl imines. Initial studies investigated the use of alkyl radicals in 
the formation of one ring by radical addition onto a variety of different imine 
systems.83a However, this work has been applied successfully to the synthesis of 
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bicyclic compounds via cascade processes. 87 For example, using the alkylselenoate 
131 as a precursor, they were able to generate the alkyl radical 132. A 6-exo-trig 
cyclisation and then a Lewis acid activated 5-exo-trig cyclisation of the intermediate 
aminyl radical 134, resulted in the isolation of the bicycle 133 in 57 % yield as a 
mixture of diastereoisomers (Scheme 32). 
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Bowman et ai. found that precursors such as 131 could not be isolated due to the 
instability of the imine. Therefore, the condensation reaction to form the imine was 
performed in the same pot as the radical cyclisation reaction. Warkentin and co-
workers approached the problem of imine instability by using highly reactive aryl 
radicals in cyclisations onto stabilised imines.88 Thus, the aryl bromide 135, when 
treated with tributyltin hydride and AIBN in benzene gave the tetrahydro-iso-
quinoline 136 in 70 % yield (Scheme 33). 
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Glover et al.89 have shown an interest in the cyclisation of aryl radicals onto 
enamines for the formation of tricyclic systems. They investigated the use of 
cyclohexenyl enamines as radical acceptors in a number of precursors and were able 
to show that systems of this type suffer from regioselectivity and stereoselectivity 
problems. For example, the ethyl substituted system 137, upon treatment with 
tributyltin hydride/AIBN in toluene at 80aC gave a complex mixture of products. The 
fully reduced system 138 was isolated in 12 % yield. Both the cis and trans angular 
fused tricycles 139 and 140, resulting from 6-elldo-trig cyclisations, were isolated in 
31 % and 13 % yields, respectively. Also the spirocycle 141 resulting from 5-exo-trig 
cyclisation was isolated in 28 % yield (Scheme 34). This result has probably 
hindered the development of the use of enamines in synthesis but has aided the 
development of the use of their structurally related cousins, enamides. 
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1.3.7 Enamides 
Using enamines and imines as electrophores in the synthesis of nitrogen heterocycles 
has resulted in problems with the stability of these functional groups in their 
preparation and in their radical reactions.73.89 These problems have been overcome 
by the use of stabilised systems such as aromatic substituted imines,88 oximes80 and 
enamides.90-93 Enamides can take a number of guises depending on the arrangement 
of the carbon-carbon double bond and the amide. For example, the three systems 
142, 143 and 144 have been used in the synthesis of heterocycles. 
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The enamide functional group has been used in the synthesis of many natural 
products by radical cyclisation due to its flexibility, stability and predictable 
regioselectivity. This was exemplified by the work of Castedo and Dominguez.90 
Using the common intermediate 145 they were able to synthesise the natural product 
lennoxamine 148 by two routes (Scheme 35). Radical cyclisation of 145 gave the 10-
membered heterocycle 146 which after base catalysed cyclisation and desilyation 
yielded the natural product 148. The alternative approach was to facilitate the base 
catalysed cyclisationldesilyation first to give the tetracycIe 147 and then follow that 
with a 7-endo-trig radical cyclisation to again yield the natural product lennoxarriine 
148. This synthetic effort shows the flexibility of enamides as radical acceptors in 
synthesis. There have been many other natural product synthesis using similar 
methodology.73.91 
42 
OMe 
MeO 
H 0 
O ~ N N .. < < 1# 0 0 OMe o Br II OMe 
SiMe3 
145 146 
IiV ii. iii I 
MeO OMe 
0 
0 < 0 OMe .. 
O ~ N N< 1# OMe o Br 
147 148 
Reagellts: i. BU3SnH. AIBN. C6H6. SO·C; ii. t-BuOK. 
THF; iii. TBAF. THF; iv. K2C03. MeOH. 
Scheme 35 
As well as the use of enamides in natural product synthesis there have been many 
methodology orientated investigations into their synthetic potential. Ikeda and co-
workers demonstrated the use of enamides as radical acceptors in 1991 when they 
investigated the cyclisation of various systems based on the enamide radical 149.92a 
For example, the a-chloroenamides 150a and 150b, when reacted under standard 
radical generating conditions gave a varying mixture of products (Scheme 36). The 
6,6 ring system 150a gave the a-amidyl radical 151a which underwent 4-exo-trig 
cyclisation to give the ~ - l a c t a m m 152a in 50 % yield. None of the product 153a from 
the 5-endo-trig cyclisation was isolated, but there was some of the reduced product 
154a (32 %). In contrast the 6,7 ring system 150b gave a very different mixture of 
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products. The corresponding radical 151b cyclised in a 5-endo-trig manor to yield 41 
% of the y-Iactam 153b, with none of the p-Iactam 152b isolated. Again there was 
some of the reduced starting material 154b (20 %) resulting from direct quenching of 
the radical 151b. Using molecular modelling in an attempt to explain these results 
Ikeda postulated that the p-orbital of the intermediate radical 155 overlapped with the 
neighbouring aromatic Tt-orbitals stabilising the system. However, in the intermediate 
156 the p- and Tt-orbitals were perpendicular resulting in the formation of the 
observed 6,7,5 ring system 153b. 
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Ikeda then used this methodology to generate the perhydroerythrinane skeleton 159 in 
a tandem radical reaction from the a-chloroenamide 157.92c Generation of the radical 
species 158 followed by 5-endo-trig and then 6-endo-trig cyclisations gave the 
tetracyclic radical 160 which was quenched exclusively from the ~ - f a c e e to give the 
perhydroerythrinane skeleton 159 in 44 % yield (Scheme 37). Also isolated was the 
product resulting from the reduction of the intermediate radical 158 (4 %) and the 
monocyclised product in 9 % yield. 
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Reagents; i. BU3SnH. AIBN, C6HSMe. retlux. 
Scheme 37 
45 
As part of their studies into enamides as radical acceptors, Beckwith and co-workers 
employed an imaginative approach to the generation of tertiary radicals for 5-exo-trig 
cycIisation onto enamides.93b Treatment of the bromobenzene 161 with tributyltin 
hydride gave the aryl radical 162. Then, 1,5 hydrogen abstraction generated the 
intermediate tertiary radical 165 which cyclised onto the enamide double bond to 
yield the pyrrolidinone 163 (Scheme 38). 
Br (' 
&x )III 
161 
y>=o 
N 
Ph 
163 
....... 1--- y>=o ....... 1---
~ h h
164 
Reagellts: i. BU3SnH. AIBN. C6H6. 80·C. 
Scheme 38 
165 
Goodall and Parsons investigated methodology for the synthesis pyroglutamates.94 
For example, taking the dichloro substituted enamide 166 and treating this with 2.2 
equivalents of tributyltin hydride, in benzene, with catalytic AIBN they were able to 
generate the radical 167 which underwent 5-elldo-trig cyclisation to give the 
captodative radical 169. Quenching of the radical 169 followed by a radical reduction 
of the remaining chloride then gave the pyroglutamate 168 in 70 % yield (Scheme 
39). 
46 
166 
O ~ C 0 2 M e e ~ " ' f . - - - -
Bn 
168 
167 
CI ! 
O ~ C 0 2 M e e
Bn 
169 
Reagellfs: i. BU3SnH. AIBN. C6H6. So·e. 
Scheme 39 
47 
1.4 ACYL RADICALS 
1.4.1 History 
Acyl radicals are centred on the carbon of a carbonyl group and it has become 
apparent that this structure imparts different reactive properties upon them when 
compared with alkyl radicals. Acyl radicals generated from aldehydes by reaction 
with peroxides and by photochemistry were used in addition reactions to double 
bonds by Kharasch95 and Patrick96 as early as 1948. Tributyltin hydride reactions 
with acyl chlorides were identified in 1966 by Kuivila and he proposed that they 
proceeded via a radical mechanism.97 However, it was not until 1972 that Cekovic 
used this methodology to synthesise cycIohexanones.98 Taking 5-hexenoyl chloride 
170 and generating the acyl radical 171, he isolated cycIochexanone in 36 % yield, 
after an unprecedented 6-elldo-trig cyclisation onto the double bond (Scheme 40). 
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Since the ground breaking work of Cekovic there have been many methods devised 
for the formation of acyl radicals from a variety of precursors. The use of acyl 
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selenium, germanium and tellurium compounds has been well documented,99 as well 
as acyl xanthates lOO and acyl colbalts. 101 
1.4.2 Generation of Acyl Radicals 
During the development and utilisation of acyl radicals in synthesis many techniques 
have been used to generate them. The initial generation methods of aldehyde and 
acid chloride homolysis soon went out of vogue when new milder techniques were 
developed. In 1980, Pfenninger and co-workers identified a radical induced 
decarbonylation from a selenyl ester precursor. 102 Taking the tetracyclic compound 
172 and treating it with tributyltin hydride they isolated the decarbonylated product 
173 along with the expected aldehyde 174 in its hemiacetal form (Scheme 41). In a 
subsequent investigation into the effect of solvent and temperature on this reaction the 
authors found that increasing the temperature caused a decrease in the yield of the 
hemiacetal product 174.103 Despite this early investigation into the use of selenyl 
esters as precursors to acyl radicals, it was not until 1988 that Boger and Mathvink 
started synthetic work with selenyl esters. Since then they have become the group of 
choice for the generation of acyl radicals under mild conditions.99.I04 
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Barton and co-workers initiated the use of acyl xanthates as precursors to acyl 
radicals for decarbonylation reactions. lOS However, Zard and co-workers have 
applied this methodology in intramolecular cyclisation reactions. 100 Thus, exposing 
the acyl xanthate precursor 175 to ultraviolet light formed the carbon and sulfur 
centred radicals 176 and 177, respectively. Cyclisation of 176 and trapping of the 
resulting radical 179 by the sulfur radical 177 gave the chromanone 178 in 70 % yield 
(Scheme 42). 
"JL)'OEt U O ~ ~ .. + 
175 176 177 
6-exo-trig 
Reagellts: i, hv, C6HSMe, reflux. 
Scheme 42 
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Pattenden and co-workers have used acyIcobalt salophens for the addition of acyl 
radicals to activated carbon-carbon double bonds in the synthesis of enones and 
functionalised ring systems. 101 For example, exposing the acylcobalt salophen 180 to 
ultraviolet light generated an acyl radical which underwent a 5-exo-trig cyclisation. 
Trapping of the intermediate radical 181 with cobalt followed by dehydrocobaltation 
gave the five membered ring 182 (Scheme 43). 
o 
~ ~Co(salophen)py ~ P h h
o 6-'Ph .. .. ~ P h h
180 181 182 
Reagellts: i. hv. CH2Cl2. reflux. 
Scheme 43 
Acyl tellurides have recently been used for the generation of acyl radicals and 
employed in the synthesis of bicyclic molecules by Crich and co-workers. 106 Using a 
system analogous to that described by Zard (Scheme 42),100 Crich et al. exposed the 
telluryl ester 183 to ultraviolet light which resulted in cyclisation via the two radicals 
176 and 179 (Scheme 42) to give the bicyclic compound 184 in 80 % yield (Scheme 
44). A number of other systems such as thioesters, I 07 and acyl germanes 108 have 
been employed in the generation of acyl radicals but by far the majority of synthetic 
work has used selenyl esters as precursors in reductive cyclisations with tributyltin 
hydride. 
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1.4.3 5-Exo versus 6-endo Cyclisation 
During the course of the many investigations into the synthesis of cyclic compounds 
with acyl radicals it has emerged that they have a synthetically useful tendency to 
favour 6-endo cyclisations over the usually preferred 5-exo cycIisations,l09 This was 
first highlighted in the work of Cekovic (Scheme 40) and reinvestigated by the group 
of Walsh in 1980. 110 A detailed study of the effects of temperature, sol vent and 
concentration highlighted a number of different products from the reaction of the 5-
hexenoyl radical 171 that Cekovic had not isolated. Walsh showed a different 1:5 
ratio of cyclohexanone to 2-methylcyclopentanone in refluxing benzene (Scheme 45) 
when compared to Cekovic's results. Interestingly, they did not isolate any of the 
aldehyde 186 resulting from direct reduction of the acid chloride but found that this 
compound reacted with the acyl radical 171 to form the ester 188 (Scheme 46). Later, 
a study by Penn and Liu found similar results from the photo induced homolysis of 2-
naphthyl thioesters giving a similar distribution of products. I I I 
c ~ ~ .. Q 6-elldo-tri¥.,. Q. 0 0 0 .. Q o 
170 171 185 
reduction 1 ~ n B B
~ ~ 9--. 0 0 ~ 9 - -o 
186 187 
Reagents: i. BU3SnH. AIBN. C6H6• reflux. 
Scheme 45 
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Even though the amount of 6-elldo-trig cyclisation observed by Walsh was small, and 
did not compare to the ratios claimed by Cekovic, it was unusual when compared to 
the alkyl radical cyclisation of the same system. Beckwith's study of this reaction 
showed that the alkyl radical 181 underwent preferential 5-exo-trig cyclisation to give 
a 98:2 ratio of methylcyclopentane and cyclohexane (Scheme 47). I09b 
189 98% 2% 
Scheme 47 
These initial observations sparked a lot of research into the mode of the 6-elldo-trig 
cyclisation. In 1990, Boger and Mathvink used acyl radical intermediates in the 
synthesis of 6/5 and 6/6 ring systems and concurrently investigated the mechanism of 
these radical cyclisations. 1l2 The initial cyclisation was directed exclusively in the 6-
endo-trig mode by substitution of a methyl group on the carbon-carbon double bond. 
They suggested that this cyclisation mode resulted from kinetic deceleration of the 5-
exo-trig cyclisation and kinetic acceleration of the 6-endo-trig mode by steric factors. 
Thus, for example, a solution of the ene/yne selenyl esters 1908 and 190b in refluxing 
benzene gave the acyl radicals 1918 and 191b respectively. after syringe pump 
addition of tributyltin hydride and AIBN over one hour. These radicals 1918 and 
191b underwent initial 6-endo-trig cyclisation followed by a 5-exo-dig process to give 
the bicycle 1928, as a single diastereoisomer in 77 % yield. or a 6-exo-dig cyclisation 
to give 192b, as a 58:42 mixture of cis:trans isomers in 82 % yield (Scheme 48). 
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In an attempt to explain the mode of radical cyclisation the authors synthesised 
precursors to some of the potential intermediate radicals from this pathway.1l3 Thus, 
the radical 191 could undergo a direct 6-endo-trig cyclisation (path a) to the cyclic 
product 193. It is also possible for 191 to undergo a 5-exo-trig cyclisation to give 194 
(path b), followed by a 3-exo-trig cyclisation to give 195 and a subsequent ring 
expansion reaction to 193 (Scheme 49). 
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They found that generation of the radical 194a from the corresponding bromide 196a 
resulted in the formation of the bicycIic compound 192a. However, in a related series 
using 196b as starting material none of the bicycle 192b was isolated, though the 
authors did not say what the product of this reaction was (Scheme 50). From this 
significant result they concluded that even though the ring expansion route (Scheme 
49) was a possible mechanism for the cyclisation of the radical it was not the route by 
which the cyclisation occurred, implying that direct 6-endo-trig cyclisation was the 
pathway that these reactions followed. erich and co-workers have also hypothesised 
that a ring expansion pathway is a possible route for 7-elldo-trig cyclisations and after 
a through investigation with a number of substrates they concluded that the mode of 
cyclisation was a result of a subtle interplay of conformation effects and the 
reversibility of the ring c1osure. 114 
Ph 
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Ph 
o 
194a;n=1 
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There have been some recent investigations into this cyclisation pathway using ab 
illitio studies of the reactions involved in the transformation of radical 194 to 193 via 
the two possible intermediates 191 and 195 (Scheme 49).115 These studies used a 
simplified model and demonstrated that the reaction of 194 to 191 was unfavourable 
when compared to the reaction 194 to 195. However, they did not address the issue 
of whether the initial cyclisation 191 to 194 underwent a preferred 6-endo-trig or 5-
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exo-trig cyclisation. Also, the effects of substitution patterns used by synthetic 
chemists in these reactions were not explored though these studies are apparently 
being performed. From these various investigations it seemed likely that 5-methyl 
substituted 5-hexenoyl radicals cyclise in a direct 6-endo-trig mode. It has become 
apparent that the reaction would follow the ring expansion mechanism rather than 
reverse if an initial 5-exo-trig cyclisation occurred. 
1.4.4 Synthetic Applications of Acyl Radicals 
Crich and co-workers have investigated the synthesis of (+)-1a,25-dihydroxyvitamin 
D3 and initially used a stereochemically controlled acyl radical mediated cyclisation 
for the construction of the A-ring. However they found that the starting materials 
were difficult to synthesise and turned to a different approach.116 
!"fost of the work in the synthetic exploitation of these results in cascade reactions has 
been left to the group of Pattenden. They performed extensive studies in this area as 
part of a synthetic effort towards a steroid nucleus using a cascade reaction. I 17 Initial 
studies highlighted the effect of substitution patterns on the mode of cyclisation that 
the acyl radical prefers. Substituted 5-hexenyl acyl radicals undergo 6-endo and 5-
exo cyclisation in varying ratios depending on the substituting group and its position 
in the molecule. For example phenyl 5-phenyhex-5-enselenoate (197) undergoes 
exclusive 6-elldo-trig cyclisation to yield the 3-phenylcyclohexan-1-one (198). 
However, if the double bond is substituted in the C-6 position such as in the selenyl 
ester 199 then a 3:2 ratio of the 6 and 5 membered rings 200 and 201 are produced 
(Scheme 51). 
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This observation was then used in the synthesis of a steroid ring system 204 from the 
tetraene selenyl ester 202 in 60-80 % yield (Scheme 52). The reaction involved four 
consecutive 6-elldo-trig cyclisations from the acyl radical 203 to give the alkyl radical 
205. It has been proposed that the intermediate 203 adopts a highly ordered transition 
state leading to the isolation of just one diastereoisomer from this reaction. Other 
carbocyclic steroid ring systems were then synthesised using the same 
methodology. I 17 
This strategy has been employed in the first total synthesis of the marine sponge 
diterpene spongian-16-one 208 isolated from Dictyodendrilla cavemosa.11 8 Thus, 
generation of the acyl radical intermediate 207, from the selenyl ester 206, followed 
by serial 6-endo-trig cyclisations lead to the ketone 209 in 65 % yield. Subsequent 
functional group manipulations gave spongian-16-one 208 in three steps (Scheme 53). 
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Recently, this strategy has been further elaborated for use as part of a cascade process 
followed by a macrocyclisation/transannulation reaction sequence for the synthesis of 
an unnatural steroid isomer 212.119 Thus, the cyc1opropane-triene-selenyl ester 210 
when treated with tributyltin hydride under standard conditions generated the acyl 
radical 211. This radical underwent two 6-endo-trig cyclisations and a cyclopropane 
ring opening to give the alkyl radical 213. A 9-endo-trig macrocyclisation followed 
by a transannulation gave the cis, anti, cis, anti, cis steroid 212 in 45 % yield (Scheme 
54). The stereochemistry of this product was confirmed by X-ray analysis of the 4-
hydroxy derivative of 212. 
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212 
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... 
.. 
transannulation 
211 
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Reagenrs: i. BU3SnH. AIBN. ~ H 6 . . reflux. 
Scheme S4 
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2. DISCUSSION 
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2.1 INTRODUCTION 
Following the successful application of acyl radical cascade reactions to the "pseudo 
biomimetic" synthesis of carbocyclic steroids and related natural products,117-119 we 
aimed to synthesise azasteroids using this methodology.120 As we have highlighted 
earlier in Section 1.2 there have been many syntheses of azasteroids. Hitherto, work 
in this area has relied largely on the degradation of conveniently available steroids 
followed by reconstruction with simultaneous introduction of nitrogen functionality.27 
Therefore, application of acyl radical cascade reactions to the synthesis of nitrogen 
containing ring systems, in the form of azasteroids, opens up a complementary 
approach to these novel and biologically interesting molecules. 
2.2 ACYL RADICALS IN SYNTHESIS 
For the synthetic application of radicals to be successful a number of criteria have to 
be met. Thus, the radical has to be generated under mild conditions by homolytic 
cleavage of a suitable functional group, without interfering with other sensitive 
functional groups in the molecule. Then, reaction of this radical with the desired 
electrophore has to be competitive when compared to undesired side reactions. 
Finally, in the reaction sequence the resulting radical must quench with a hydrogen 
donating agent. We discussed earlier in Section 1.4 that most acyl radicals are 
currently generated from a selenyl ester in refluxing benzene by reaction with 
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tributyltin radical 215 which in tum is generated by reaction with the radical 214 
produced from decomposition of AIBN. As we used this ·system in our synthetic 
approach to azasteroids, only effects relating to it will be discussed here (Scheme 55). 
~ N = N N CN \ .. NC'Co + N2 
NC Y I 
214 
\ 
+ NC1-H NC'Co + BU3SnH .. BU3Sn° I 
214 215 216 
Scheme 55 
The tributyltin radical 215 then propagates the sequence by homolytic cleavage of the 
carbon-selenium bond in the precursor 217 leading to the formation of the acyl radical 
218 together with the stable tin-selenium by-product 219. The acyl radical 218 then 
goes on to perform the synthetic transformations such as addition to the carbon-
carbon double bond 220 which results in carbon-carbon bond formation and 
generation of the radical 221. At the end of the reaction sequence the carbon centred 
radical 221 abstracts hydrogen from tributyltin hydride yielding the product 222 and 
regenerating tributyltin radical 215 which re-enters the cycle as the radical propagator 
(Scheme 56). 
The reaction is terminated either by dimerisation of the carbon centred radicals 218 
and 221 though these are not common, or by dimerisation of the tributyltin radical 
215 to give hexabutylditin 223 (Scheme 57). Diphenyl diselenide is also formed in 
small quantities during these reaction sequences. 
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For the synthetic transformations to occur the lifetime of the intermediate radicals 
such as 218 and 221 have to be as long as possible. Therefore, to minimise side 
reactions high dilution conditions are employed to lower the concentration of radicals 
in the solution. However, this method is ineffective for the cascade synthesis of 
steroids in which sequences of three or four cyclisations are involved. Syringe pump 
addition of a solution of tributyltin hydride to the reaction over a number of hours has 
been used to keep the concentration of both tributyltin hydride and other radicals 
down. This methodology has resulted in the successful synthesis of a number of 
steroid systems (Schemes 52_54).117 0 119 
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2.3 CASCADE SYNTHESIS OF AZASTEROIDS 
Approaches to azasteroids from linear molecules using acyl radical cascade 
cyclisations can give two different electrophore structures. To generate ring junction 
azasteroids a suitably positioned imine has to be present in the radical precursor. To 
synthesise azasteroids where nitrogen is in the body of the ring then an en amine or 
similar electrophore has to be present in the radical precursor. 
2.4 IMINE PRECURSORS 
To synthesise azasteroids with nitrogen at the ring junction it is necessary for the 
precursor to contain an imine electrophore. For example, the 8 and 9-azasteroids 224 
and 230 can be disconnected to the imine containing selenyl esters 225 and 231 
respectively. In the cascade sequence for the synthesis of 224 the carbon centred 
radical 227 has to cyclise onto the carbon of the imine giving the aminyl radical 226, 
which in turn has to cyclise further to give the azasteroid 224 (Scheme 58). The 
retrosynthesis of 8-azasteroids is analogous to the disconnection for the 10 and 13-
azasteroids 228 and 229, when relating to the sequence of cyclisation reactions. 
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The 9-azasteroid 230 is analogous to 5, 14 and 17-azasteroids 234, 235 and 236 
respectively, when considering the type of radical cascade reaction required in their 
synthesis. In can be envisaged that the precursor 231, upon treatment with tributyltin 
hydride and AIBN, gives the corresponding acyl radical which cyclises giving the 
tertiary carbon centred radical 233. This, in turn would have to cyclise onto the 
nitrogen in the imine functionality resulting in the a-aminyl radical 232 which then 
gives the steroid 230 in the final cyclisations (Scheme 59). 
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2.4.1 Synthetic Studies 
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Initial synthetic studies were directed towards the nitrogen containing heterocycles 
237 and 239. Both targets are fused bicycles with nitrogen situated on the ring 
junction and these molecules were chosen as simplified models for azasteroids. 
Retrosynthetic analysis of 237 and 239 led to the imine containing precursors 238 and 
240 (Scheme 60). 
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Further disconnection of the precursors 238a and 238b led us to attempt the synthesis 
from the corresponding amine and aldehyde/ketone via a condensation protocol 
(Scheme 61). The ketone 241b was readily synthesised from commercially available 
5-oxohexanoic acid using diphenyl diselenide and tributylphosphine (Scheme 62). 
However, initial condensation reactions were attempted using aniline as we were 
unable to isolated the amine 242. These reactions proved unsuccessful and we were 
never able to isolate the precursor 243. We therefore investigated the alternative 
system 240. 
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Retrosynthetic analysis of the selenyl ester 240 gave the amine 244 and the aldehyde 
245 as partners in a condensation reaction (Scheme 63). The aldehyde 245 was 
readily synthesised in two steps using a literature procedure from 2-methylprop-2-en-
1-01 (Scheme 64).117 However, synthesis of the amine 244 could not be effected and 
the coupling reaction was never attempted. 
~ N H 2 2 V > PhSe I + 
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240 244 245 
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Reagents: i. Hg(02CCF3). ethyl vinyl ether; ii. 120·C. 24 h. 56%-2 steps. 
Scheme 64 
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The difficulties encountered in synthesising imines and their inherent instability led us 
to reconsider our approach to azasteroids.Disconnecting the steroidal core for 
azasteroids where nitrogen is not on the ring junction gives greater flexibility in the 
choice of electrophore and we therefore changed our approach to these systems. 
2.5 ENAMINE PRECURSORS 
Disconnection of 6 and 7-azasteroids 248 and 255 gives the enamine containing 
selenyl esters 249 and 256. Thus, synthesis of the 6-azasteroid 248 involves the 
cyclisation of the carbon centred radical 251 onto the carbon a to the nitrogen in the 
enamine and results in the formation of the ~ - a m i n y l l radical 250, which could 
continue the cascade to give the steroid 248 (Scheme 65). This cyclisation protocol is 
analogous to the mode of cyclisation required to form the 11, 15 and 16-azasteroids 
252,253 and 254, respectively. 
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For the 7-aza system 255 the cyclisation from the carbon centred radical 258 would be 
required to react with the carbon ~ ~ to nitrogen resulting in the formation of the u-
aminyl radical 257 which could cascade further to give the steroid 255 (Scheme 66). 
This protocol is analogous to the cyclisations required to give 1 and 12-azasteroids 
259 and 260. With these different approaches in mind we started work on the 
synthesis of azasteroids using acyl radical cascades. 
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2.6 CYCLOHEXENYL ENAMIDE PRECURSORS 
Imines and enamines such as 240 and 249 (R=alkyl) are inherently unstable to 
hydrolysis, difficult to synthesis, isolate and characterise. We therefore turned our 
attention to more stable nitrogen containing functional groups for cascade reactions. 
Looking at synthetic pathways to the tricyclic system 261, as a simplified model for 
an azasteroid, we considered a strategy that involved disconnecting to the enamide 
containing precursor 262. We chose the enamide functional group as it is stable to 
hydrolysis and its use in radical reactions has been well documented by other 
researchers.90-94 This strategy involved two 6-endo-trig cyclisations from the acyl 
radical 264, terminating with quenching of the a-aminyl radical 263 to give the 
tricycle 261 (Scheme 67). 
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2.6.1 Model Studies 
Model studies were performed on the enamide 265·so that the stability of the system 
present in 262 towards hydrolysis and selenyl ester formation could be tested. Also 
an examination of the conformation of this functional group using n.m.r. experiments 
was performed. The enamide 265 was synthesised in one step using the methodology 
developed by Ikeda and co-workers in their studies into the radical reactions of 
enamides.92a Condensation of cyclohexanone and l-aminoprop-2-ene in a sealed tube 
followed by acylation using acetyl chloride resulted in the isolation of the enamide 
265 in 52 % yield (Scheme 68). 
.. Q LNAC 
Reagellts: i. C6HSMe. sealed tube. lOO'C; 
AcCl. Et3N. DMAP. C6HSMe. O·C. 52%. 
Scheme 68 
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Using parallel reactions we were able to test the functional group present in 265 
whilst synthesising both the acid and the selenyl ester required in the final synthetic 
steps towards the precursor 262. Both the enamide 265 and methyl hex-5-enoate were 
submitted to ester hydrolysis conditions, viz: LiOH, THF, H20, and after complete 
hydrolysis of methyl hex-5-enoate to hex-5-enoic acid we were able to isolate the 
enamide 265 in near quantitative yield. Subsequently we were able to show that the 
enamide 265 was stable to the conditions that we planned to use for the formation of 
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our selenyl ester by using the same strategy. Hex-5-enoic acid was converted into the 
selenyl ester 266 in the presence of the enamide 265 using tributylphosphine and 
diphenyl diselenide (Scheme 69). 
265 265 
266 265 
Reagellts: i, LiOH. THF, H20, rt; ii, Ph2Se2, BU3P, C6H6, rt. 
Scheme 69 
A conformational analysis of the enamide moiety present in the selenyl ester 262 was 
performed using extensive 2D n.m.r. techniques on the model system 265. Studies 
were carried out on this system because both the 1 H and the l3C n.m.r. spectra were 
fully assignable from IH-IH COSY and IH-13C COSY interactions. This leads to a 
simplification in nOe analysis that could not be achieved with the precursor 262. 
A 500 MHz NOESY experiment along with variable temperature experiments were 
performed to identify the lowest energy conformations of this system. Three through 
space nOes were clearly defined in the NOESY experiment. These correspond to the 
interactions b, between the protons in the 1 and 2' positions, c, between the protons in 
the 2' and 2" positions, and d between the protons in the 1 and 6' positions in 
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conformers 267 and 268. The interaction a was not detectable due to the similar 
chemical shift of the two signals involved. No nOe was seen for the interaction e 
between the protons in the 2" and 112/3 positions of the allyl functionality from 
conformations 269 and 270. Variable t e m p e r a t u n ~ ~ n.m.r., _5°C to 80°C, showed no 
change in the 1 H spectra and titrating the sample with C6D6, along with other solvent 
changes, did not lead to a splitting of the signals required to visualise the nOe 
interaction a. 
These collected data imply that the two conformations 267 and 268 are the most 
stable with an undetectable population of the conformations 269 and 270. This relates 
well to electronic arguments which point to the form 267 having increased through 
bond conjugation, with the five bonds of the enamide system as the linear "W" 
conformation 271. The enamides 268 and 270 exist as the more bent "sickle" form 
272, thus breaking down conjugation. The enamide 269 is in a "U" conformation 273 
with low through bond conjugation. There appears to be relatively free rotation about 
the N-cyclohexenyl bond and very limited rotation about the N-acetyl bond. Rotation 
about the N-allyl bond appears to be unrestricted though analysis of this portion of the 
molecule is limited. 121 
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2.6.2 Tricycle Synthesis 
After these initial studies we started the synthesis of the precursor 262. Disconnection 
across the cyclohexenyl-nitrogen bond split the molecule into two halves (Scheme 
, 70). This approach to the molecule gave cyclohexanone as the right hand side. 
However, in more complex systems where we would have to construct the right hand 
side it was envisaged that this disconnection would result in a convergent synthesis 
for any precursor. The left hand side could be seen to be a suitably oxidised amine 
274a which could be synthesised in a protected form 274b. From the model studies 
that we had undertaken, we knew that the use of a methyl ester in this portion was 
appropriate. Therefore, our first synthetic target was the protected E-amine 274b. 
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The route of choice was via a Wadsworth-Emmons coupling reaction between 5-
oxohexanoic acid and triethylphosphonoacetate to give the ester acid 275 as a 2:1 
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mixture of Z:E isomers. The geometry of the carbon-carbon double bond was 
assigned through comparison of the 1 Hand 13C n.m.r: spectra with known 
compounds of defined geometry.217-219 The first double bond has been shown by 
others to have little effect on the mode and stereochemistry of the cyclisation 
reactions and so it was decided to carry the mixture of isomers through the synthetic 
route.217-219 Selective reduction of the ester to the hydroxy acid 276 using DIBAL-H 
and subsequent conversion of the acid 276 to the hydroxy ester 277 gave the carbon 
skeleton and oxidation state required in our amine portion. However, the conversion 
of the alcohol 277 into the corresponding amine 274b via various intermediates failed 
in the presence of the methyl ester and so other synthetic routes were investigated 
(Scheme 71). 
H O ~ ~ ~ O E t t ii rcOH .. .. HO I HO I 0 o 0 0 
275 276 
iii 1 
rcNHR .. 7 ~ ~ rcOH Mea I MeO I 
a 0 
274b 277 
R=protecting group 
Reagellts: i. ( E t O h P O C H z C ~ E t . . NaH. THF. O·C. 96%; ii. DIBAL-H. 
CHzCI2. -78·C; iii. TMSCHN2. MeOH. C6H6. rt. 81 %-2 steps. 
Scheme 71 
Consequently, we were forced to perform a double reduction of both the ester and the 
acid present in 275 and carry the material through the amine formation stage as the 
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protected alcohol. Thus, starting from the Wandsworth-Emmons product 275, we 
were able to synthesise the alcohol 280 by activation of the acid to the carbonic 
anhydride 278 followed by in situ reduction with sodium borohydride. Protection of 
the hydroxy group in 280 yielded 279 and reduction"with DIBAL-H then gave the key 
intermediate alcohol 281 (Scheme 72). 
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Reagellts: i, i-Bu02CCI, Et3N, CH2CI2' rt; ii, NaBH4' MeOH, O·C 84%·2 steps; 
iii, TBDPSCl, Et3N, CH2CI2, rt, 100%; iv, DIBAL-H, CH2CI2, -78·C, 92%. 
Scheme 72 
78 
Introduction of the amine functionality into 281 required reagent 282. This was 
synthesised in quantitative yield from para-toluenesulfonyl isocyanate and tert-
butanol (Scheme 73) using the method of Weinreb,122 A Mitsunobu reaction on 281 
using the amine 282 gave the triprotected amine-dial 283 in nearly quantitative yield 
(99 %). Sequential deprotection first using sodium amalgam gave the Boe protected 
amine 285 and then using TBAF yielded the alcohol 284. Oxidation of this alcohol 
using Dess-Martin periodinane gave the aldehyde 286 which was further oxidised to 
the acid 287. Subsequent protection of 287 as the methyl ester with trimethylsilyl 
diazomethane to give our target 274b in 11 steps and 40 % overall yield (Scheme 74). 
282 
Reagellts: i, I-BuOH, rt, 100%. 
Scheme 73 
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MeOH, rt, 85%; iii, TBAF, TsOH, THF, rt, 100%; iv. Dess Martin, CH2CI2. rt. 
70%; v, NaClz04. K2HP04, 2-methyl-2-butene, H20. t-BuOH, rt; vi, TMSCHN2' 
C6H6, MeOH. rt. 92%-2 steps. 
Scheme 74 
With the protected amine 274b in hand, subsequent elaboration to the enamide 288 
proceeded smoothly via deprotection with TFA to give the amine salt, followed by 
80 
condensation with cycIohexanone and acylation of the intennediate imine to give the 
product 288. Hydrolysis of the ester in 288 generated the acid 289 which was used 
without further purification to synthesise the selenyl ester 262 (Scheme 75). These 
reactions worked well and we were able to isolate 262 in 35 % yield from the 
protected amine 274b. 
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274b 288 
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Reagents: i. TFA. rt; ii. Et3N. C6H6; cyclohexanone. molecular 
sieves. C6H6. rt; AcCl, Et3N. DMAP. C6H6. rtf 56%-2 steps; iii. 
LiOH. THF. H20. rt; iv. Ph2Se2. BU3P, C6H6. rtf 62%-2 steps. 
Scheme 75 
Following this synthetic route we were able to access enough of the selenyl ester 262 
to study the radical chemistry of this system in some depth. Treatment of the seJenyl 
ester 262 under radical generating conditions resulted in the formation of the reduced 
azaphenanthridine 261 in 65 % yield (Scheme 76). We used high dilution conditions 
and syringe pump addition to help prolong the life of the intermediate radicals in 
solution. After investigating a number of addition times we found that this optimised 
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yield was obtained from a two hour addition of a solution of 1.25 equivalents of 
tributyltin hydride and catalytic AIBN in degassed benzefle to a refluxing 5 mM 
solution of the selenyl ester 262 and AIBN in degassed benzene. After a further two 
hours at reflux t.l.e. showed that there' was rio starting material remaining. 
Purification using column chromatography allowed us to isolate the tricycle 261 in 65 
% yield as a single rotamer of one diastereoisomer (Scheme 76). This product was 
formed after the initial acyl radical 264 cyclised in a 6-endo-trig manner to give the 
tertiary alkyl radical 290. This radical 290 subsequently underwent 6-endo-trig 
eyclisation to form the a-amidyl radical 263, which in turn was quenched with 
tributyltin hydride, to yield the isolated product 261. 
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Scheme 76 
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Identification of the product followed from extensive analysis of one and two 
dimensional 500 MHz n.m.r. spectra. Initially from the 1 H n.m.r. spectra we were 
able to see that cyclisation had occurred and that we had isolated a tricyclic structure 
as there were no olefinic protons in the spectra. Analysis of the l3C n.m.r spectra 
showed us that there were two carbonyl carbons, one at 8 209 p.p.m. corresponding to 
a cyclic ketone and at 5 172 p.p.m. corresponding to the amide. In the aliphatic 
region of the I3C n.m.r. spectra there were 14 signals which, from the DEPT, we were 
able to assign as one quaternary centre, three CH, eight CH2 and two methyl groups. 
Analysing the different reaction pathways available to our system during the radical 
reaction we were able to show that the most likely routes to this pattern of carbons in 
the DEPT was either two sequential 6 - e l l d o - t ~ g g cyclisations or a 5-exo-trig followed 
by a 5-endo-trig cyclisation. Of these two, by far the most probable cyclisation 
pathway would be the tandem 6-endo-trig cyclisation. We were able to confirm the 6, 
6,6 angular fused structure by looking at the IH-IH and IH-l3C COSY n.m.r. spectra. 
From this it was possible to verify that the nitrogen was adjacent to both a CH at C-8 
(using steroid numbering) (5 3.37 p.p.m. in the IH n.m.r. spectra and 8 57.4 p.p.m. in 
the l3C n.m.r spectra) and a CH2 at C-6 (8 3.73 and 83.43 p.p.m. in the IH n.m.r. 
spectra and 8 40.1 p.p.m. in the l3C n.m.r. spectra) which was adjacent to the CH at 
C-5 (8 2.51 p.p.m. in the 1 H n.m.r. spectra and 8 57.1 p.p.m. in the l3C n.m.r. 
spectra). This pattern would not be possible in the 5 and 5,6 tricyclic molecule 
obtained from the other possible cyclisation pathway. With conclusive evidence that 
the 6, 6, 6 angular fused tricycle was the skeleton that we had generated from our 
studies we then attempted to assign the stereochemistry by comparing our n.m.r. 
results to those published in the literature. 111 Very little information could be 
obtained from the 1 H n.m.r. spectra as the signals are concentrated in the aliphatic 
region of the spectra between 82.5 and 80.5 p.p.m. and the coupling constants are 
masked. However, H-8 appeared as an apparent triple doublet with vicinal coupling 
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constants to H-9 and H-14(a) of 10.7 Hz and to H - 1 4 ( ~ ) ) of 2.8 Hz. Also, the protons 
at C-6 had vicinal couplings of 8.3 and 7.1 Hz to the proton' at C-5. These coupling 
constants are consistent with a slightly flattened chair, chair, chair conformation that 
we would expect for the trans, anti, trans stereochemistry. Using an analysis of the 
carbon spectra similar to the one employed by Patten den and co-workers in the initial 
study of carbocyclic steroids we were able to predict the expected spectra for the 
trans, anti, trans stereochemistry .117 This prediction was very similar to the actual 
spectra confirming our hypothesis that the compound we had isolated in 65 % yield 
, 
was the trans, anti, trans tricycle 261. 
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After one year following the completion of these studies we attempted to obtain a 
crystalline derivative of 261 as part of a model study into the stereochemistry of the 
tetracycle 296. However, when we reinvestigated the molecule we found that it had 
undergone transformation into two compounds. Chromatographic separation of the 
mixture allowed us to isolate the initial tricyclic system 261 along with a related 
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rotameric crystalline material 291.§ X-ray analysis confirmed its structure as the cis, 
anti, trans tricycle 291. Upon submitting this compound to basic conditions (NaOMe, 
MeOH, reflux) we were able to regenerate an equilibrium system of the two tricyclic 
compounds 261 and 291 which were separated by chromatography (Scheme 77). As 
this compound 291 was rotameric we were unable to perform the interesting 
comparison between the n.m.r. spectra of the two isomers. 
.. + 
291 261 291 
Reagellts: i, MeONa, MeOH. reflux. 
Scheme 77 
In an attempt to rationalise these findings we performed some molecular modelling 
(MM2 force field) on both systems and their two rotameric forms. The trans, anti, 
trans system, unsurprisingly, showed two chair, chair, chair conformations for the 
lowest energy forms of both rotamers 261 and 292. However, the rotameric forms 
were vastly different in energy at 18.1 kJmol- 1 for the isolated material 261 and 34.7 
kJmol- 1 for the unseen rotamer 292. For the cis, anti, trans material the molecular 
modelling studies showed that the crystalline material 291 had the lowest energy 
conformation at 18.9 kJmol- l . The structure of 291 from the molecular modelling 
was superimposable on the structure of 291 from the X-ray studies. The other 
rotameric form 293 had a very similar energy (21.4 kJmol- 1) and a twist boat, boat, 
chair conformation. These results explain the ability of the system (261-291) to 
§ We were unable to obtain a melting point on this material due to the unsuitable nature of the semi-
solid that was returned from the X-ray laboratory. 
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undergo epimerisation and the rotameric nature of the cis, anti, trans 291 system 
when compared to the trans, anti, trans system 261. 
261 292 
291 293 
During the course of these initial studies contemporaneous work was published by 
Sen and co-workers using cationic cascades to synthesise a very similar system to the 
phenanthredine 261. 123 Thus, the acetal protected E-aldehyde-enamide 294 cyclised 
when treated with iron (III) chloride in dichloromethane to yield the two tricycles 
295a and 295b in 55 % and 10 % yield respectively (Scheme 78). 
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Reagents: i, FeCI3.6H20, CH2CI2' rt. 
Scheme 78 
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2.6.3 Steroid Synthesis 
With the success of our initial studies towards the synthesis of the reduced 
phenanthridine 261 using a cyclohexenyl enamide as the terminating electrophore in a 
radical cascade, we undertook an investigation into the synthesis of a steroid system 
using similar methodology. Thus, disconnecting the 12-aza-D-homosteroid 296 
identified a radical cascade reaction from the selenyl ester 297. We thought that the 
acyl radical 299 could undergo three consecutive 6-endo-trig cyclisations to give the 
a-amidyl radical 298. Quenching of the radical 298 would yield the steroid 296 
(Scheme 79). 
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Scheme 79 
Retrosynthetic analysis of the selenyl ester 297 showed that the allyl amine 300 or its 
protected equivalent would be a key component for this synthesis (Scheme 80). The 
synthetic route that we had used for the synthesis of the precursor 262 was rather long 
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and we felt that a shorter route to these systems would be beneficial. We were aware 
of the work of Rollin and co-workers124 utilising a Mitsunobu reaction for the 
synthesis of allyl azides from allyl alcohols and we decided to use this methodology 
I • 
in the synthesis of our amine portion 300. Therefore, our initial target was the allyJic 
alcohol 304 and this was achieved in three steps. 
> 
297 300 
Scheme 80 
Thus, using the methodology of Nakamara and co-workers,125 we were able to 
synthesise the allylic chloride 302 from geranyl acetate 301. Copper catalysed 
addi tion of the zinc homoenolate 303 yielded the allylic acetate 305 as a 2: 1 mixture 
of E:Z isomers at the C-5 double bond. Again the geometry of the C-5 double bond 
was assigned by comparison with the spectra from known compounds along with the 
results from Nakamara and co-workers.l 25 Potassium cyanide mediated 
transesterification in ethanol gave the key allylic alcohol 304 in 73 % overall yield 
(Scheme 81). 
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Scheme 81 
Formation of the precursor 297 followed the methodology that Rollin et al. 123 had 
developed in the synthesis of allylic azides. Thus, from the alcohol 304 we 
introduced the azide via a Mitsunobu reaction to yield 306. This relied on the use of a 
zinc azide-dipyridine complex as a source of azide. The use of zinc azide was said to 
suppress SN2' addition to allylic systems which is a major problem in the 
displacement of bromide with inorganic azides. Its use also removed the need to use 
highly toxic hydrazoic acid which has also been shown to undergo reactions with 
alcohols under Mitsunobu conditions. 126.127 
The 1 H n.m.r. spectra showed a terminal olefin in the molecule along with a 
broadened peak for the C-lO proton. This was consistent with a system that was in 
equilibrium with the SN2' addition product and the cis isomer of the double bond. 
Therefore, the azide 306 was isolated as a mixture of compounds. However, upon 
Staudinger reduction of the azide 306 with triphenylphosphine and subsequent 
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hydrolysis of the intermediate iminophosphorane only the amine 300 was isolated. 
None of the SN2' product 309 was seen. Analysis of the IHand 13C spectra showed 
the amine 300 now existed as a 2: 1 E:Z mixture at both C-5 and C-9 double bonds. 
The stereochemical scrambling that resulted ·from this reaction was most 
disappointing as it has been shown that the stereochemistry of the second double bond 
can affect the stereochemistry of the product from the radical reaction. 1l7-119 
304 
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Reagents: i. Zn(N3h.2py. DIAD. PPh3. C6HsMe. rt. 62%; ii. PPh3. THF; H20. 
THF. rt, 74%; iii. cyclohexanone. molecular sieves. C6H6; AcCI. lutidine. C6H6. 
rt. 43%; iv. LiOH. THF. H20. rt. 99%; v, N-PSP. BU3P, CH2CI2' -30'C. 80%. 
Scheme 82 
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The enamide formation proceeded smoothly to give the ester 307 which was 
subsequently hydrolysed to the acid 308. Conversion of the acid in 308 into the 
selenyl ester produced the precursor 297 in 8 steps from geranyl acetate (Scheme 82). 
The seJenyl ester 297 was subjected to a number of radical generating conditions in an 
attempt to optimise the cascade reaction. It was found that the highest yield (45 %) of 
the D-homo-12-azasteroid 296 resulted from syringe pump addition of a solution of 
tributyItin hydride (1.25 equivalents) and AIBN (catalytic) in degassed banzene over 
8 hours to a refluxing 3 mM solution of 297 in degassed benzene followed by a 
further 4 hours reflux (Scheme 83). The tetracycle 296 was obtained as a 4: 1 mixture 
of the trailS, anti, trailS, anti, trails diastereoisomer and another unidentified isomer. 
This product 296 resulted from three consecutive 6-endo-trig cyclisations from the 
acyl radical 299 terminating in the quenching of the a-amidyl radical 298 with 
tributyltin hydride. Also isolated from this reaction mixture was the monocyclised 
product 310 in 10 % yield resulting from just one 6-endo-trig cyclisation followed by 
quenching of the intermediate tertiary alkyl radical 311. 
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The mixture of stereoisomers isolated from this reaction made the assignment of the 
structure quite complex. In order to confirm the proposed trans, anti, trans, anti, 
trails stereochemistry we attempted to synthesis a derivative of 296 suitable for X-ray 
analysis. Thus, a diastereoselective sodium borohydride reduction of the ketone in 
296 resulted in the isolation of the alcohol 312. Subsequent derivatisation with 3,5-
dinitrobenzoyl chloride yielded the ester 313 (Scheme 84). The two isomers of this 
compound were separated by flash column chromatography. The major isomer was 
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isolated as a semi-solid but we were still unable to crystallise the material in order to 
obtain X-ray data. 
.. 
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o 
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Reagents: i, NaBH4' MeOH, Et20, rt, 99%; ii, 3,5-dinitrobenzoyl 
chloride, Et3N, DMAP, CH2CI2, rt, 61 %. 
Scheme 84 
However, with a single isomer in hand we were able to perform a similar n.m.r. study 
to the one used in the identification of 261. From all the data that we had obtained 
from the molecules 296,312 and 313 we were able to see that the product we had 
isolated had undergone three cyclisation reactions as there were no olefinic protons 
present. Using data mainly from the single isomer 313 for which we had obtained 
variable temperature IH and l3C n.m.r. spectra along with IH-IH COSY and HMQC 
data we were able to identify the structure of the molecule. In the high temperature 
spectra of 313 the protons at C-ll and C-13 showed very similar coupling constants 
and chemical shifts as the protons at C-6 and C-8 respectively, in the molecule 261. 
Using the HMQC spectra to assign carbons to the protons in this region of the spectra 
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we were able to show that the carbon signals were also similar to those in 261. So the 
CH at C-13 was at 0 3.34 p.p.m. in the IH n.m.r. spectra and at 0 57.8 p.p.m. in the 
l3C n.m.r. spectra (0 3.37 p.p.m. in the IH n.m.r. spectra and 057.4 p.p.m. in the l3C 
n.m.r. spectra of 261). It appeared as an apparent trIple doublet with vicinal coupling 
constants to H-14 and H-17a(a) of 10.7 Hz and to H - 1 7 a ( ~ ) ) of 2.8 Hz. The CH2 at C-
11 was at 0 3.54 and 0 3.40 p.p.m. in the IH n.m.r. spectra and at 0 40.7 p.p.m. in the 
l3C n.m.r. spectra (0 3.73 and 0 3.43 p.p.m. in the IH n.m.r. spectra and 0 40.1 p.p.m. 
in the l3C n.m.r. spectra of 261). It appeared as two double doublets with couplings 
of 13.3 Hz and 9.9 Hz at 0 3.54 p.p.m. and 13.3 Hz and 9.4 Hz at 0 3.40 p.p.m. These 
splitting patterns are very similar to the B, C ring junction in 261. This information 
showed us that the molecule 313 contained at least three six membered rings with a 
trans, anti, trans stereochemistry. 
When we looked at the l3C and DEPT n.m.r. spectra for 313 we were able to see 6 C, 
7 CH, 10 CH2 and 3 CH3. As we already knew that there were three six membered 
rings in the molecule and as this pattern of carbons could only correspond to either a 
6, 6, 6, 6 molecule or a 5, 5, 6, 6 molecule we knew that the structure we had 
originally isolated was the steroid 296. The chemical shift of the ketone signal from 
the l3C n.m.r. spectra of 296 at 0212.2 p.p.m. also pointed towards a 6 membered A 
ring. Chemically the 6, 6, 6, 6 structure was far more likely as the initial acyl radical 
has been shown to prefer a 6-endo-trig cyclisation pathway. We were able to assign 
the A, B ring junction as trans from the position of the methyl group in the l3C n.m.r. 
spectra at 0 15.3 p.p.m. This chemical shift is indicative of a trans ring junction and 
very similar to previous studies in our work. From this collaborated evidence we 
were able to confidently assign the structure 296 as the trans, anti, trans, anti, trans 
12-aza-D-homosteroid shown. We did not perform the same calculations to predict 
the carbon spectra of 296 as we had for 261 because we felt that the comparison of 
these two spectra gave us a better insight into the structure and stereochemistry of the 
molecule. 
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2.7 LINEAR ENAMIDES 
Cyclohexenyl enamides have now been shown to be very useful electrophores in 
azasteroid synthesis by radical cascades. In an attempt to further investigate the 
behaviour of enamides in radical cascades we started looking at linear systems. Initial 
interest was in the synthesis of the tricyclic system 314 via three consecutive 6-endo-
trig processes from the selenyl ester 317 with the acyl radical 315 as a reactive 
intermediate (Scheme 85). Disconnection of the precursor 317 led to the known 
ketone 318 and the amine 274b which had been synthesised previously (Scheme 86). 
However, we had used an 11 step route in the synthesis of the amine 274b and we felt 
that this could be improved by the use of the methodology employed in the synthesis 
of the amine 300. 
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Before attempts were made on the synthesis of this precursor 317 potential problems 
were identified with the regioselectivity of the formation of the enamide double bond. 
It was anticipated that the conditions used previously for this acylation step (i.e. acetyl 
chloride, Et3N, DMAP, C6H6, rt) would generate mainly the undesired, kinetic 
product 316 and not the required thermodynamic product 317. To test this hypothesis 
a model system was developed, using the condensation of l-aminoprop-2-ene and 
heptan-2-one followed by the in situ acylation of the resulting imine 319 under 
standard conditions. It was hoped that if a problem was found it would be possible to 
optimise conditions in the model system and then apply these in the synthesis of the 
required enamide 317. When this study was performed, acylation of the imine 319, 
resulted in the isolation of the two regioisomers 320 and 321 in a ratio of 24:76 
respectively, and an overall yield of 62 % (Scheme 87). Fortuitously, the 
regioisomers were readily separable by flash column chromatography and full 
characterisation and structural identification was possible by analysis of their IH and 
l3C n.m.r. spectra. 
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Scheme 87 
The reaction was investigated at different temperatures to try and increase the yield of 
the required thermodynamic enamide 320 (Table 1). The ratios of 320 to 321 were 
calculated from the 1 H n.m.r. of the crude reaction mixture and the yields are the 
combined yields of the two products after purification by flash column 
chromatography. The most favourable ratio was obtained by performing the acylation 
in refluxing xylene. However, the reduced yield meant that the best conditions for the 
synthesis of 320 was the reaction carried out in refluxing toluene. The isolatable yield 
of the enamide 320 from this reaction was 39 %. With these optimised conditions in 
place we investigated the synthesis of the precursor 317. 
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Temperature Solvent Ratio 320:321 Overall yield Yield of 320 
25°C Benzene 1:3 62 15 
42°C Benzene 3:71 65 18 
60°C Benzene 1:2 64 20 
110°C Toluene 3:2 65 39 
142°C Xylene 2:1 52 35 
Table 1 
The ketone portion 318 for the selenyl ester 317 was synthesised via a modified 
literature procedure in an overall yield of 49 % (Scheme 88).128 Thus, the known 
iodide 323, was prepared in two steps from 3-methyl-3-buten-l-ol, via the tosylate 
322. Alkylation of the anion of ethyl acetoacetate gave the {3-ketoester 324 which was 
decarboxylated, generating the required ketone 318. 
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Reagems: i, TsCI, py, rt, 75%; ii, NaI, acetone, reflux, 77%; 
iii, NaH, THF, rt; 323, rt, 84%; iv. 50% NaOH, reflux, 100%. 
Scheme 88 
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A modified version of the methodology employed in the synthesis of the amine 300 
was utilised for our new approach towards the protected amine 274b. Returning to 
the alcohol 277, we used Rollin and co-workers zinc azide mediated Mitsunobu 
reaction to install the nitrogen functionality into 'our system. 124 The Mitsunobu 
reaction proceeded smoothly in 67 % yield, affording a 7: 1 equilibrium mixture of the 
SN2 product 325 and the SN2' product 326, respectively. Subsequent reduction of the 
azide mixture 325 and 326 with triphenylphosphine and hydrolysis of the resulting 
iminophosphorane, followed by in situ Boc protection of the amine gave the product 
274b, in 97 % yield. The high isolated yield of 274b from this reaction suggests that 
the SN2' product 326 does not react with triphenylphosphine and that the system is in 
equilibrium. The product was isolated as a 2: 1 mixture of E:Z isomers after inversion 
of the C-5 the double bond (Scheme 89). The geometry of the double bond was 
assigned by comparison of the l3C n.m.r. spectra obtained from similar systems. This 
high yielding fi ve step route to the protected amine allowed us to access the large 
amounts of material required for our studies into the precursor 317 and its derivatives. 
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Scheme 89 
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We then applied our optimised conditions for the synthesis ofthe enamide 327 to the 
protected amine 274b and the ketone 318 (Scheme 90). The yields obtained for the 
1 • 
synthesis of the model system 320 could not be reproduced and only 5 % of the 
desired product 327 was isolated. Attempting the reaction at room temperature also 
resulted in low yields. 
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Scheme 90 
In order to investigate the problems associated with this synthetic route we attempted 
the synthesis of longer chain enamides as model systems. For example, condensation 
of geranyl amine 328 with the ketone 318 at room temperature resulted in the 
isolation of the enamides 329 and 330 in 31 % and 23 % yields, respectively (Scheme 
91). However, we were still unable to repeat this reaction on our amine 274b. 
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We also investigated the steric constraints of enamide formation by attempting the 
reaction with the ethyl ketone 334. The synthesis of 334 followed the same strategy 
that we had used for the methyl ketone 318 (Scheme 88). Firstly, ethyl 3-
oxopentanote 333 was prepared from ethyl acetoacetate via the tin chloride complex 
331.129 Using the same iodide 323 as that employed in the synthesis of the ketone 
318 we first alkylated ethyl 3-oxopentanote 333 to give the ~ - k e t o e s t e r r 332. 
Decarboxylation, as before, then gave us the required ethyl ketone 334 (Scheme 92). 
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Using the ketone 334 in enamide forming reactions with l-aminoprop-2-ene again 
gave low yield and an inseparable mixture of isomers in the product 335 (Scheme 93). 
We therefore changed our strategy to more stable intermediates in an attempt to obtain 
radical precursors in high yield. 
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Scheme 93 
2.8 STABILISED ENAMIDES 
After previous attempts to synthesise fully linear precursors containing nitrogen had 
failed, we considered the use of stabilised enamines such as the functional group 336. 
These groups overcome a number of problems that we had encountered in the 
synthetic attempts towards the precursor 317. There were no regioselectivity issues 
arising as only one regiochemical product could be formed during the synthesis. The 
stability of the intermediate imines formed during the condensation reaction would be 
higher than the intermediates from the synthesis of 327. Therefore, we felt that access 
to precursors for our radical reactions was possible. Looking at the 7-azaandrostane 
337 as our initial synthetic target, we disconnected this molecule to the selenyl ester 
338. This step involved three 6-elldo-trig cyclisations followed by a 5-exo-trig 
cyclisation from the acyl radical 340 to give the alkyl radical 341. Quenching of the 
radical 341 would yield a steroid which could be converted into 337 after 
decarboxylation (Scheme 94). We recognised that during the course of this cascade 
one of the intermediate steps involved the cyclisation of the captodative a-amidyl, a-
ester radical 339 in a 6-endo-trig manner. We felt that this step may be hindered due 
to the stability of this radical, but thought that if the cascade was halted at this stage 
we could regenerate a radical at the 8 position by a decarboxylation protocol. 
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2.8.1 Model Studies 
To test the stability of the functional group 336 in linear systems the model 343 was 
synthesised. Thus, 4-bromobutane was converted' to the a-ketoester 342 using the 
modified Grignard conditions developed by Weinstock and co-workers.130 The a-
ketoester 342 was then successfully condensed with l-aminoprop-2-ene and the 
intermediate imine was acylated using the methodology developed by Parsons et al.94 
This gave the enamide 343 in good overall yield as a 3:1 mixture of E:Z isomers 
about the newly formed double bond (Scheme 95). We were able to separate the 
major E isomer from this mixture and confirmed the stereochemistry using NOSEY 
studies. We tested the stability of the enamide 343 to hydrolysis and selenyl ester 
formation conditions using the technique applied to the synthesis of en amide 265 
(Scheme 69). Even though there was an ester present in 343 it was stable enough to 
withstand these reaction conditions resulting in near quantitative reisolation of 343 at 
the end of the study. 
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Reagellts: i, Mg, diethyl oxalate, THF, rt, 44%; ii. l-amino-prop-2-ene, 
molecular sieves, C6H6, rt; AcBr, Et2NPh, C6H6, rt, 77%. 
Scheme 95 
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In order to confirm that long chain analogues of the ester-enamide systems such as 
336 were also stable we synthesised the model 345. Following exactly the same 
methodology that we had used in the synthesis of the model 343 we were able to 
make the a-ketoester 344 from I-bromopent-4-ene, and successfully perform a 
condensation reaction with geranyl amine 328 to yield the enamide 345 in 73 %, as a 
1:1 mixture of E:Zisomers (Scheme 96). 
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Reagents: i. Mg. diethyl oxalate. THF. rt. 37%; ii, 328. 
molecular sieves. C6H6. rt; AcBr, Et2NPh. C6H6. rt' 73%. 
Scheme 96 
2.8.2 Bicycle Synthesis 
The methodology used in the synthesis of 345 was then applied to the selenyl ester 
338. Disconnection of this precursor gave the protected amine 274b for the left hand 
portion of the molecule and the a-ketoester 346 for the right hand portion. The 
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convergent nature of the synthetic plan used for the synthesis of the initial precursor 
262 was useful here due to the complex nature of both the left and right hand side in 
the selenyl ester 338 (Scheme 97). 
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With a convenient high yielding route to the protected amine 274b already established 
and the synthetic methodology for the synthesis of a-ketoesters explored we were 
confident that we would be able to access large quantities of both coupling 
components 274b and 346. For the synthesis of 346 we started from I-bromobut-3-
ene and followed a literature procedure for the synthesis of the intermediate alcohol 
348. 117 Thus, Grignard reaction of I-bromobut-3-ene with methacrolein gave the 
allylic alcohol 347 which was converted to the diene ester 349 using a Claisen 
rearrangement. Subsequent reduction of the ester 349, to the alcohol 348, and then 
conversion to the tosylate 350a followed by Finkelstein displacement gave the key 
bromide 350b. This was reacted using the modified Grignard conditions to yield the 
a-ketoester 346 in just 6 steps (Scheme 98). 
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Reagellts: i. Mg. THF. reflux. 60%; ii. (EtO}JCCH3' propinoic acid. 
reflux. 90%; iii. LiAIH4• EtzO. rt. 85%; iv. TsCl. pyridine. O·C. 80%; 
v. LiBr. acetone. reflux. 91%; vi. Mg. diethyl oxalate. THF. O·C. 52%. 
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With the a-ketoester 346 in hand we then condensed this with the protected amine 
274b to yield the tetraene 351 in 54 % yield. The product was isolated as an 
inseparable mixture of 2 and 5' double bond isomers. It was felt that this mixture of 
products would result in loss of the stereochemical integrity of the radical reaction. 
However, we continued the synthesis of the selenyl ester 338. The methyl ester was 
selectively hydrolysed to give the acid 352 which was elaborated to the selenyI ester 
338 using N-phenylselenophthalimide and tributylphosphine (Scheme 99). 
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Reagents: i, TFA, rt; ii, Et3N, C6H6' rt; 346, molecular sieves, C6H6' rt; AcBr, Et2NPh, C6H6, 
rt, 54%-2 steps; iii, LiOH, THF, H20, rt; iv, N-PSP, BU3P, CH2CI2, -30·C, 63%-2steps. 
X=C02Et 
Scheme 99 
After the successful synthesis of a fully linear precursor 338 we were excited at the 
prospect of attempting a radical cascade to give the azasteroid 337. Upon treatment 
with tributyltin hydride and AIBN under standard radical generating conditions the 
selenyl ester 338 did not generate any steroidal material. However. after optimisation 
of the reaction conditions for the major product. using an eight hour syringe pump 
addition and four hours further reflux, we were able to isolate the unusual substituted 
bicyc10[8.3.0]tridecene 354 in 35 % yield (Scheme 100). This product resulted from 
an initial lO-endo-trig cyc1isation of the acyl radical 340 to generate the captodative 
radical 352. A 5-exo-trig cyclisation of the radical 352 gave the alkyl radical 353 
which was quenched to yield the product 354. The activation of the lO-endo-trig 
cycIisation by the ester group substituted on the double bond increased the rate of this 
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reaction so that it was faster than the 6-endo-trig cyclisation. Much to our surprise the 
intermediate captodative radical 352 underwent the second cyclisation in the 
formation of the bicycle 354. The structure of the product 354 was confirmed by IH-
IH COSY and HMQC n.m.r. studies at 360 MHz, but we were unable to fully assign 
the stereochemistry of the of this molecule. 
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Initial analysis of the IH n.m.r. spectra showed us that there were still two carbon-
carbon double bonds present in the molecule that we had isolated though neither of 
them were the enamide double bond which could not be seen in either the l3C or 1 H 
I • 
n.m.r spectra. One was a terminal monosubstituted olefin and the other was 
trisubstituted. We had therefore isolated a bicyclic molecule and our cascade reaction 
had not gone to completion. We obtained COSY and HMQC spectra along with a 
l3C and DEPT study in order to fully characterise the molecule. It was possible to 
assign the sets of signals for the ester group, the amide and the terminal olefin from 
the HMQC and COSY spectra. However, this did not help in the identification of the 
core ring system. From the carbon and DEPT it was possible to see that there were 
three quaternary centres (one of which was in the remaining double bond), two CH 
(one of which was in the remaining double bond), nine CH2 groups all in the aliphatic 
region and as expected, two remaining methyl groups. Therefore, in constructing our 
molecule we could see that the ring junctions and the position of the side chain 
involved one CH and two quaternary centres. This pattern of carbons can result from 
an even and an odd number of carbons in each ring so we returned to the IH n.m.r. 
spectra and 2D n.m.r.s to glean more information. Interestingly, the two sets of 
signals remaining above 8 2.4 p.p.m. in the IH n.m.r. spectra, a CH2 at 8 3.85 and 8 
3.70 p.p.m., and a CH at 8 2.91 p.p.m. were shown to be adjacent to each other by the 
COSY spectra and not on either side of the nitrogen as originally thought. The CH is 
almost certainly next to the ketone fragment. Therefore, the CH2 at 840.0 p.p.m. in 
the carbon spectra is probably adjacent to the nitrogen with a quaternary centre on the 
other side of this key atom. From the HMQC it was possible to see that all but three 
of the CH2S were diastereomeric and so only these three could possibly be outside the 
ring. This information showed us that the two carbon-carbon double bonds that had 
reacted were the enamide and the double bond at C-6 in the precursor. The remaining 
double bonds were the terminal olefin at C-I0 and the internal double bond at C-5'. 
III 
Therefore, the only reaction pathway consistent with our n.m.r. data was an initial 10-
endo-trig followed by a 5-exo-trig cyclisation to yiela· the aza-bicycle 354. 
Comparison of the data we obtained to those obtained for a carbocyclic varient of this 
molecule synthesised in our laboratories confirmed our findings. 13 1 
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3. EXPERIMENTAL 
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3.1 GENERAL DETAILS 
All melting points were determined on a Kofler hot-stage apparatus and are 
uncorrected. Infrared spectra were obtained using a Perkin-Elmer 1600 series Ff-IR 
or a Nicolet 20 SXB instrument as liquid films. The signals are designated by the 
following abbreviations: s, strong; m, medium; w, weak; br, broad. Proton (1 H) n.m.r. 
spectra were recorded on either a Bruker WM 250 (250 MHz), a Bruker DPX 360 
(360 MHz), a Bruker AM 400 (400 MHz), a Bruker DRX 500 (500 MHz), a Joel 
JNM EX-270 (270 MHz) or a Varian VRX 400 (400 MHz) spectrometer as dilute 
solutions in deuteriochloroform and at 298 K unless otherwise stated. The chemical 
shifts are recorded relative to either added tetramethylsilane (0.0 p.p.m.) or residual 
chloroform (7.27 p.p.m.) as internal standards. The multiplicity of a signal is 
designated by one of the following abbreviations: s, singlet; d, doublet; t, triplet; q, 
quartet; quin., quintet; br., broad; m, multiplet; app., apparent. All coupling constants 
J, are reported in Hertz (Hz). Carbon (13C) n.m.r. were recorded on either a Brucker 
DPX 360 (90.6 MHz), a Bruker AM 400 (100.6 MHz), a Joel JNM EX-270 (at 67.8 
MHz) or a Varian VRX 400 (100.6 MHz) instrument as dilute solutions in 
deuteriochloroform and at 298 K unless stated otherwise. Chemical shifts are 
reported relative to either added tetramethylsilane (0.0 p.p.m.) or to 
deuteriochloroform (77.0 p.p.m.) as internal standards on a broad band decoupled 
mode. The multiplicities were obtained using a DEPT sequence and are designated 
by the following symbols: q, primary methyl; t, secondary methylene; d, tertiary 
methine; s, quaternary; br, broad. Mass spectra were recorded on a VO Autospec or a 
MM-701CF spectrometer using electron ionisation (EI), fast atom bombardment 
(FAB) or chemical ionisation (CI) techniques. Microanalytical data were obtained on 
a Perkin-Elmer 240B elemental analyser. 
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Flash chromatography was performed on Merck silica gel 60 (230-400 mesh) as the 
stationary phase and the solvents employed were either of analytical grade or were 
distilled before use. All reactions were monitored by t.l.c. using Merck silica gel 60 
F254 precoated aluminium backed plates which were visualised with ultraviolet light, 
iodine adsorbed on silica and then acidic alcoholic vanillin solution. 
Organic solvents were dried by distillation from the following: tetrahydrofuran and 
benzene (potassium benzophenone ketyl), toluene and ether (sodium benzophenone 
ketyl), dichloromethane (calcium hydride), methanol (magnesium methoxide) and 
used directly or stored under nitrogen and/or over sodium wire. Other organic 
solvents and reagents were purified by the accepted literature procedures. Solvent 
was removed on a Buchi rotary evaporator under water pump pressure. All reactions 
were performed in a flame or oven dried apparatus under a nitrogen or argon 
atmosphere, unless stated otherwise. A Buchi GKR-50 Kugelrohr apparatus was used 
for bulb-to-bulb distillations. 
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3.2 CYCLOHEXENYL ENAMIDE STUDIES· 
l-Amino-(N-acetyl, N-cyclohex-l '-ell-l ' - y l ) - p r o p - 2 ~ e n e e (265)92a 
~ N D D
O ~ ~
265 
A stirred mixture of cyclohexanone (2.1 cm3, 2.0 g, 20 mmol), l-aminoprop-2-ene 
(7.5 cm3, 5.7 g, 100 mmol) and toluene (10 cm3) was heated in a sealed tube at 100°C 
for 2 h. The solution was reduced by ~ i s t i l l a t i o n n from the sealed tube, allowed to cool 
to room temperature and toluene (40 cm3), followed by triethylamine (4.2 cm3, 3.0 g, 
30 mmol) and then 4-N,N-dimethylaminopyridine (240 mg, 2.0 mmol), were added 
sequentially in single portions. The mixture was cooled to O°C and acetyl chloride 
(2.1 cm3, 2.4 g, 30 mmol) was added dropwise over 5 min and the resulting 
suspension was stirred at O°C for 1 h. The mixture was then allowed to warm to room 
temperature and saturated aqueous sodium hydrogen carbonate (20 cm3) was then 
added. The separated organic layer was dried (MgS04) and the solvent was removed 
in vacuo to leave a brown residue, which was then purified by chromatography on 
silica, using ethyl acetate - petroleum (b.p. 40-60°C) (1:2) as eluant, to give the 
enamide (265) (1.9 g, 52 %) as a pale yellow oil. OH (500 MHz, CDCI3) 5.80 (IH, m, 
CH2CH=CH2), 5.61 (lH, m, NC=CHCH2), 5.11 (2H, m, CH2CH=CH2), 4.02 (2H, d, 
J 6.0 Hz, CHCH2N), 2.11 (2H, m, NC=CHCH2), 2.06 (2H, m, CH2C(N)=CH), 2.03 
(3H, s, NCOCH3), 1.71 (2H, m, C=CHCH2CH2), 1.59 (2H, m, CH2CH2C(N)=CH); 
Oc (90.6 MHz, CDCI3) 169.0 (s), 138.6 (s), 133.4 (d), 127.0 (d), 116.5 (t), 48.2 (t), 
27.6 (t), 24.2 (t), 22.2 (t), 21.1 (q), 21.0 (t); umax (liquid film)/cm- 1 2932 (m), 1650 
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(s), 1392 (s), 1279 (w), 1210 (w), 1142 (w), 1078 (w), 984 (w), 921 (w); mJz (El) 
180.1379 (M+H+, CllH18NO requires 180.1388). 
, 
3-Methyllzept-2-endioic acid, I-ethyl ester (275) 
~ ~ I ~ ~
E t O ~ O H H
275 
Triethyl phosphonoacetate (6.9 cm3, 7.7 g, 34.6 mmol) was added dropwise over 20 
min to a stirred mixture of sodium hydride (1.9 g, 46.1 mmol, 60 wt.% in oil) in 
tetrahydrofuran (90 cm3) at O°C. The mixture was allowed to warm to room 
temperature over 30 min, and was then cooled to O°C. 5-0xohexanoic acid (1.4 cm3, 
1.5 g, 11.5 mmol) was added dropwise over 10 min and the mixture was left to warm 
to room temperature overnight, acidified to pH 1 with hydrochloric acid (40 cm3, 2 
moldm-3) and then evaporated in vacuo. The aqueous residue was extracted with 
ethyl acetate (3x120 em3), and the combined organic extracts were then washed with 
brine (40 cm3), dried (MgS04) and reduced in vacuo. The yellow residue was 
purified by chromatography on silica using ethyl acetate - petroleum (b.p. 40-60°C) 
(2:3) as eluant to give the half ester (275) (2.2 g, 96 %) as an oily 2:1 mixture of Z 
and E isomers. Major Z isomer: OH (250 MHz, CDC)3) 5.70 (lH, S, C=CHC02Et), 
4.13 (2H, q, J 7.2 Hz, OCH2CH3), 2.69 (2H, t, J7.5 Hz, CH2C(Me)=CH), 2.42 (2H, t, 
J 7.5 Hz, CH2C02H), 1.90 (3H, s, C(CH3)=CH), 1.80 (2H, app. quin., J 7.5 Hz, 
CH2CH2CH2), 1.27 (3H, t, J 7.2 Hz, OCH2CH3); oe (67.8 MHz, CDC)3) 179.0 (s), 
165.9 (s), 158.7 (s), 116.6 (d), 59.2 (t), 33.2 (t), 32.0 (t), 24.5 (q), 22.6 (t), 13.8 (q); 
Minor E isomer: OH (250 MHz, CDC}3) 5.69 (1H, s, C=CHC02Et), 4.13 (2H, q, J 7.2 
Hz, OCH2CH3 ), 2.40 (2H, t, J 7.5 Hz, CH2C02H), 2.20 (2H, t, J 7.5 Hz, 
CH2C(Me)=CH), 2.18 (3H, s, C(CH3)=CH), 1.80 (2H, app. quin., J 7.5 Hz, 
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CH2CR2CH2), 1.27 (3H, t, J 7.2 Hz, OCH2CRj); Be (67.8 MHz, CDCI3) 178.6 (s), 
166.3 (s), 158.2 (s), 115.9 (d), 59.2 (t), 39.5 (t), 32.8 (t), 21.'9 (t), 18.1 (q), 13.8 (q); 
Both isomers: 'Umax (liquid film)/cm- 1 2979 (m), 1711 (s), 1650 (s), 1445 (m), 1378 
(m), 1225 (m), 1158 (m), 1096 (w), 1077 (w), 1035 (w); Found %: C, 59.4; H, 8.2 
(CIOH1604 requires C, 59.9; H, 8.1); rnIz (EI) 200.1054 (M+, ClOH1604 requires 
200.1049). 
Methyl 7-hydroxy-5-methylhept-5-enoate (277) 
H O ~ O M . .
277 
A solution of di-iso-butylaluminium hydride in toluene (19 cm3, 1.5 moldm-3, 29 
mmol) was added dropwise, via syringe pump, over 20 min to a stirred solution of 3-
methylhept-2-endioic acid, I-ethyl ester (275) (2.3 g, 12 mmol) in dichloromethane 
(90 cm3) at -78°C. The solution was then allowed to warm to room temperature over 
30 min. then cooled to -78°C and methanol (10 em3) was added dropwise over 2 min. 
Hydrochloric acid (120 em3, 2 moldm-3) was then added and the mixture was allowed 
to warm to room temperature over 10 min. The layers were separated and the acidic 
aqueous layer was extracted with ethyl acetate (3x100 cm3), the combined organics 
were dried (MgS04) and reduced in vacuo to leave a colourless oil. 
A solution of trimethylsilyl diazomethane in hexane (7 em3, 2 moldm-3, 14 mmol) 
was added dropwise at room temperature, via syringe pump, over 20 min to a stirred 
solution of the colourless oil in benzene (100 cm3) and methanol (30 cm3). The 
solution was then left to stir for a further 5 min at room temperature and reduced in 
vacuo to leave a pale yellow oil. The oil was purified by chromatography on silica 
using ethyl acetate - petroleum (b.p. 40-60°C) (1 :3) as eluant to give the hydroxy ester 
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(277) (1.6 g, 81 %) as an oily inseparable 2:1 mixture of Z and E-isomers. Major Z 
isomer: 8H (400 MHz, CDCI3) 5.42 (lH, t, J 6.7 Hz, C=CHCH2), 4.04 (2H, d, J 6.7 
Hz, CHCH20H), 3.62 (3H, s, C02CH3), 2.25 (2H, t, J 7.3 Hz, CH2C02Me), 2.07 
I . (2H, t, J 7.0 Hz, CH2C(Me)=CH), 1.71 (2H, m, CH2CH2CH2), 1.68 (3H, s, CCH3); 
8c (67.8 MHz, CDCI3) 174.0 (s), 138.0 (s), 125.3 (d), 58.4 (t), 51.4 (q), 33.1 (t),30.7 
(t), 22.9 (q), 22.8 (t); Minor E isomer: 8H (400 MHz, CDC13) 5.36 (IH, t, J 6.7 Hz, 
C=CHCH2), 4.09 (2H, d, J 6.7 Hz, CHCH20H), 3.63 (3H, s, OCH3), 2.25 (2H, t, J 
7.3 Hz, CH2C02Me), 2.00 (2H, t, J 7.0 Hz, CH2C(Me)=CH), 1.71 (2H, m, 
CH2CH2CH2), 1.62 (3H, s, CCH3); 8C (67.8 MHz, CDC13) 174.0 (s), 137.7 (s), 
124.3 (d), 58.8 (t), 51.3 (q), 38.5 (t), 30.7 (t), 22.5 (t), 15.7 (q); Both isomers: Umax 
(liquid film)/cm-l 3206 (b), 2953 (m), 2874 (m), 1874 (m), 1741 (s), 1439 (m), 1376 
(m), 1252 (m), 1184 (m), 1011 (m); Found %: C, 62.5; H, 9.7 (C9H1603 requires C, 
62.7; H, 9.4); mlz (EI) 155.1000 (M-OH+, C9HlS02 requires 155.1072). 
Ethyl 7-hydroxy-3-methylhept-2-enoate (280) 
280 
iso-Butyl chlorofonnate (1.1 cm3, 1.1 g, 8.1 mmol) was added dropwise over 10 min 
at O°C to a solution of 3-methylhept-2-endioie acid, I-ethyl ester (275) (1.6 g, 8.1 
mmol) and triethylamine (1.1 em3, 820 mg, 8.1 mmol) in dichloromethane (80 em3). 
The mixture was stirred for 1.5 h at O°C and then reduced in vacuo to leave a white 
semi-solid. The residue was taken up in ether (50 cm3), then filtered and the solvent 
removed in vacuo to leave a colourless oil. 
Sodium borohydride (460 mg, 12.1 mmol) was added in one portion to a stirred 
solution of the oil in methanol (40 cm3) at O°C and then left to stir at O°C for 5 min. 
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Water (30 cm3) was then added and the solution was evaporated in vacuo. The 
resulting aqueous mixture was extracted with ethyl acetate (3x160 cm3), the 
combined organic layers were then washed with brine (30 cm3), dried (MgS04) and 
the solvent was removed in vacuo to leave an oily residue. The residue was purified 
by chromatography on silica, using ethyl acetate - petroleum (b.p. 40-60°C) (2:3) as 
eluant to leave the alcohol (280) (1.3 g, 84 %) as a colourless oily 2: 1 mixture of Z 
and E isomers. Major Z isomer: OH (400 MHz, CDCI3) 5.67 (lH, s, C=CHC02Et), 
4.15 (2H, q, J 7.2 Hz, OCH2CH3), 3.70 (2H, t, J 6.0 Hz, CH2CH20H), 2.61 (2H, t, J 
7.4 Hz, CH2C(Me)=CH), 1.90 (3H, s, C(CH3)=CH), 1.60 (4H, m, CH2CH2CH2CH2), 
1.27 (3H, t, J 7.2 Hz, OCH2CH3); oe (67.8 MHz, CDCI3) 166.4 (s), 160.8 (s), 115.8 
(d), 61.7 (t), 59.4 (t), 32.5 (t), 32.0 (t), 25.1 (q), 24.1 (t), 14.1 (q); Minor E isomer: OH 
(400 MHz, CDCI3) 5.67 (lH, s, C=CHC02Et), 4.15 (2H, q, J 7.2 Hz, OCH2CH3), 
3.66 (2H, t, J 6.0 Hz, CH2CH20H), 2.17 (2H, t, J 7.4 Hz, CH2C(Me)=CH), 2.14 (3H, 
s, C(CH3)=CH), 1.60 (4H, m, CH2CH2CH2CH2), 1.27 (3H, t, J 7.2 Hz, OCH2CH3); 
oe (67.8 MHz, CDCI3) 166.7 (s), 159.7 (s), 115.5 (d), 62.0 (t), 59.3 (t), 40.4 (t), 31.9 
(t), 23.4 (t), 18.5 (q), 14.1 (q); Both isomers: U max (liquid film)!cm- 1 3376 (s), 2979 
(s), 2937 (s), 2866 (s), 1714 (s), 1646 (s), 1446 (s), 1378 (s), 1351 (m), 1324 (m), 
1271 (m), 1226 (s), 1148 (s), 1039 (s), 984 (w), 859 (m), 725 (w); Found %: C, 64.0; 
H, 9.9 (ClOHlS03 requires C, 64.4; H, 9.7); mlz (El) 186.1256 (M+, C lOH 1S03 
requires 186.1256). 
Ethyl 7-(tert-butyldiphellylsilallyloxy )-3-methylhept-2-elloate (279) 
o E t O ~ O T B D P S S
279 
120 
Imidazole (500 mg, 7.4 mmol) was added in one portion to a stirred solution of ethyl 
7-hydroxy-3-methylhept-2-enoate (280) (1.3 g,.6.8 mmol) and ter!-
butyldiphenylsilylchloride (1.9 cm3, 2.0 g, 7.4 mmol) in dichloromethane (14 em3) at 
i . 
room temperature and the solution was stirred for 15 min. The solvent was removed 
in vacuo and the solid residue was then taken up in ether (25 cm3), filtered and 
reduced in vacuo to leave the protected alcohol (279) (2.6 g, 100 %) as a colourless 
oil. Major Z isomer: OH (400 MHz, CDCI3) 7.69-7.67 (4H, m, Ar-H), 7.44-7.37 (6H, 
m, Ar-H), 5.67 (1H, s, C=CHC02Et), 4.14 (2H, q, 17.2 Hz, OCH2CH3), 3.69 (2H, t, 
16.0 Hz, CH2CH20TBDPS), 2.64 (2H, t, 1 7.4 Hz, CH2C(Me)=CH), 1.88 (3H, s, 
C(CH3)=CH), 1.56 (4H, m, CH2CH2CH2CH2), 1.29 (3H, t, 1 7.2 Hz, C02CH2CH3), 
1.06 (9H, s, SiC(CH3}J; Be (67.8 MHz, CDCI3) 166.0 (s), 160.1 (s), 135.4 (d), 133.8 
(s), 129.3 (d), 127.4 (d), 116.2 (d), 63.5 (t), 59.1 (t), 32.7 (t), 32.3 (t), 26.7 (q), 24.8 
(q), 24.2 (t), 19.0 (s), 14.1 (q); Minor E isomer: BH (400 MHz, CDCI3) 7.69-7.67 
(4H, m, Ar-H), 7.44-7.37 (6H, m, Ar-H), 5.66 (1H, s, C=CHC02Et), 4.14 (2H, q, 1 
7.2 Hz, OCH2CH3), 3.69 (2H, t, 1 6.0 Hz, C H2CH20TBDPS), 2.15 (3H, s, 
C(CH3)=CH), 2.14 (2H, t, 1 7.4 Hz, CH 2 C(Me)=CH), 1.56 (4H, m, 
CH2CH 2CH 2CH2), 1.29 (3H, t, 1 7.2 Hz, OCH2CH 3), 1.06 (9H, s, SiC(CH3h); Be 
(67.8 MHz, CDCI3) 166.5 (s), 159.6 (s), 135.4 (d), 133.8 (s), 129.3 (d), 127.4 (d), 
115.5 (d), 63.3 (t), 59.2 (t), 40.3 (t), 31.8 (t), 26.7 (q), 23.4 (t), 19.0 (s), 18.4 (q), 14.1 
(q); Both isomers: umax (liquid fiIm)/cm- 1 3071 (m), 3049 (m), 2932 (s), 2858 (s), 
1959 (w), 1890 (w), 1824 (w), 1716 (s), 1647 (s), 1590 (w), 1472 (s), 1428 (s), 1389 
(s), 1378 (s), 1273 (m), 1224 (s), 1145 (s), 1111 (s), 1040 (m), 1008 (w), 998 (w), 859 
(m), 823 (s), 740 (s), 702 (s); Found %: C, 73.9; H, 8.7 (C26H3603Si requires C, 73.5; 
H, 8.5); mlz (FAB) 367.1764 (M-IBu+, C22H2703Si requires 367.1729). 
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7-(tert-Blltyldiphenylsilanyloxy )-3-methylhept-2-en-l-ol (281) 
H O ~ O T B D P S S
281 
A solution of di-iso-butylaluminium hydride in toluene (11 em3, 1.5 moldm-3, 17 
mmol) was added dropwise over 5 min to a stirred solution of ethyl 7-(tert-
butyldiphenylsilanyloxy)-3-methylhept-2-enoate (279) (2.6 g, 6.8 mmol) in 
diehloromethane (70 cm3) at -78°C. The solution was stirred for 1 h at -78°C, then 
methanol (5 em3) was added and the mixture was allowed to warm to room 
temperature. A saturated aqueous solution of Roehelles salt (70 cm3) was added and 
the mixture was left to stir vigorously for 2 h. The resulting clear layers were 
separated and the aqueous fraction was extracted with ethyl acetate (3x60 cm3) and 
the combined organic layers were then washed with brine (30 cm3), dried (MgS04) 
and reduced in vacuo. The yellow residue was purified by chromatography on silica, 
using ethyl acetate - petroleum (b.p. 40-60°C) (1:2) as eluant to leave the allylic 
alcolzol (281) (2.4 g, 92 %) as a colourless oil. Major Z isomer: OH (250 MHz, 
CDCI3) 7.70-7.66 (4H, m, Ar-H), 7.48-7.36 (6H, m, Ar-H), 5.43 (lH, t, J 7.0 Hz, 
C=CHCH20), 4.11 (2H, ct, J 7.0 Hz, C=CHCH20H), 3.67 (2H, t, J 6.0 Hz, 
CH2CH20TBDPS), 2.08 (2H, t, J 7.4 Hz, CH2C(Me)=CH), 1.74 (3H, s, 
C(CH3)=CH), 1.52 (4H, m, CH2CH2CH2CH2), 1.06 (9H, s, SiC(CH3b; Oc (67.8 
MHz, CDCI3) 140.1 (s), 135.5 (d), 134.0 (s), 129.5 (d), 127.6 (d), 124.2 (d), 63.6 (t), 
59.0 (t), 32.2 (t), 31.5 (t), 26.8 (q), 24.4 (t), 23.3 (q), 19.2 (s); Minor E isomer: OH 
(250 MHz, CDCI3) 7.70-7.66 (4H, m, Ar-H), 7.48-7.36 (6H, m, Ar-H), 5.40 (lH, t, J 
7.0 Hz, C=CHCH20), 4.15 (2H, d, J 7.0 Hz, CHCH20H), 3.67 (2H, t, J 6.0 Hz, 
CH2CH20TBDPS), 2.02 (2H, t, J 7.4 Hz, CH2C(Me)=CH), 1.66 (3H, s, 
C(CH3)=CH), 1.52 (4H, m, CH2CH2CH2CH2), 1.06 (9H, s, SiC(CH3b); Bc (67.8 
122 
MHz, CDCI3) 139.8 (s), 135.5 (d), 134.0 (s), 129.5 (d), 127.6 (d), 123.3 (d), 63.6 (t), 
59.4 (t), 39.2 (t), 32.1 (t), 26.8 (q), 23.8 (t), 19.2 (s), 16.0 (q); Both isomers: umax 
(liquid film)/cm- 1 3334 (b), 3070 (s), 3048 (s), 2997 (s), 3930 (s), 2856 (s), 2738 (m), 
I . 
1958 (w), 1888 (w), 1823 (w), 1714" (w), 1667 (m), 1589 (m), 1567 (w), 1471 (s), 
1462 (s), 1446 (s), 1427 (s), 1389 (s), 1360 (s), 1305 (w), 1262 (w), 1234 (w), 1188 
(m), 1158 (m), 1111 (b), 998 (s), 940 (m), 858 (m), 823 (s), 764 (m), 740 (s), 701 (s), 
688 (s), 614 (s); mlz (FAB) 381.2215 (M-H+, C25H3302Si requires 381.2250) 
N-tert-Butylcarboxy, N-para-toluenesulfonylamine (282)122 
282 
para-Toluenesulfonyl isocyanate (7.6 em3, 10 g, 50 mmol) was added dropwise over 
5 min to stirred tert-butanol (50 em3) at 25°C and the solution was left to stir for 48 h. 
The solvent was evaporated in vacuo and the residue dried under vacuum (0.5 mmHg) 
for 48 h to leave the diprotected amine (282) (14 g, 100%) as a white powder. m.p. 
120-122°C (lit. m.p. 115-11rC); OH (400 MHz, CDCI3) 7.90 (2H, d, J 8.3 Hz, Ar-H), 
7.34 (2H, d, J 8.3 Hz, Ar-H), 2.46 (3H, s, Ar-CH), 1.39 (9H, s, OC(CHJh); oe (67.8 
MHz, CDC1 3) 149.3 (s), 144.6 (s), 135.9 (s), 129.4 (d), 128.1 (d), 84.0 (s), 27.8 (q), 
21.6 (q); u max (liquid film)/cm- 1 3248 (b), 2981 (m), 2932 (w), 1745 (s), 1435 (m), 
1396 (m), 1347 (s), 1237 (m), 1148 (s), 1089 (s), 912 (m), 830 (m), 733 (m). 
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l-Amino-(N-tert- but y I car box y I, N - par a-toluenesulfonyl)-7-(tert-
butyldiphenylsilanyloxy)-3-methylhept-2-ene (283) 
B o C T S N ~ O T B D P S S
283 
Diethyl azodicarboxylate (1.1 cm3, 1.2 g, 6.9 mmol) was added dropwise over 10 min 
to a stirred solution of 7-(tert-butyldiphenylsilanyloxy)-3-methylhept-2-en-l-01 (281) 
(2.4 g, 6.3 mmol), triphenylphosphine (1.8 g, 6.9 mmol) and N-tert-butylcarboxy, N-
para-toluenesulfonylamine (282) (1.9 g, 6.9 mmol) in tetrahydrofuran (90 cm3) at 
room temperature. The solution was left to stir at room temperature for 2 h and then 
reduced in vacuo to leave a pale yellow semi-solid. The residue was adsorbed on 
silica and purified by chromatography on silica, using ethyl acetate - petroleum (b.p. 
40-60°C) (1 :9) as eluant, to leave the protected amine (283) (3.9 g, 99 %) as a pale 
yellow oil. Major Z isomer: OH (360 MHz, CDCI3) 7.80-7.78 (2H, m, Ar-H), 7.71-
7.68 (4H, m, Ar-H), 7.46-7.37 (6H, m, Ar-H), 7.31-7.26 (2H, m, Ar-H), 5.33 (lH, t,) 
7.0 Hz, C=CHCH2N), 4.46 (2H, d, J 7.0 Hz, CHCII2N), 3.70 (2H, t, ) 6.0 Hz, 
CH2CH20), 2.44 (3H, s, C(CH3)=CH), 2.22 (2H, t,) 7.0 Hz, CH2C(Me)=CH), 1.77 
(3H, s, ArCH3), 1.57 (4H, m, CH2CH2CH2CH2), 1.35 (9H, s, OC(CH3h), 1.08 (9H, 
s, SiC(CH3h; Be (90.6 MHz, CDCI3) 150.9 (s), 143.8 (s), 140.1 (s), 137.5 (s), 135.5 
(d), 134.0 (s), 129.5 (d), 129.1 (d), 127.9 (d), 127.6 (d), 120.7 Cd), 83.9 (s), 63.7 (t), 
44.6 (t), 32.3 (t), 31.6 (t), 27.9 (q), 26.8 (q), 24.2 (t), 23.3 (q), 21.5 (q), 19.1 (s); Minor 
E isomer: OH (360 MHz, CDCI3) 7.80-7.78 (2H, m, Ar-H), 7.71-7.69 (4H, m, Ar-II), 
7.46-7.37 (6H, m, Ar-H), 7.31-7.26 (2H, m, Ar-H), 5.35 (tH, t, J 7.0 Hz, 
C=CHCH2N), 4.50 (2H, d, ) 7.0 Hz, CHCH2N), 3.70 (2H, t, ) 6.0 Hz, CH2CH20), 
2.40 (3H, s, C(CH3)=CH), 2.06 (2H, t, ) 7.4 Hz, CH2C(Me)=CH), 1.77 (3H, s, 
ArCH3), 1.57 (4H, m, CH2CH2CH2CH2), 1.35 (9H, s, OC(CH3h), 1.08 (9H, s, 
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SiC(CH3}J); eSc (67.8 MHz, CDCI3) 150.9 (s), 143.8 (s), 140.0 (s), 137.5 (s), 135.5 
(d), 134.0 (s), 129.5 (d), 129.1 (d), 127.9 (d), 127.6 (d), 119.8 (d), 83.9 (s), 63.7 (t), 
44.6 (t), 39.3 (t), 32.1 (t), 27.8 (q), 26.8 (q), 23.9 (t), 21.5 (q), 19.2 (s), 16.1 (q); Both 
I . 
isomers: 'Omax (liquid film)/cm- 1 2932 (s), 2859 (s), 2360 (w), 1728 (s), 1598 (w), 
1472 (m), 1457 (m), 1428 (s), 1358 (s), 1309 (m), 1276 (m), 1266 (m), 1154 (s), 1111 
(s), 1080 (s), 998 (w), 929 (w), 848 (m), 822 (m), 768 (s), 703 (s), 675 (s); Found %: 
C, 67.9; H, 7.7; N, 2.2 (C36H49N05SSi requires C, 68.0; H, 7.8; N, 2.2); rnIz (FAB) 
578.2391 (M-tBu+, C32H40N05SSi requires 578.2396) 
l-Amillo-(N -tert-butylcarboxyl)-7-(tert-butyldiphenylsilanyloxy )-3-methylhept-2-
ene (285) 
B O C H N ~ O T B D P S S
285 
Sodium amalgam (35 g, 4.5 % w/w, 70 mmol) was added in one portion to a stirred 
mix ture of 1-amino-(N-tert-butyIcarboxyl, N-para-toluenesulfonyl)-7-(tert-
butyldiphenylsilanyloxy)-3-methylhept-2-ene (283) (2.2g, 3.5 mmol) and disodium 
hydrogen phosphate (2.0 g, 14 mmol) in methanol (30 em3) at room temperature and 
the resulting mixture left to stir for 1 h. Water (30 em3) was added and the mixture 
was left to stir for 10 min, then filtered through a pad of celite and reduced in vacuo. 
The remaining aqueous portion was extracted with ethyl acetate (3x120 cm3), the 
combined organics were dried (MgS04) and the solvent removed in vacuo to leave a 
colourless oil. The oil was purified by chromatography on silica, using ethyl acetate -
petroleum (b.p. 40-60CC) (1:7) as eluant to leave the protected amine (285) (1.4 g, 85 
%) as a colourless oily 2:1 mixture of Z:E isomers. Major Z isomer: eSH (270 MHz, 
CDCI3) 7.73-7.69 (4H, m, Ar-H), 7.48-7.36 (6H, m, Ar-H), 5.22 (1H, t, J 7.0 Hz, 
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C=CHCH2N), 4.47 (IH, br, CH2NHBoc), 3.70 (4H, m, CH2CH20 and C=CHCH2N), 
2.07 (2H, t, J 7.4 Hz, CH2C(Me)=CH), 1.72 (3H, s, C(CH3)=CH), 1.53 (4H, m, 
CH2CH2CH2CH2), 1.46 (9H, s, OC(CH3)' 1.06 (9H, s, SiC(CH3h; 8e (67.8 MHz, 
CDCI3) 155.7 (s), 139.4 (s), 135.5 (d), 133.9 (s), li9.4 (d), 127.5 (d), 121.4 (d), 79.0 
(8),63.6 (t), 38.1 (t), 32.2 (t), 31.4 (t), 28.4 (q), 26.8 (q), 24.2 (t), 23.2 (q), 19.1 (s); 
Minor E isomer: 8H (270 MHz, CDCI3) 7.73-7.69 (4H, m, Ar-H), 7.48-7.36 (6H, m, 
Ar-H), 5.18 (lH, t, J 7.0 Hz, C=CHCH2N), 4.47 (lH, br, CH2NHBoc), 3.70 (4H, m, 
CH2CH20 and C=CHCH2N), 2.00 (2H, t, J 7.4 Hz, CH2C(Me)=CH), 1.65 (3H, s, 
C(CH3)=CH), 1.53 (4H, m, CH2CH2CH2CH2), 1.46 (9H, s, OC(CH3), 1.06 (9H, s, 
SiC(CH3h; 8e (67.8 MHz, CDCI3) 155.7 (s), 139.1 (s), 135.5 (d), 133.9 (s), 129.4 
(d), 127.5 (d), 120.6 (d), 79.0 (s), 63.6 (t), 39.0 (t), 38.4 (t), 32.0 (t), 28.4 (q), 26.8 
(q), 23.7 (t), 18.9 (s), 16.0 (q); Both isomers: umax (liquid fiIm)/cm- 1 3358 (m), 3071 
, 
(m), 2932 (s), 2858 (s), 1704 (s), 1589 (w), 1503 (s), 1472 (m), 1428 (m), 1390 (m), 
1366 (m), 1247 (m), 1172 (s), 1111 (s), 936 (w), 866 (m), 823 (m), 758 (s), 703 (s), 
688 (m), 666 (w), 613 (m); mlz (FAB) 482.3095 (M+H+, C29H44N03Si requires 
482.3090). 
j-Amino-(N-tert-blltylcarboxyl)-3-metlzyllzept-2-en-7-01 (284) 
B O C H N ~ O H H
284 
A sol ution of I-ami nO-(N-tert-butylcarboxyl)-7-(tert-butyldiphenylsilanyloxy)-3-
methylhept-2-ene (285) (1.2 g, 2.4 mmol) in tetrahydrofuran (25 cm3) was added 
dropwise over 10 min to a stirred solution of tert-butylamonium floride (3.0 g, 9.5 
mmol) and para-toluenesulfonic acid ( 0.9 g, 4.8 mmol) in tetrahydrofuran (50 cm3) 
at room temperature and was left to stir for 3 days. The solvent was removed in 
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vacuo and the colourless oil was purified by chromatography on silica, using ethyl 
acetate - petroleum (b.p. 40-60°C) (1: 1) as eluant, to leave the alcohol (284) (580 mg, 
100 %) as a colourless oil. Major Z isomer: OH (250 MHz, CDCI3) 5.18 (1H, t, J 7.0 
Hz, C=CHCH2N), 4.50 (IH, br, CH2NHBoc),' 3.64 (4H, m, CH2CH20H and 
CHCH2N), 2.08 (2H, t, J 7.4 Hz, CH2C(Me)=CH), 1.89 (1H, br, CH20H), 1.70 (3H, 
s, C(CH3)=CH), 1.51 (4H, m, CH2CH2CH2CH2), 1.44 (9H, s, OC(CH3); Oe (67.8 
MHz, CDCI3) 155.8 (s), 139.1 (s), 121.3 (d), 79.0 (s), 62.1 (t), 38.0 (t), 32.1 (t),31.3 
(t), 28.3 (q), 24.0 (t), 23.1 (q); Minor E isomer: 8H (250 MHz, CDCI3) 5.18 (1H, t, J 
7.0 Hz, C=CHCH2N), 4.50 (1H, br, CH2NHBoc), 3.65 (4H, m, CH2CH20H and 
CHCH2N), 2.01 (2H, t, J 7.4 Hz, CH2C(Me)=CH), 1.89 (1H, br, CH20H), 1.64 (3H, 
s, C(CH3)=CH), 1.53 (4H, m, CH2CH2CH2CH2), 1.46 (9H, s, OC(CH3); oe (67.8 
MHz, CDCI3) 155.8 (s), 138.8 (s), 120.7 (d), 79.0 (s), 62.3 (t), 38.9 (t), 38.3 (t), 32.0 
(t), 28.3 (q), 23.6 (t), 15.9 (q); Both isomers: 'Umax (liquid film)/cm- 1 3348 (br), 2934 
(s), 1692 (s), 1524 (s), 1454 (s), 1391 (s), 1366 (s), 1275 (s), 1251 (s), 1173 (s), 1057 
(m), 934 (w), 866 (w), 781 (w); mlz (EI) 187.1217 (M+H.tBu+, C9H17N03 requires 
187.1209). 
7-Amino-(N -tert-butylcarboxyl)-S-methylhept-S-en-l-al (286) 
B O C H N ~ O O
286 
Dess Martin reagent (1.5 g, 3.6 mmol) was added in one portion to a stirred solution 
of l-amino-(N-tert-butylcarboxyl)-3-methylhept-2-en-7-o1 (284) (580 mg, 2.4 mmol) 
in dichloromethane (30 cm3) and the mixture was left to stir at room temperature for 1 
h. The mixture was diluted with ether (20 cm3) and a solution of sodium hydrogen 
carbonate (1.2 g) and sodium thiosulfate pentahydrate (4.1 g) in water (60 cm3) was 
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added in one portion and then left to stir for a further 30 min. The layers were 
separated and the aqueous was extracted with ether (2xI20· cm3) and the combined 
organics were washed with brine (30 cm3), dried (Na2S04) and reduced in vacuo. 
The resulting oil was purified by chromatography on silica, using ethyl acetate -
petroleum (b.p. 40-60°C) (1:4) as eluant, to leave the aldehyde (286) (410 mg, 70 %) 
as a colourless oil. Major Z isomer: OH (500 MHz, CDCI3) 9.77 (lH, d, J 1.5 Hz, 
CH2CHO), 5.24 (1H, t, J 7.0 Hz, C=CHCH2N), 4.50 (1H, br, CH2NHBoc), 3.70 (2H, 
br, CHCH2N), 2.43 (2H, dt, J 1.5 Hz and 7.0 Hz, CH2CH2CHO), 2.10 (2H, t, J 7.0 
Hz, CH2C(Me)=CH), 1.75 (2H, m, CH2CH2CH2), 1.71 (3H, s, C(CH3)=CH), 1.44 
(9H, s, OC(CH3); 8c (125.8 MHz, CDCI3) 202.3 (d), 155.9 (s), 138.2 (s), 122.7 (d), 
79.3 (s), 43.4 (t), 38.6 (t), 31.0 (t), 28.5 (q), 23.1 (q), 20.3 (t); Minor E isomer: OH 
(500 MHz, CDCI3) 9.77 (IH, d, J 1.5 Hz, CH2CHO), 5.19 (lH, t, J 7.0 Hz, 
C=CHCH2N), 4.50 (lH, br, CH2NHBoc), 3.70 (2H, br, CHCH2N), 2.43 (2H, dt, J 1.5 
Hz and 7.0 Hz, CH2CH2CHO), 2.03 (2H, t, J 7.0 Hz, CH2C(Me)=CH), 1.75 (2H, m, 
CH2CH2CH2), 1.65 (3H, s, C(CH3)=CH), 1.44 (9H, s, OC(CH3); Oc (125.8 MHz, 
CDCI3) 202.3 (d), 155.9 (s), 138.0 (s), 122.0 (d), 79.3 (s), 43.4 (t), 38.6 (t), 38.2 (t), 
28.5 (q), 20.0 (t), 16.0 (q); Both isomers: Umax (liquid film)/cm- 1 3357 (br), 2976 (s), 
2933 (s), 2723 (w), 2249 (w), 1699 (s), 1514 (s), 1454 (s), 1391 (s), 1366 (s), 1249 
(s), 1172 (s), 1045 (m), 1023 (m), 934 (w), 866 (w), 757 (s), 666 (w); m/z (EI) 
185.1068 (M+H-tBu+, C9H15N03 requires 185.1052). 
Methyl 7 -amillo-(N -tert-butylcarboxyl )-5-metllylllept-5-enoate (27 4b ) 
o B O C H N ~ O M . .
274b 
128 
A solution of sodium chlorite (1.2 g, 14 mmol) and potassium dihydrogen phosphate 
(1.5 g, 11 mmol) in water (20 em3) was added dropwise over 5 min to a solution of 1-
amino-(N-tert-butylcarboxyl)-3-methylhept-2-en-7-al (286) (370 mg, 1.5 mmol) and 
2-methylbut-2-ene (10 cm3) in tert-butanol' (40 em3) at room temperature and then 
stirred for 2 h. The solvent was reduced in vacuo and the resulting aqueous mixture 
was extracted with ether (3x75 em3) and the organics were dried (Na2S04) and 
evaporated in vacuo to leave a colourless oil. 
The oil was taken up in benzene (14 em3) and methanol (3.5 em3) and set stirring. A 
solution of trimethylsilyl diazomethane in hexanes (990 J.ll, 2.0 moldm-3, 2.0 mmo]) 
was added dropwise over 10 min to the stirred solution at room temperature and then 
stirred for 20 min. The solvent was removed in vacuo and to leave a pale yellow 
which oil was purified by chromatography on silica, using ethyl acetate - petroleum 
(b.p. 40-60 D C) (1:4) as eluant, to leave the methyl ester (274b) (380 mg, 92 %) as a 
colourless oily 2: 1 mixture of Z and E isomers. Major Z isomer: OH (250 MHz, 
CDCI3) 5.24 (lH, t, J 7.0 Hz, C=CHCH2N), 4.50 (1H, br, CH2NHBoc), 3.70 (2H, br, 
CHCH2N), 3.67 (3H, s, C02CH3), 2.29 (2H, t, J 7.5 Hz, CH2C02Me), 2.10 (2H, t, J 
7.0 Hz, CH2C(Me)=CH), 1.73 (2H, m, CH2CH2CH2), 1.70 (3H, s, CH2C(CH3)=CH), 
1.45 (9H, s, OC(CH3); Oc (67.8 MHz, CDCI3) 174.2 (s), 156.2 (s), 138.1 (s), 122.9 
(d), 79.2 (s), 52.0 (q), 39.1 (t), 33.8 (t), 31.4 (t), 28.8 (q), 23.5 (q), 23.5 (t); Minor E 
isomer: OH (250 MHz, CDCI3) 5.19 (1H, t, J 7.0 Hz, C=CHCH2N), 4.50 (lH, br, 
CH2NHBoc), 3.70 (2H, br, CHCH2N), 3.67 (3H, s, C02CH3), 2.28 (2H, t, J 7.5 Hz, 
CH2C02Me), 2.02 (2H, t, J 7.0 Hz, CH2C(Me)=CH), 1.73 (2H, m, CH2CH2CH2), 
1.65 (3H, s, CH2C(CH3)=CH), 1.45 (9H, s, OC(CH3); Oc (67.8 MHz, CDCI3) 174.2 
(s), 156.2 (s), 138.1 (s), 122.0 (d), 79.2 (s), 52.0 (t), 38.5 (t), 33.8 (t), 31.4 (t), 28.8 (q), 
23.1 (t), 16.4 (q); Both isomers: 'Umax (liquid film)/em- 1 3369 (br), 2975 (s), 1714 (s), 
1516 (s), 1454 (m), 1437 (m), l391 (m), 1366 (s), 1249 (s), 1172 (s), 1047 (m), 1018 
(m), 934 (w), 865 (w); Found %: C, 61.9; H, 9.6; N, 4.9 (ClsH2SN04 requires C, 
62.0; H, 9.3; N, 5.2); mlz (EI) 214.1086 (M-tBu+, ClOH16N04 requires 214.1079). 
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Methyl 7-amino-(N-acetyl, N-cyclohex-l '-en-l '-yl)-5-methylhept-5-enoate (288) 
288 
Triflouroacetic acid (1.0 cm3, 1.6 g, 14 mmol) was added dropwise over 5 minutes to 
stirred methyl 7-amino-(N-tert-buty1carboxyl)-5-methylhept-5-enoate (274b) (380 
mg, 1.4 mmol) at room temperature and the oil was left to stir for 5 min. Toluene (20 
cm3) was added and the solution was reduced in vacuo to leave a colourless oil. 
The oil was taken up in benzene (40 cm3), triethyl amine (200 ,.Ll, 140 mg, 1.4 mmol) 
was added in one portion and the resulting solution was stirred at room temperature 
for 5 min. Molecular sieves (4 A, activated) were added to the solution followed by 
cyc1ohexanone (170 ,.Ll, 160 mg, 1.6 mmol) in one portion and the resulting mixture 
was left to stir at room temperature for 12 h. 4-N,N-Dimethylaminopyridine (17 mg, 
0.14 mmol) and triethylamine (290 Ill, 210 mg, 2.1 mmol) were added in two separate 
portions to the stirred mixture at room temperature followed by acetyl chloride (150 
Ill, 170 mg, 2.1 mmol) added dropwise over 5 min at room temperature and then left 
to stir for 2 h. The mixture was filtered through a pad of celite and washed with water 
(30 cm3), brine (20 cm3), dried (Na2S04) and the solvent was removed in vacuo to 
leave a yellow oil. This oil was purified by chromatography on silica, using ethyl 
acetate - petroleum (b.p. 40-60°C) (l: 1) as eluant, to leave the enamide (288) (230 
mg, 56 %) as a colourless oily 2: 1 mixture of Z:E isomers. Major Z isomer: OH (250 
MHz, CDCI3) 5.58 (IH, m, CH=CN), 5.21 (lH, t, J 7.0 Hz, C=CHCH2N), 3.98 (2H, 
d, J 7.0 Hz, CHCH2N), 3.66 (3H, s, C02CH3), 2.28 (2H, t, J 7.5 Hz, CH2C02), 2.11-
2.04 (6H, m, CH2C(Me)=CH and CH2CH=C(N)CH2), 1.99 (3H, s, NCOCH3), 1.78-
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1.52 (6H, m, CH2CH2CH2 and CH2CH2CH2CH2)' 1.69 (3H, s, C(CH3)=CH); Be 
(67.8 MHz, CDCI3) 174.0 (s), 168.6 (s), 139.3 (s), 137.7 (8), 127.5 (d), 121.9 Cd), 
51.6 (q), 43.4 (t), 38.9 (t), 33.6 (s), 31.1 (t), 28.4 (t), 24.9 (t), 23.3 (q), 22.9 (t), 21.7 
, 
(q), 21.7 (t); Minor E isomer: BH (250'MHz, CDCI3) 5.58 (lH, m, CH=CN), 5.18 (lH, 
t, J 7.0 Hz, C=CHCH2N), 4.02 (2H, d, J 7.0 Hz, CHCH2N), 3.66 C3H, s, C02CH3), 
2.25 (2H, t, J 7.5 Hz, CH 2C O2), 2.11-2.04 (6H, m, CH2C(Me)=CH and 
CH2CH=C(N)CH2), 1.99 (3H, s, NCOCH3), 1.78-1.52 (6H, m, CH2CH2CH2 and 
CH2CH2CH2CH2), 1.62 (3H, s, C(CH3)=CH); Be (67.8 MHz, CDCI3) 174.0 (s), 
168.6 (s), 139.3 (s), 137.7 (s), 127.5 (d), 121.2 (d), 51.6 (q), 43.4 (t), 38.9 (t), 33.6 (s), 
33.4 (t), 28.4 (t), 24.9 (t), 23.3 (t), 22.9 (t), 21.7 (q), 16.0 (q); Both isomers: 'Umax 
(liquid film)/cm- 1 2932 (s), 1737 (s), 1650 (s), 1436 (s), 1396 (m), 1172 (m), 922 (w); 
mlz (EI) 293.1986 (M+, C17H27N03 requires 293.1991). 
Phellyl 7-amillo-(N-acetyl, N -cyclohex-l '-ell-1'-yl)-S-methylhept-S-ellselelloate 
(262) 
262 
A solution of lithium hydroxide (50 mg, 1.2 mmol) in water (15 cm3) was added in 
one portion to a stirred solution of methyl 7-amino-(N-acetyl, N-cyclohex-l '-en-l '-
yl)-5-methylhept-5-enoate (288) (240 mg, 0.8 mmol) in tetrahydrofuran (15 cm3) at 
room temperature and was left to stir for 2 h. The solution was reduced in vacuo and 
acidified to pH 1 with hydrochloric acid (2 moldm-3). The aqueous was extracted 
with dichloromethane (3x20 cm3), the combined organics were dried (Na2S04) and 
reduced in vacuo to leave a colourless oily residue. 
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The residue was taken up in benzene (9 em3), diphenyl diselenide (510 mg, 1.6 mmol) 
was added and the solution was set stirring. Tri-n-butylphosphine (410 J.d, 330 mg, 
1.6 mmol) was added dropwise over 10 min to the stirred solution at room 
temperature and the mixture was left overnight. The solvent was removed in vacuo 
and to leave a yellow whieh oil was purified by chromatography on silica, using 
petroleum (b.p. 40-60°C) and then ether - petroleum (b.p. 40-60°C) (3:2) as eluant, to 
leave the seiellyl ester (262) (210 mg, 62 %) as a very pale yellow oil. Major Z 
isomer: OH (400 MHz, CDCI3) 7.50 (2H, m, Ar-H), 7.37 (3H, m, Ar-H), 5.58 (lH, s, 
CH=CN), 5.23 (lH, t, J 7.0 Hz, C=CHCH2N), 3.99 (2H, d, J 6.9 Hz, CHCH2N), 2.69 
(2H, t, J 7.2 Hz, CH2COSe), 2.64-2.05 (6H, m, CH2CH=C(N)CH2 and 
CH2C(Me)=CH), 2.00 (3H, s, NCOCH3), 1.81-1.56 (6H, m, CH2CH2CH2CH2 and 
CH2CH2CH2), 1.69 (3H, s, CCH3); it (67.8 MHz, CDC13) 199.5 (s), 169.0 (s), 138.8 
(s), 136.8 (s), 135.3 (d), 128.9 (d), 128.4 (d), 127.0 (d), 126.1 (d), 121.7 (d), 46.5 (t), 
42.9 (t), 30.3 (t), 27.8 (t), 24.4 (t), 23.1 (t), 22.7 (q), 22.4 (t), 21.2 (q), 21.2 (t); Minor 
E isomer: OH (400 MHz, CDC]3) 7.50 (2H, m, Ar-H), 7.37 (3H, m, Ar-H), 5.58 (lH, 
s, CH=CN), 5.22 (IH, t, J 7.0 Hz, C=CHCH2N), 4.03 (2H, d, J 6.9 Hz, CHCH2N), 
2.67 (2H, t, J 7.2 Hz, CH 2COSe), 2.64-2.05 (6H, m, CH2CH=C(N)CH2 and 
CH2C(Me)=CH), 2.00 (3H, s, NCOCH3), 1.81-1.56 (6H, m, CH2CH2CH2CH2 and 
CH2CH2CH2), 1.63 (3H, s, CCH3); it (67.8 MHz, CDC13) 199.5 (s), 169.0 (s), 138.8 
(s), 136.8 (s), 135.3 (d), 128.9 (d), 128.4 (d), 127.0 (d), 126.1 (d), 121.1 (d), 46.3 (t), 
38.0 (t), 30.3 (t), 27.8 (t), 24.4 (t), 23.1 (t), 22.7 (q), 22.4 (t), 21.2 (t), 15.5 (q);Both 
isomers: umax (liquid film)/cm- 1 3425 (b), 2931 (s), 2857 (m), 1722 (s), 1648 (s), 
1578 (w), 1477 (w), 1438 (s), 1396 (s), 1365 (w), 1283 (w), 1260 (w), 1201 (w), 1139 
(w), 1066 (w), 1021 (w), 999 (w), 979 (w), 922 (w), 840 (w), 740 (m), 690 (m), 671 
(w); Found %: C, 63.0; H, 6.90; N, 3.4 (C22H29N02Se requires C, 63.1; H, 7.0; N, 
3.4); m/z (CI) 420.1437 (M+H+, C22H30N0280Se requires 420.1442), 418.1425 
(M+H+' C22H30N0278Se requires 418.1450). 
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9-Aza-(N-acetyl)-4a{3-methyl-3, 4, 4ba, 5, 6, 7,.8, 8a{3, 10, 10aa-
decahydrophenanthren-l (2H)-one (261) 
261 
A solution of tributyltin hydride (60 ,.Ll, 60 mg, 0.21 mmol) and AIBN (7 mg) in 
degassed benzene (2 cm3) was added dropwise over 2 h to a refluxing solution of 
phenyl 7 -amino-(N-acetyl, N-cyclohex-! '-en-! '-yl)-5-methylhept-5-enselenoate (262) 
(70 mg, 0.17 mmol) and AIBN (8 mg) in degassed benzene (38 cm3) under argon and 
the solution was left to reflux for a further 2 h. The solvent was removed in vacuo 
and the resulting residue was purified by chromatography on silica using ethyl acetate 
- petroleum (b.p. 40-60°C) (1:3) as eluant, to leave the cyclised product (261) (30 mg, 
65 %) as a colourless oil. oH(500 MHz, CDCI3) 3.73 (lH, dd, J 13.9 Hz and 8.3 Hz, 
CHHN), 3.43 (lH, dd, J 13.9 Hz and 7.1 Hz, CHHN), 3.37 (IH, app. td, J 10.7 Hz 
and 2.8 Hz, CHN), 2.51 (IH, app. t, J 7.7 Hz, COCH), 2.48-2.30 (3H, m, CH2CO), 
2.14 (3H, s, NCOCH3), 2.10 (lH, m), 1.97 (lH, m), 1.91-1.73 (4H, m), 1.56-1.38 
(4H, m), 1.32 (lH, m), 1.12 (lH, m), 0.71 (3H, s, CCH3); oe (125.8 MHz, CDCI3) 
209.8 (s), 171.9 (s), 57.4 (d), 57.1 (d), 52.0 (d), 40.7 (s). 40.4 (t), 40.1 (t), 36.0 (t), 
31.7 (t), 26.4 (t), 26.1 (t), 25.6 (t), 23.6 (q), 22.3 (t), 13.0 (q); 'Umax (liquid film)/cm- 1 
3395 (br), 2934 (s), 2359 (s), 1714 (s), 1634 (s), 1454 (s), 1200 (s), 1049 (m), 668 (s); 
mlz (EI) 263.1883 (M+, Cl6li25N02 requires 263.1885). 
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Epimeristation reaction 
261 291 
A mixture of the tricycle (291) (10 mg, 0.04 mmol) and sodium methoxide (5 mg) in 
methanol (1 cm3) was heated at reflux for 60 h. The mixture was allowed to cool to 
room temperature and diluted with ethyl acetate (10 cm3) and water (10 cm3), the 
layers were separated and the aqueous fraction was extracted with ethyl acetate (2xlO 
cm3). The combined organics were dried (MgS04) and reduced in vacuo to leave an 
oil which was purified by chromatography on silica using ethyl acetate - petroleum 
(b.p. 40-60°C) (1:3) as eluant, to give the 9-aza-(N-acetyl)-4a{3-methyl-3, 4, 4ba, 5, 6, 
7, 8, 8a{3, 10, 10aa-decahydrophenanthren-l(2H)-one (261) (4 mg, 40 %) eluted first, 
as a colourless oil, as before, and its 9-aza-(N-acetyl)-4a{3-methyl-3, 4, 4ba, 5, 6, 7, 8, 
8a{3, 10, 10a{3-decahydrophenantlzrell-l(2H)-one (291) (4 mg, 40%) eluted second, as 
a white crystaline solid. BH (500 MHz, CDCI3, 328K) 4.00 (1H, br, CRN), 3.60 (1H, 
br, CHHN) , 3.42 (lH, br, CHHN), 2.42 (2H, m), 2.27 (lH, m), 2.07 (3H, s, 
NCOCH3), 2.02 (2H, m), 1.81 (4H, m), 1.57 (lH, m), 1.47 (lH, m), 1.35 (1H, m), 
1.25 (1H, m), 1.15 (1H, m), 1.06 (3H, s, CCH3); Be (125.8 MHz, CDC)3' 328K) 213.0 
(s), 169.2 (s), 56.1, 54.2, 47.2, 39.3, 37.7, 35.8, 30.7, 26.5, 26.0, 26.0, 25.3, 22.9, 21.6. 
18.1; mJz (EI) 263.1883 (M+, C16H2SN02 requires 263.1885). 
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6-Chloro-3, 7-dimethylocta-2, 7-dienyl acetate (302) 125 
AcO 
CI 
302 
tert-Butylhypochlorite (2.2 cm3, 2.1 g, 19 mmol) was added dropwise over 5 min to a 
stirred mixture of geranyl acetate (301) (3.8 cm3, 3.4 g, 18 mmoJ) and silica (4.4 g) in 
petroleum (b.p. 40-60°C) (70 cm3) at O°C. The mixture was stirred for a further 40 
min at O°C and then allowed to warm to room temperature over 1.5 h. A saturated 
aqueous solution of sodium sulfite (70 cm3) was added, the layers were separated and 
the aqueous layer was washed with pentane (2x60 cm3). The combined organics were 
then washed with water (50 cm3), dried (Na2S04) and reduced in vacuo to leave a 
pale yellow oil. The oil was purified by chromatography on silica using ethyl acetate 
- petroleum (b.p. 40-60°C) (1: 19) as eluant to leave the allylic chloride (302) (3.9 g, 
96 %) as a colourless oil. DH (360 MHz, CDCI3) 5.34 (lH, t, 17.0 Hz, C=CHCH20), 
4.98 (lH, s, C=CHH), 4.87 (1H, s, C=CHH), 4.55 (2H, d, 1 7.0 Hz, CHCH20Ac), 
4.31 (lH, t, J 6.3 Hz, CCCIHCH2), 2.l8-1.84 (4H, m, CCIHCH2CH2C), 2.02 (3H, s, 
CH3C02), 1.78 (3H, s, CH2=CCH3), 1.68 (3H, s, C(CH3)=CH); DC (90.6 MHz, 
CDCI3) 170.9 (s), 144.0 (s), 140.4 (s), 119.3 (d), 114.2 (t), 66.0 (d), 61.1 (t), 36.4 (t), 
34.2 (t), 20.9 (q), 16.9 (q), 16.3 (q); u max (thin film) 2951 (m), 2360 (w), 2254 (w), 
1739 (s), 1670 (w), 1646 (w), 1446 (m), 1366 (m), 1234 (s), 1024 (m), 956 (w), 911 
(m), 790 (w), 734 (m). 
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Ethyl ll-acetoxy-5,9-dimethylllndeca-5,9-dienoate (305) 125. 
AcO OEt 
305 
Zinc chloride (3.4 g, 25 mmol) was heated at 0.5 mmHg until it melted and then was 
left to cool to room temperature and ether (60 cm3) was added. The mixture was 
heated at reflux for 1 h, left to cool to room temperature and ethoxy 
cyclopropyloxytrimethylsilane (10 cm3, 8.8 g, 50 mmol) was added in one portion. 
The cloudy mixture was stirred at room temperature for 1 h and then refluxed for a 
further 30 min, cooled to room temperature and trimethylsilyl chloride (6.4 cm3, 5.5 
g, 50 mmol) was added in one portion. The resulting solution was transfered via 
cannula, dropwise over 5 min to a stirred solution of 6-chloro-3,7-dimethylocta-2,7-
dienyl acetate (303) (3.9 g, 17 mmol) and copper bromide.dimethyl sulfide (210 mg, 
1.0 mmol) in dimethyl formamide (80 cm3) at room temperature. The pale yellow 
solution was left to stir overnight and then diluted with ether (600 cm3) and water 
(600 cm3). The layers were separated and the organic phase was washed with water 
(500 cm3) and brine (200 cm3), dried (MgS04) and reduced in vacuo to leave a 
colourless oil. The oil was purified by chromatography on silica using ethyl acetate -
petroleum (b.p. 40-60°C) (1:9) as eluant to leave the ester (305) (4.5 g, 89 %) as an 
oily C-5 2: 1 mixture of E:Z isomers. Major E isomer: OH (360 MHz, CDCb) 5.34 
(lH, t, J 7.0 Hz, C=CHCH20), 5.10 (lH, t, J 7.6 Hz, C=CHCH2), 4.58 (2H, d, J 7.0 
Hz, C=CHCH20), 4.12 (2H, q, J 7.2 Hz, OCH2CH3), 2.26 (2H, m, CH2C02Et), 2.11-
1.98 (6H, m, CH2C=CHCH2CH2C), 2.06 (3H, s, CH 3C02), 1.72 (2H, m, 
CH2CH2CH2) , 1.70 (3H, s, C(CH3)=CH), 1.59 (3H, s, C(CH3)=CH), 1.26 (3H, t, J 
7.2 Hz, OCH2CHj); Be (90.6 MHz, CDCI3) 173.4 (s), 170.7 (s), 141.7 (s), 134.2 (s), 
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124.4 (d), 118.2 (d), 61.0 (t), 59.9 (t), 39.2 (t), 38.7 (t), 33.6 (t), 25.9 (t), 22.8 (t), 20.7 
(q), 16.2 (q), 15.5 (q), 14.0 (q); Minor Z isomer: ~ ~ (360 MHz, CDC13) 5.34 (lH, t, J 
7.0 Hz, C=CHCH20), 5.12 (1H, t, J 7.6 Hz, C=CHCH2), 4.58 (2H, d, J 7.0 Hz, 
I . 
C=CHCH20), 4.12 (2H, q, J 7.2 Hz, OCH2CH3), 2.26 (2H, m, CH2C02Et), 2.11-1.98 
(6H, m, CH2C=CHCH2CH2C), 2.06 (3H, s, CH3C02), 1.72 (2H, m, CH2CH2CH2), 
1.70 (3H, s, C(CH3)=CH), 1.68 (3H, s, C(CH3)=CH), 1.26 (3H, t, J 7.2 Hz, 
OCH2CH3); Be (90.6 MHz, CDC}3) 173.4 (s), 170.7 (s), 141.7 (s), 134.2 (s), 125.0 
(d), 118.2 (d), 61.0 (t), 59.9 (t), 39.5 (t), 33.6 (t), 30.8 (t), 25.8 (t), 22.9 (q), 22.9 (t), 
20.7 (q), 15.5 (q), 14.0 (q); Both isomers: 'l>max (thin film) 2934 (m), 1737 (s), 1446 
(m), 1368 (m), 1233 (s), 1096 (w), 1026 (m), 955 (w), 858 (w); Found %: C, 68.7; H, 
9.8 (C17H2S04 requires C, 68.9; H, 9.5); mlz (EI) 237.1831 (M-OCOCH3+, 
ClSH2502 requires 237.1855). 
Ethyl 5,9-dimethyl-ll-hydroxyundeca-5,9-dienoate (304)125 
HO OEt 
304 
Potassium cyanide (920 mg. 14 mmol) was added in one portion to a stirred solution 
of ethyl 11-acetoxy-5,9-dimethylundeca-5,9-dienoate (305) (2.1 g, 7.1 mmol) in 
ethanol (50 em3) at room temperature and resulting mixture was heated at reflux for 
15 h. The mixture was reduced in vacuo and taken up in ether (100 em3) and water 
(50 cm3), the layers were then separated and the aqueous portion was washed with 
ether (50 em3), the combined organics were then washed with brine (25 cm3), dried 
(MgS04) and reduced in vacuo. The oily residue was purified by chromatography on 
silica using ethyl acetate - petroleum (b.p. 40-60°C) (1:3) as eluant to leave the 
alcohol (304) (1.5 g, 83 %) as an oily 2: 1 mixture of C-5 E:Z isomers. Major E 
137 
isomer: BH (400 MHz, CDCI3) 5.41 (lH, t, J 7.0 Hz, C=CHCH20), 5.12 (IH, t, J 7.6 
Hz, C=CHCH2), 4.14 (4H, m, C=CHCH20 and OCH2CH3), 2.24 (2H, t, J 7.0 Hz, 
CH2C02Et), 2.15-1.98 (6H, m, CH2C=CHCH2CH2C), 1.61 (2H, m, CH2CH2CH2), 
1.57 (3H, s, C(CH3)=CH), 1.50 (3H, s, C(CH3)=CH), 1.26 (3H, t, J 7.2 Hz, 
OCH2CH3); Bc (90.6 MHz, CDC13) 173.9 (s), 138.6 (s), 134.0 (s), 124.7 (d), 123.6 
(d), 60.2 (t), 59.0 (t), 39.2 (t), 38.6 (t), 33.4 (t), 25.9 (t), 22.7 (t), 16.0 (q), 15.5 (q), 
14.0 (q); Minor Z isomer: BH (400 MHz, CDCI3) 5.41 (lH, t, J 7.0 Hz, C=CHCH20), 
5.15 (lH, t, J 7.6 Hz, C=CHCH2), 4.14 (4H, m, C==CHCH20 and OCH2CH3), 2.24 
(2H, t, J 7.0 Hz, CH2C02Et), 2.15-1.98 (6H, m, CH2C==CHCH2CH2C), 1.61 (2H, m, 
CH2CH2CH2), 1.57 (6H, s, C(CH3)==CH and C(CH3)=CH), 1.26 (3H, t, J 7.2 Hz, 
OCH2CH3); Bc (90.6 MHz, CDCI3) 173.9 (s), 138.6 (s), 134.3 (s), 125.3 (d), 123.5 
(d), 60.1 (t), 59.0 (t), 39.5 (t), 33.7 (t), 30.8 (t), 26.0 (t), 23.0 (q), 22.9 (t), 15.5 (q), 
14.0 (q); Both isomers: 'Umax (thin film) 3424 (br), 2933 (m), 1733 (s), 1446 (m), 1375 
(m), 1304 (w), 1242 (m), 1197 (m), 1158 (m), 1096 (w), 1027 (m), 857 (w), 785 (w); 
Found %: C, 70.7; H, 10.3 (ClsH2603 requires C, 70.8; H, 10.3); mlz (EI) 236.1768 
(M-H20+, ClsH2402 requires 236.1776). 
Zinc azide dipyridille compiex124 
A solution of sodium azide (3.0 g, 46 mmo) in water (23 cm3) was added portionwise 
over 5 min to a stirred solution of zinc nitrate (6.9 g, 23 mmol) in water (12 cm3) at 
room temperature. The solution was heated to 50°C for 2 h and then pyridine (7.5 
cm3, 7.3 g, 92 mmol) was added dropwise over 5 min resulting in the formation of a 
dense white precipitate. The suspension was allowed to cool to room temperature 
over 5 h, cooled in ice, filtered and washed with ice cold water. The collected white 
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solid was dried in vacuo (P205) for 4 h to leave the azide (5.7 g, 80 %) as a fine white 
crystalline solid. . 
Ethyl ll-aZido-5,9-dimethylundeca-5,9-di(moate (306) 
OEt 
306 
Di-iso-propyl azodicarboxylate (740 ~ l , , 760 mg, 3.8 mmol) was added dropwise over 
3 min at room temperature to a mixture of zinc azide (790 mg, 2.6 mmol), 
triphenylphosphine (990 mg, 3.8 mmol) and ethyl 5,9-dimethyl-l1-hydroxyundeca-
5,9-dienoate (304) (870 mg, 3.4 mmol) in toluene (36 cm3). The solution was stirred 
for 10 min and then filtered through a pad of celite. The resulting clear pale yellow 
solution was reduced in vacuo and the residue was adsorbed on silica and then 
purified by chromatography on silica using ethyl acetate - petroleum (b.p. 40-60·C) 
(1:9) as eluant to give the azide (306) (590 mg, 62 %) as an oily C-5 and C-9 E:Z 
mixture of isomers. Major C-5 E and C-9 E isomer: OH (360 MHz, CDC13) 5.30 (lH, 
t, J 7.3 Hz, C=CHCH2N3), 5.08 (lH, m, C=CHCH2), 4.08 (2H, t, J 7.2 Hz, 
OCH2CH3), 3.73 (2H, d, J 7.3 Hz, C=CHCH2N3), 2.21 (2H, t, J 7.3 Hz, CH2C02Et), 
2.13-1.95 (6H, m, CH2C=CHCH2CH2C), 1.72 (2H, m, CH2CH2CH2), 1.67 (3H, s, 
C(CH3)=CH), 1.57 (3H, s, C(CH3)=CH), 1.22 (3H, t, J 7.2 Hz, OCH2CH3); oe (90.6 
MHz, CDCI3) 173.6 (s), 142.8 (s), 134.4 (s), 124.3 (d), 117.0 (d), 60.0 (t), 47.8 (t), 
39.3 (t), 38.7 (t), 33.5 (t), 26.1 (t), 22.9 (t), 16.0 (q), 15.6 (q), 14.1 (q); umax (thin 
film) 2925 (s), 2097 (s), 1736 (s), 1448 (m), 1375 (m), 1249 (m), 1032 (m), 879 (w); 
mlz (FAB) 252.1948 (M+H-N2+, C15H2t>N02 requires 252.1964). 
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Ethylll-amino-5,9-dimethylundeca-5,9-dienoate (300) 
OEt 
300 
Triphenylphosphine (520 mg, 2.0 mmo!) was added in one portion to a stirred 
solution of ethyl ll-azido-5,9-dimethylundeca-5,9-dienoate (306) (370 mg, 1.3 mmol) 
in tetrahydrofuran (15 em3) at room temperature and left to stir overnight. Water (26 
J,LI, 26 mg, 1,4 mmol) was then added at room temperature and the solution was left to 
stir overnight, diluted with water (20 em3) and ether (30 em3) and the layers were 
then separated. The aqueous layer was extracted with ether (2x30 cm3) and the 
combined organics were then dried (Na2S04) and reduced in vacuo. The resulting 
colourless residue was purified by chromatography on silica using dichloromethane -
methanol - di-iso-propylamine (90: 10: 1) as eluant to give the amine (300) (240 mg, 
74 %) as a colourless oily mixture of isomers. Major C-5 E, C-9 E isomer: OH (360 
MHz, CDCI3) 8.00 (2H, br, CH2NH2), 5.37 (1H, t, J 6.5 Hz, C=CHCH2NH2), 5.09 
(lH, m, C=CHCH2), 4.12 (2H, t, J 7.2 Hz, OCH2CH3), 3.59 (2H, br, 
C=CHCH2N H 2), 2.25 (2H, t, J 7.6 Hz, CH2C02Et), 2.10-1.97 (6H, m, 
CH2C=CHCH2CH2C), 1.72 (5H, m, CH2CH2CH2 and C(CH3)=CH), 1,48 (3H, S, 
C(CH3)=CH), 1.26 (3H, t, J 7.2 Hz, OCH2CH3); Be (90.6 MHz, CDCI3) 173,4 (s), 
136.1 (s), 134.0 (s), 125.8 (d), 124.8 (d), 60.0 (t), 39.5 (t), 39.3 (t), 38.8 (t), 33.5 (t), 
26.2 (t), 22.9 (t), 16.0 (q), 15.6 (q), 14.1 (q); Umax (thin film) 3372 (br), 2931 (s), 2857 
(m), 1734 (s), 1665 (w), 1589 (w), 1447 (m), 1374 (m), 1304 (w), 1246 (m), 1178 
(m), 1157 (m), 1097 (w), 1031 (m), 856 (w); mlz (FAB) 254.2128 (M+H+, 
C15H2SN02 requires 254.2120). 
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Ethyill-amino-(N-acetyl, N-cyclohex-l '-en-l '-yl)-S,9-dimethylundeca-S,9-dienoate 
(307) 
OEt 
307 
Cyclohexanone (200 Ill, 190 mg, 1.9 mmol) was added in one portion at room 
temperature to a stirred mixture of ethyl l1-amino-5,9-dimethylundeca-5,9-dienoate 
(300) (240 mg, 0.96 mmol) and molecular sieves (4 A, activated) in benzene (55 cm3) 
and the mixture was left to stir for 24 h. Lutidine (170 Ill, 150 mg, 1.4 mmol) was 
then added to the mixture in one portion at room temperature followed by acetyl 
chloride (100 Ill, 105 mg, 1.3 mmol), in one portion also. The solution was then left 
to stir for 2 h, filtered through a pad of celite and reduced in vacuo to leave a yellow 
residue which was purified by chromatography on silica using ethyl acetate -
petroleum (b.p. 40-60·C) (1:3) as eluant to give the enamide (307) (160 mg, 43 %) as 
a colourless oil. Major C-5 E, C-9 E isomer: OH (360 MHz, CDCh) 5.58 (1H, m, 
CH=CN), 5.21-5.07 (2H, m, 2xC=CHCH2), 4.12 (2H, q, J 7.1 Hz, OCH2CH3), 4.02 
(2H, d, J 7.0 Hz, C=CHCH2N), 2.27 (2H, m, CH2C02Et), 2.11-1.97 (10H, m, 
CH2C=CHCH2CH2C and CH2C(N)=CHCH2), 2.01 (3H, s, NCOCH3), 1.76-1.56 
(12H, m, CH2CH2C(CH3)=CH, C(CH3)=CH and CH2CH2CH2CH2), 1.26 (3H. t. J 
7.1 Hz, OCH2CH3); oe (90.6 MHz. CDCI3) 173.8 (s), 169.5 (s), 139.2 (s), 138.6 (s). 
134.2 (s), 127.3 (d), 124.9 (d), 120.1 (d). 60.2 (t), 43.4 (t). 39.5 (t), 33.9 (t), 33.7 (t), 
29.7 (t), 28.2 (t), 24.8 (t), 23.4 (q), 23.1 (t), 22.8 (t), 21.6 (t), 21.6 (q), 15.7 (q), 14.2 
(q); umax (thin film) 2929 (s), 2856 (m), 1733 (s), 1651 (s), 1446 (m), 1393 (m), 1259 
(m), 1178 (m), 1031 (m); mlz (EI) 375.2770 (M+, C23H37N03 requires 375.2773) 
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]]-amino-(N-acetyl, N-cyclolzex-] ' -en-] '-yl)-S,9-dimethylundeca-S,9-dienoic acid 
(308) 
OH 
308 
A solution of lithium hydroxide (33 mg, 0.80 mmol) in water (8 cm3) was added in 
one portion to a stirred solution of ethyl ll-amino-(N-acetyl, N-cyclohex-l'-en-l'-yl)-
5,9-dimethylundeea-5,9-dienoate (307) (150 mg, 0.40 mmol) in tetrahydrofuran (8 
em3) at room temperature. The solution was left to stir for 12 h and then acidified to 
pH 1 with hydrochloric acid (2 moldm-3) and diluted with dichloromethane (30 em3) 
and water (20 em3). The layers were separated and the aqueous layer was extracted 
with dichloromethane (2x30 em3) and the combined organics were dried (Na2S04) 
and reduced in vacuo to leave the acid (308) (140 mg, 99 %) as a colourless oily 
mixture of isomers. Major C-5 E, C-9 E isomer: ~ ~ (400 MHz, CDCI3) 9.35 (lH, br, 
C02H), 5.60 (lH, m, CH=CN), 5.16 (2H, m, 2xC=CHCH2), 4.02 (2H, d, J 7.0 Hz, 
C=CHCH2N), 2.33 (2H, m, CH2C02), 2.11-1.97 (IOH, m, CH2C=CHCH2CH2C and 
CH2C(N)=CHCH2), 2.03 (3H, s, NCOCH 3), 1.76-1.56 (l2H, m, 
CH2CH2C(CH3)=CH, C(CH3)=CH and CH2CH2CH2CH2); Oc (90.6 MHz, CDCI3) 
177.8 (s), 170.2 (s), 138.6 (s), 138.4 (s), 134.3 (s), 127.4 (d), 124.9 (d), 120.0 (d), 43.8 
(t), 39.3 (t). 33.2 (t), 31.8 (t), 29.6 (t), 28.2 (t), 28.1 (t), 26.0 (t), 24.7 (t), 22.9 (t), 21.5 
(q), 16.0 (q), 15.6 (q); Umax (thin film) 3211 (br), 2930 (s), 2857 (m), 1731 (s), 1650 
(s), 1678 (s), 1447 em), 1409 (m), 1260 (m), 1031 (m); mlz (FAB) 348.2558 (M+H+, 
C21H34N03 requires 348.2539). 
142 
Phenyl ll-amino-(N -acetyl, 
dienselenoate (297) 
N-cyclohex-l ' -en-I' -yl)-5,9-dimethylundeca-5,9-
SePh 
297 
Tri-n-butylphosphine (150 ,.tI, 120 mg, 0.59 mrnol) was added dropwise over 2 min to 
a solution of 11-amino-(N -aeety I, N-eyclohex-l'-en-l'-yl)-5,9-dimethylundeea-5,9-
dienoic acid (308) (140 mg, 0.40 mmol) in dichloromethane (3 cm3) at _30°C and was 
left to stirr for 5 min. N-Phenylselenophthalamide (180 mg, 0.59 mmol) was added in 
one portion and then after 5 min at -30°C brine (4 em3) and water (4 em3) were added 
and the resulting mixture was allowed to warm to room temperature over 20 min. The 
mixture was diluted with dichloromethane (30 em3), the layers were separated and the 
aqueous layer was extracted with diehloromethane (2x30 em3), the combined organics 
were dried (Na2S04) and reduced in vacuo to leave a pale yellow oil. The oil was 
purified by chromatography on silica using ethyl acetate - petroleum (b.p. 40-60°C) 
(2:3) to leave a pale yellow semi-solid which was further purified by titiration from 
pentane to give the selenyl ester (297) (160 mg, 80 %) as a colourless oily mixture of 
isomers. Major C-5 E, C-9 E isomer: OH (360 MHz, CDCI3) 7.50 (2H, m, Ar-H), 7.39 
(3H, m, Ar-H), 5.58 (1H, m, CH=CN), 5.20 (2H, m, 2xC=CHCH2), 4.04 (2H, d, J 7.0 
Hz, C=CHCH2N), 2.66 (2H, m, CH2COSe), 2.11-1.97 (lOH, m, CH2C=CHCH2CH2C 
and CH2C(N)=CHCH2), 2.01 (3H, s, NCOCH3), 1.76-1.56 (l2H, m, 
CH2CH2C(CH3)=CH, C(CH3)=CH and CH2CH2CH2CH2); Be (90.6 MHz, CDCI3) 
200.3 (s), 169.5 (s), 139.2 (s), l38.5 (s), l35.7 (d), l33.7 (s), 129.3 (d), 128.8 (d), 
127.3 (d), 126.5 (s), 125.4 (d), 120.1 (d), 46.8 (t), 43.4 (t). 39.5 (t), 30.7 (t), 28.2 (t), 
26.4 (t), 24.8 (t), 23.4 (t), 22.8 (t), 21.6 (q), 21.6 (t), 16.1 (q), 15.6 (q); 'Umax (thin 
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film) 2930 (s), 2857 (m), 1725 (s), 1650 (s), 1438 (m), 1395 (m), 1281 (w), 1066 (w), 
1022 (w), 922 (w); mlz (FAB) 488.2058 (M+H+, C27H38N0280Se requires 488.2068), 
486.2046 (M+H+, C27H38N0278Se requires 486.2076). 
l-Amino-(N-acetyl, N-cyclohex-l'-en-l'-yl)-5-(3 "-methylcyclohex-l "-on-2 "-yl)-3-
methylpent-2-ene (310) and tetracyclic compound (296) 
310 296 
A solution of tri-ll-butyltin hydride (70 J,ll, 75 mg, 0.26 mmol) and AIBN (5 mg) in 
degassed benzene (5 cm3) was added dropwise over 8 h to a refluxing solution of 
phenyl 12-amino-(N-acetyl, N-cyclohex-l'-en-l'-yl)-5,9-dimethylundeca-5,9-
dienselenoate (297) (100 mg, 0.21 mmol) and AIBN (5 mg) in degassed benzene (63 
. cm3), under argon. The solution was left to reflux for a further 4 h and then allowed 
to cool to room temperature and reduced in vacuo to leave a colourless oil. The oil 
was then purified by chromatography on silica using ethyl acetate - petroleum (b.p. 
40-60·C) (2:3) to ethyl acetate - petroleum (b.p. 40-60·C) (7:3) as eluant to give 1-
amino-eN-ace fyi, N -cyclohex-l '-enol '-yl)-5-( 3"-mefhylcyclo/zex-1 "-on-2"-yl)-3-
methylpent-2-ene (310) (10 mg, 10 %) as a colourless oily 4:1 mixture of isomers, 
eluted first. Major isomer: OH (500 MHz, CDCh) 5.58 (lH, m, NC=CH), 5.17 (lH, t, 
J 6.8 Hz, C=CHCH2), 4.02 (2H, d, J 6.8 Hz, C=CHCH2N), 2.45-2.25 (3H, m), 2.l1-
2.02 (4H, m), 2.00 (3H, s, NCOCH3), 1.89 (2H, m), 1.69 (3H, s, CCH3), 1.68-1.56 
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(6H, m), 1.29-1.23 (5H, m), 0.81 (3H, d, 17.1 Hz, CHCH3); Be (l25.S MHz, CDC13) 
213.4 (s), 169.5 (s), 139.3 (s), 138.3 (s), 127.3 (d), 121.3 (d), 54.6 (d), 43.4 (t), 41.6 
(t), 36.6 (t), 31.8 (t), 28.2 (t), 25.0 (t), 24.S (t), 24.7 (t), 23.4 (t), 23.3 (q), 22.S (t), 21.6 
(q), 21.6 (t), 14.2 (q); m/z (EI) 331.2522 (M+, C21H33N02 requires 331.2511) and the 
tetra cycle (296) (42 mg, 45 %) as a colourless oily 4: 1 mixture of isomers. Major 
trans, anti, trans, anti, trans isomer: OH (360 MHz, CDC}3, 328 K) 3.55 (2H, m, 
CHCH2N), 3.32 (lH, dd,1 10.6 Hz and 2.6 Hz, NCHCH2), 2.32 (3H, m), 2.11 (3H, s, 
NCOCH3), 2.15-0.97 (ISH, m), 0.85 (3H, s, CCH3), 0.S3 (3H, s, CCH3); Oe (90.6 
MHz, CDCI3) 212.2 (s), 171.S (s), 59.4 (d), 57.9 (d, br.), 55.S (d), 55.0 (d), 43.0 (s), 
41.7 (t, br.), 40.8 (t), 37.6 (t), 36.3 (t), 33.9 (s), 33.6 (t), 26.6 (t), 25.4 (t), 25.3 (t), 23.0 
(q), 22.1 (t), 17.1 (t), 14.7 (q), 13.4 (q); m/z (EI) 331.2500 (M+, C21H33N02 requires 
331.2511). 
Reduced tetracycle (312) 
. 312 
Sodium borohydride (1.5 mg, 39 J,.I.mol) was added in one portion at room temperature 
to a stirred solution of the ketone (297) (11 mg, 36 J,.I.mol) and methanol (5.0 Ill, 4.S 
mg, 120 J,.I.mol) in ether (2 em3) and left to stir for 4 hours. Methanol (5.0 Ill, 4.8 mg, 
120 J,.I.mol) was added in one portion followed by sodium borohydride (4.5 mg, 120 
Ilmol) also in one portion and the mixture was left to stir at room temperature 
overnight. Water (10 em3) was added and the mixture was diluted with ether (5 em3), 
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the layers were separated and the aqueous fraction was washed with ether (2x5 cm3). 
The combined organics were dried (Na2S04) and reduced in vacuo to leave an oily 
residue. This residue was purified by chromatography on silica using methanol -
diehloromethane (6:94) as eluant to leave the reduced tetra cycle (312) (10 mg, 99%) 
as a colourless oily 4: 1 mixture of isomers. Major trans, anti, trans, anti, trans 
isomer: 5H (360 MHz, CDCI3, 328K) 3.86 (1H, m, CHOH), 3.54 (lH, dd, J 13.3 Hz 
and 9.9 Hz, NCHHCH), 3.40 (lH, dd, J 13.3 Hz and 9.4 Hz, NCHHCH), 3.33 (lH, 
app. td, J 10.6 Hz and 2.6 Hz, NCHCH2), 2.36 (lH, m, CHCHOH), 2.10 (3H, s, 
NCOCH3), 1.89-1.01 (21H, m), 1.10 (3H, s, CCH3), 0.87 (3H, s, CCH3); 5c (90.6 
MHz, CDCI3) 171.7 (s), 72.0 (d), 57.7 (d), 56.4 (d), 55.7 (d), 50.8 (d), 41.1 (t), 38.6 
(t), 37.1 (s), 34.6 (s), 33.8 (t), 33.1 (t), 26.7 (t), 25.6 (t), 25.5 (t), 23.2 (t), 23.1 (q), 
16.2 (t), 15.3 (q), 15.2 (q); m/z (EI) 333.2676 (M+, C21H35N02 requires 333.2668) 
Ester tetracycle (313) 
o 
o 
313 
3,5-Dinitrobenzyl chloride (15 mg, 32 Jlmol) was added in one portion at room 
temperature to a stirred solution of the alcohol (312) (10 mg, 32 J,1mol), 4-N,N-
dimethylaminopyridine (2 mg) and triethylamine (9.0 J,11, 6.5 mg, 64 J,1mol) in 
dichloromethane (1.0 em3). The mixture was left to stir for 10 min at room 
temperature and then a saturated aqueous solution of sodium hydrogenearbonate (10 
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cm3) and dichloromethane (10 cm3) were added. The layers were separated and the 
aqueous layer was extracted with dichloromethane (2xlO em3), then the combined 
organics were dried (Na2S04) and reduced in vacuo. The residue was purified by 
I • 
chromatography on silica using ethyl acetate - petroleum (b.p. 40-60°C) (2:5) as 
eluant to leave the tetracycle (313) trans, anti, trans, anti, trans isomer (10 mg, 61 
%) as a white solid. OH (500 MHz, CDC}3, 328K) 9.21 (1H, t, J 2.1 Hz, Ar-H), 9.15 
(2H, d, J 2.1 Hz, Ar-H), 5.37 (lH, app. q, J 2.5 Hz, CHC02Ar), 3.68 (1H, dd, J 13.4 
Hz and 9.8 Hz, NCHHCH), 3.44 (1H, dd, J 13.4 Hz and 8.4 Hz, NCHHCH), 3.34 
(1H, app. td, J 10.7 Hz and 2.7 Hz, NCHCH2), 2.37 (1H, m, CHH), 2.13 (3H, s, 
NCOCH3), 2.04 (lH, m, CHHCHO), 1.85-1.73 (6H, m, CHH, CHH, CH2, CH2), 1.67 
(3H, m, CHH, CHH, CHHCHO), 1.48 (IH, m, CHH), 1.45 (4H, m, CHH, CHH, 
NCH2CH, CHCHO), 1.28-1.24 (2H, m, CHH, CHH), 1.26 (3H, s, CCH3), 1.18-1.03 
(3H, m, CHH, CHH, NCHCH), 0.89 (3H, s, CCH3); Oc (125.8 MHz, CDC}3) 171.5 
(s), 162.3 (s), 148.7 (8), 134.3 (s), 129.3 (d), 122.2 (d), 79.1 (d), 57.8 (d, br), 56.4 (d), 
55.5 (d), 49.9 (d), 40.7 (t, br), 38.3 (t), 37.5 (t), 37.2 (s), 34.6 (s). 33.2 (t). 30.5 (t). 
26.6 (t), 25.6 (t), 25.5 (t), 23.0 (q), 23.0 (t), 16.7 (t), 15.3 (q), 15.3 (q); mlz (EI) 
527.2641 (M+, C2SH37N307 requires 527.2631). 
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3.3 LINEAR ENAMIDE STUDIES 
2-Amino-(N-acetyl, N-prop-2'-en-1'-yl)-hepl-1-ene (321) and 2-amillo-(N-acetyl, N-
prop-2 '-en-1 '-yl)-hepl-2-ene (320) 
l-Aminoprop-2-ene (210 J.d, 160 mg, 2.8 mmol), heptan-2-one (390 f..ll, 320 mg, 2.8 
mmol) and molecular sieves (4 A, activated) in benzene (80 cm3) were set stirring at 
room temperature and left overnight. 4-N,N-dimethylaminopyridine (34 mg, 0.28 
mmol) was added to the mixture in one portion at room temperature followed by 
triethylamine (590 f..ll, 430 mg, 4.2 mmol), also added in one portion, and then acetyl 
chloride (300 f..ll, 330 mg, 4.2 mmol) was added dropwise over 5 min at room 
temperature. The solution was allowed to stir at room temperature for 2 h and then 
filtered through a pad of celite and the solvent was removed in vacuo. The resulting 
oily residue was purified by chromatography on silica, using ethyl acetate - petroleum 
(b.p. 40-60°C) (1:2) as eluant to give 2-amino-(N-acetyl, N-prop-2'-en-1 '-yl)-hept-l-
ene (321) (190 mg, 34%) eluted first, OH (250 MHz, CDC)3) 5.81 (lH, m, 
CH2CH=CH2), 5.13 (2H, m, CH2CH=CH2), 5.06 (1H, s, C=CHH), 4.88 (1H, s, 
C=CHH), 4.04 (2H, d, 1 6.2 Hz, CHCH2N), 2.15 (2H, t,l 7.1 Hz, CH2=CCH2), 2.07 
(3H, S, COCH3), 1.46 (2H, m, CH2CH2CH2), 1.32 (4H, m, CH2CH2CH2CH3), 0.90 
(3H, m, CH2CH3); Oc (67.8 MHz, CDC)3) 169.1 (s), 148.3 (s), 133.3 (d), 116.8 (t), 
113.1 (t), 48.1 (t), 34.0 (t), 31.1 (t), 26.1 (t), 22.1 (t), 21.4 (q), 13.6 (q); Umax (liquid 
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film)/cm- 1 2928 (s), 2858 (s), 1654 (s), 1431 (m), 1388 (s), 1278 (m), 1240 (m), 1148 
(w), 1106 (w), 1036 (w), 982 (m); mlz (EI) 195.1621 (M+, C12H21NO requires 
195.1623), and 2-amino-(N-acetyl, N-prop-2 '-en-}' -yl)-hept-2-ene (320) (140 mg, 
I • 
25%) eluted second, OH (250 MHz, CDCI3) 5.80 (lH. m. CH2CH=CH2). 5.32 (IH. t. 
J 7.6 Hz, CH2CH=C). 5.11 (2H. m, CH2CH=CH2). 4.01 (2H. d. J 6.1 Hz. CHCH2N), 
2.01 (5H, m, CH2CH=C and COCH3), 1.77 (3H, s, CH=C(N)CH]). 1.33 (4H, m. 
CH2CH2CH2CH3), 0.90 (3H, t. J7.0 Hz. CH2CH3); Oc (67.8 MHz. CDCI 3) 169.6 (s), 
135.6 (s), 133.8 (d), 131.3 (d), 117.2 (t). 48.6 (t). 31.1 (t). 27.4 (t). 22.2 (t). 21.7 (q). 
16.0 (q). 13.6 (q); Umax (liquid film)/cm- 1 2928 (m). 2858 (m). 1655 (s). 1390 (s). 
1277 (w), 1223 (s), 1036 (w), 982 (w). 
2-Methyl-4- para-toluenesulfonyloxybut-l-ene (322) 128 
~ O T S S
322 
para-Toluenesulfonyl chloride (4.9 g. 26 mmol) was added in one portion to a stirred 
solution of 2-methylbut-l-en-4-ol (3.1 cm3• 3.6 g, 23 mmol) in pyridine (25 cm3) at 
O°C and the resulting solution was allowed to warm to room temperature over 2 h. 
The mixture was diluted with ether (200 em3) and washed with water (200 em3), a 
saturated aqueous solution of copper (II) sulfate (300 cm3). water (100 cm3) and brine 
(l00 cm3). The organics were dried (Na2S04). reduced in vacuo and the residue was 
then purified by chromatography on silica, using ether - petroleum (b.p. 40-60°C) 
(1:19) as eluant, to leave the tosylate (322) (7.6 g. 75 %) as a colourless oil. OH (400 
MHz, CDCI3) 7.80 (2H, d, J 8.0 Hz. Ar-H). 7.35 (2H. d, J 8.0 Hz, Ar-H), 4.80 (lH, s, 
C=CHH), 4.69 (lH, s. C=CHH), 4.14 (2H, t, J 7.0 Hz, CH20Ts), 2.46 (3H, s, Ar-
CH]). 2.36 (2H, t, J 7.0 Hz. CH2CMe=CH2), 1.67 (3H, s, CH2=CCH3); Be (67.8 
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MHz, CDCI3) 144.6 (s), 139.9 (s), 132.8 (s), 129.6 (d), 127.6 (d), 112.8 (t), 68.3 (t), 
36.4 (t), 22.0 (q), 21.3 (q); Umax (liquid film)/cm- 1 3077 (m), ·2970 (s), 1923 (w), 1810 
(w), 1652 (s), 1560 (s), 1359 (s), 1176 (s), 1120 (m), 1097 (s), 1020 (m), 964 (s), 894 
(s), 816 (s), 779 (s), 705 (w). 
4-lodo-2-methylbut-l-ene (323)128 
~ I I
323 
Sodium iodoide (9.4 g, 63 mmol) was added in one portion to a stirred solution of 2-
methyl-4-para-toluenesulfonyloxybut-l-ene (322) (7.5 g, 31 mmol) in acetone (90 
cm3) at room temperature and the mixture was then heated at reflux overnight. The 
solution was then allowed to cool to room temperature and diluted with petrol (200 
em3) and the resulting suspension was filtered through a pad of eelite. The filtrate 
was reduced in vacuo and then taken up in ether (400 em3) and the solution was then 
washed with 10 % w/v aqueous sodium thiosulfate solution (200 em3), water (200 
em3) and then brine (100 em3), dried (MgS04) and the solvent was removed in vacuo 
to leave the iodide (323) (4.7 g, 77 %) as a pale pink mobile liquid. OH (250 MHz, 
CDCI3) 4.87 (lH, s, C=CHH), 4.76 (lH, s. C=CHH). 3.27 (2H, t, J 7.5 Hz, C1l21), 
2.59 (2H, t, J 7.5 Hz, CH2CMe=CH2), 1.75 (3H. s, CH2=CCH); ~ ~ (67.8 MHz, 
CDCI3) 143.7 (s), 112.2 (t), 41.8 (t), 21.6 (q), 3.4 (d); umax (liquid film)/cm- 1 3076 
(m), 2968 (s), 2934 (s), 2866 (m), 1650 (s), 1445 (s), 1374 (m), 1339 (w), 1234 (s), 
1170 (s), 1118 (w), 894 (s). 
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5-( Ethyl carboxy)-2-methylhept-l-en-6-one (324) 
Ethyl acetoacetate (4.5 cm3, 4.6 g, 35 mmol) was added dropwise over 10 min to a 
stirred slurry of sodium hydride (1.33 g, 33 mmol, 60 wt.% in oil) in tetrahydrofuran 
(34 cm3) as O°C and left to stir at O°C for 30 min. The resulting clear solution was 
transfered via cannula, dropwise over 5 min, to a stirred solution of 4-iodo-2-
methylbut-l-ene (323) (3.4 g, 18 mmol) in tetrahydrofuran (34 cm3) at O°C. The 
resulting solution was heated at reflux for 4 hours, cooled to room temperature and 
water (70 cm3) was added. The mixture was reduced in vacuo and the resulting 
aqueous layer was extracted with ether (3x70 em3) and the combined organics were 
washed with brine (50 em3), dried (MgS04) and the solvent was removed in vacuo. 
The residue was purified by chromatography on silica using ethyl acetate - petroleum 
(b.p. 40-60°C) 0:9) as eluant to give the ketoester (324) (3.0 g, 84 %) as a colourless 
mobile oil. OH (400 MHz, CDCI3) 4.76 OH, s, C=CHH), 4.69 (lH, s, C=CHH), 4.20 
(2H, t, J 7.1 Hz, OCH2CH3), 3.43 (IH, m, CH2CH(C02EOCO), 2.24 (3H, s, 
COCH3), 2.01 (4H, m, CH2CH2), 1.72 (3H, s, CH2=CCH3), 1.28 (3H, t, J 7.1 Hz, 
OCH2CH3); Oc (67.8 MHz, CDCI3) 202.8 (s), 169.5 (s), 144.0 (s), 111.0 (t). 61.1 (t), 
58.7 (d), 35.0 (0, 28.8 (q), 25.6 (t), 21.9 (q), 13.9 (q); \)max (liquid film)/cm-l 3074 
(m), 2978 (s), 2937 (s), 1741 (s), 1717 (s), 1648 (m), 1447 (s), 1359 (s), 1243 (s). 
1148 (s), 1096 (m), 1026 (m), 890 (m), 859 (w); mlz (EI) 180.1152 (M-H20+, 
CIIH1602 requires 180.1150). 
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2-Methylhept-l-en-5-one (318)128 
318 
A stirred mixture of 5-(ethyl carboxy)-2-methylhept-l-en-6-one (324) (3.0 g, 15 
mmol) and 50% aqueous w/v sodium hydroxide (16 cm3) were heated at reflux for 4 h 
and then cooled to room temperature and acidified to pH 1 with hydrochloric acid (2 
moldm- 3). The aqueous mixture was extracted with ether (3x60 cm3) and the 
combined organics were dried (MgS04) and reduced in vacuo to leave the ketone 
(318) (1.9 g, 99 %) as a mobile colourless oil. OH (2S0 MHz, CDCI3) 4.73 (IH, s, 
C=CHH), 4.68 (lH, s, C=CHH), 2.43 (2H, t, J 7.2 Hz, CH2CO), 2.14 (3H, s, 
COCH3), 2.02 (2H, t, J 7.0 Hz, CH2CMe=CH2), 1.71 (SH, m, CH2=CCH3 and 
CH2CH2CH2); Oc (67.8 MHz, CDCI3) 208.5 (s), 144.9 (s), IIO.S (t), 42.9 (t), 36.9 (t), 
29.9 (q), 22.1 (q), 21.3 (t); umax (liquid fiIm)/cm- 1 2938 (s), 1717 (s), 1648 (m), 1446 
(m), 1367 (m), 1224 (w), 1183 (w), 1158 (m), 889 (m), 757 (m). 
Methyl 7-azido-5-methyl hept-5-enoate (325) 
Di-iso-propyl azodicarboxylate (2.0 cm3, 2.0 g, 10 mmol) was added dropwise over 3 
min at room temperature to a mixture of zinc azide dipyridine complex (2.1 g, 6.8 
mmol), triphenylphosphine (2.6 g, 10 mmol) and methyl 7-hydroxy-S-methylhept-5-
enoate (277) (1.6 g, 9.1 mmol) in toluene (75 cm3). The solution was stirred for 10 
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min and then filtered through a pad of celite. The resulting clear pale yellow solution 
was reduced in vacuo and the residue was absorbed on· silica and purified by 
chromatography on silica using ethyl acetate - petroleum (b.p. 40-60°C) (1:9) as 
eluant to give the azide (325) (1.2 g, 67 %) as an oily 2:1 mixture of E and Z-isomers. 
Major E isomer: OH (400 MHz, CDCI3) 5.37 (IH, t, J 6.7 Hz, C=CHCH2), 3.78 (2H, 
d, J 6.7 Hz, CHCH2N3), 3.68 (3H, s, OCH3), 2.31 (2H, t, J 7.3 Hz, CH2C02Me), 2.14 
(2H, t, J 7.0 Hz, CH2C(Me)=CH), 1.79 (2H, m, CH2CH2CH2), 1.80 (3H, s, CCH3); 
Oe (67.8 MHz, CDCl3) 173.7 (s), 142.0 (s), 117.8 (d), 51.4 (q), 47.8 (t), 38.6 (t), 33.1 
(t), 23.1 (q), 22.7 (t); Minor Z isomer: OH (400 MHz, CDCl3) 5.35 (lH, t, J 6.7 Hz, 
C=CHCH2), 3.76 (2H, d, J 6.7 Hz, CHCH2N3), 3.69 (3H, s, OCH3), 2.31 (2H, t, J 7.3 
Hz, CH2C02Me), 2.11 (2H, t, J 7.0 Hz, CH2C(Me)=CH), 1.79 (2H, m, 
CH2CH2CH2), 1.71 (3H, s, CCH3); oe (67.8 MHz, CDCI3) 173.6 (s), 142.0 (s), 
118.6 (d), 51.4 (q), 47.7 (t), 38.6 (t), 31.0 (t), 23.0 (t), 16.1 (q); Both isomers: 'Umax 
(liquid film)/cm- 1 2951 (s),2099 (s), 1737 (s), 1436 (m), 1364 (m), 1252 (s), 1174 (s), 
1097 (w), 993 (w), 882 (m); mlz (EI) 169.1112 (M-N2+, C9H lSN02 requires 
169.1103). 
Methyl 7-amblO-(N-tert-blltylcarboxylate )-S-methylhept-S-elloate (27 4b) 
o B O C H N ~ O M e e
274b 
Triphenylphosphine (1.6 g, 6.1 mmol) was added in one portion to a stirred solution 
of methyl 7-azido-5-methylhept-5-enoate (325) (800 mg, 4.0 mmol) in 
tetrahydrofuran (40 cm3) at room temperature. The solution was left to stir at room 
temperature for 24 h, then water (150 Ill, 150 mg, 8.1 mmol) was added and the 
mixture was then left to stir for 24 h. tert-Butyl dicarboxylate (1.8 g, 8.1 mmol) then 
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triethylamine (620 J,11, 450 mg, 4.4 mmol) were added in two separate portions and the 
mixture was then left to stir at room temperature for 24 h. The mixture was reduced 
in vacuo and partitioned between water (100 cm3) and ether (100 cm3). The layers 
I 
were separated and the aqueous was extracted with ether (2xloo cm3), the combined 
organics were then washed with saturated aqueous sodium bicarbonate (60 cm3), 
brine (40 cm3), dried (MgS04) and the solvent removed in vacuo. The residue was 
purified by chromatography on silica, using ethyl acetate - petroleum (b.p. 40-60 °C) 
(1:4) as eluant, to leave the protected amine (274b) (1.1 g, 97 %) as a colourless oily 
2:1 mixture of E and Zisomers. Major E isomer: OH (250 MHz, CDCI3) 5.19 (IH, t, J 
7.0 Hz, C=CHCH2N), 4.50 (IH, br, CH2NHBoc), 3.70 (2H, br, C=CH2NHBoc), 3.67 
(3H, s, C02CH3 ), 2.28 (2H, t, J 7.5 Hz, CH2C02Me), 2.02 (2H, t, J 7.0 Hz, 
CH2C(Me)=CH), 1.73 (2H, m, CH2CH2CH2), 1.65 (3H, s, CH2C(CH)=CH), 1.45 
(9H, s, OC(CH); Oc (67.8 MHz, CDCI3) 174.2 (s), 156.2 (s), 138.1 (s), 122.0 (d), 
79.2 (s), 52.0 (t), 38.5 (t), 33.8 (t), 31.4 (t), 28.8 (q), 23.1 (t), 16.4 (q); Minor Z 
isomer: OH (250 MHz, CDCI3) 5.24 (lH, t, J 7.0 Hz, C=CHCH2N), 4.50 (lH, br, 
CH2NHBoc), 3.70 (2H, br, CHCH2N), 3.67 (3H, s, C02CH), 2.29 (2H, t, J 7.5 Hz, 
CH2C02Me), 2.10 (2H, t, J 7.0 Hz, CH2C(Me)=CH), 1.73 (2H, m, CH2CH2CH2), 
1.70 (3H, s, CH2C(CH)=CH), 1.45 (9H, s, OC(CH); Oc (67.8 MHz, CDCI3) 174.2 
(s), 156.2 (s), 138.1 (s), 122.9 (d), 79.2 (s), 52.0 (q), 39.1 (t), 33.8 (t), 31.4 (t), 28.8 
(q), 23.5 (q), 23.5 (t); Both isomers: u max (liquid fiIm)/cm- 1 3368 (m), 2975 (s), 1714 
(s), 1516 (s), 1454 (m), 1437 (m), 1391 (m), 1366 (s), 1249 (s), 1172 (s), 1047 (m), 
1018 (m), 934 (w), 865 (w), 137 (m); Found %: C, 61.9; H, 9.6; N, 4.9 (ClSli2SN04 
requires C, 62.0; H, 9.3; N, 5.2); m/z (EI) 214.1086 (M-tBu+, ClOH16N04 requires 
214.1079). 
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2-Amino-(N-acetyl, N-prop-2'-en-l '-yl)-6-methylhept-l,6-diene (355) and 2-amino-
(N-acetyl, N-prop-2'-en-l '-yl)-6-methylhept-2,6-diene (356) 
A mixture of 5-methylhept-5-en-2-one (318) (150 mg, 1.2 mmol) and l-aminoprop-2-
ene (90 J.d, 68 mg, 1.2 mmol) in benzene (20 cm3) with molecular sieves (4 A, 
activated) was stirred for 12 h at room temperature. Lutidine (210 J.l.I, 190 mg, 1.8 
mmol) was added in one portion and then acetyl chloride (90 J.l.I, 100 mg, 1.3 mmol) 
was added dropwise over 5 min at room temperature. The mixture was allowed to stir 
for 2 h, filtered through a pad of celite and the solvent evaporated in vacuo to give a 
yellow residue. The residue was purified by chromatography on silica using ethyl 
acetate - petroleum (b.p. 40-60°C) (2:3) as eluant to give 2-amino-(N-acetyl, N-prop-
2'-en-l '-yl)-6-methylhept-l,6-diene (355) (75 mg, 30 %) as a colourless oil, OH (360 
MHz, CDCI3) 5.82 (lH, m, CH2CH=CH2), 5.10 (3H, m, CH2CH=CH2 and C=C/ill), 
4.87 (lH, s, C=CHH), 4.71 (lH, s, C=CHH), 4.65 (1H, s, C=CHH), 4.01 (2H, d, J 6.3 
Hz, CHCH2N), 2.12 (2H, t, J 7.6 Hz, CH2C=CH2), 2.04 (3H, s, COCH), 2.03 (4H, 
m, CH2CH2C=CH2), 1.67 (3H, s, CCH3); 8c (67.8 MHz, CDCI3) 169.5 (s), 148.4 (s), 
144.7 (s), 133.5 (d), 117.2 (0, 113.6 (t), 110.4 (t), 48.4 (0, 37.1 (t), 33.7 (t), 24.6 (t), 
22.1 (g), 21.7 (q); umax (liquid film)/cm- 1 2936 (m), 1645 (s), 1433 (m), 1386 (s), 
1278 (m), 1238 (m), 983 (w), 920 (m), 890 (m); m/z (EI) 207.1628 (M+, C13H21NO 
reg ui res 207.1623), and 2 -amino-eN -acetyl, N -prop-2 ' -en-}' -yl )-6-methylhept-2,6-
diene (356) (31 mg, 13 %) as a colourless oil, OH (360 MHz, CDCI3) 5.78 (lH, m, 
CH2CH=CH2), 5.32 (lH, t, J 7.3, C=CHCH2), 5.11 (2H, m, CH2CH=CH2), 4.74 (1H, 
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s, C=CHH), 4.68 (lH, s, C=CHH), 4.00 (2H, d, J 6.3 Hz, CHCH2N), 2.20 (2H, 
apparent q, J 7.3 Hz, C=CHCH2CH2), 2.09 (2H, t, J 7.3 Hz, CH2CH2C), 2.01 (3H, s, 
COCH3), 1.79 (3H, s, CCH3), 1.72 (3H, s, CCH3); Oe (67.8 MHz, CDCI3) 169.6 (s), 
I . 
144.6 (s), 136.0 (s), 133.7 (d), 130.6 (d), 117.3 (t), 110.7 (t), 48.7 (t), 36.8 (t), 35.7 (t), 
22.2 (q), 21.7 (q), 16.1 (q); U max (liquid film)/cnrl 2922 (m), 1652 (s), 1393 (m), 
1280 (w), 1039 (w), 887 (w); mlz (EI) 207.1625 (M+, C13H21NO requires 207.1623) 
l-Amino-(N- a ce ty I, N-6'-methylhept-l ',6'-dien-2 '-yl)-3,7-dimethyloct-2,6-diene 
(329) and l-amino-(N-acetyl, N-6 '-methylhept-2 ',6'-dien-2 '-yl)-3, 7-dimethyloct-2,6-
diene (330) 
~ N ~ ~
o ~ ~
329 
~ N ~ ~
o ~ ~
330 
A mixture of 5-methylhept-5-en-2-one (318) (150 mg, 1.2 mmol) and geranyl amine 
(328) (220 Ill, 108 mg, 1.2 mmol) in benzene (20 em3) with molecular sieves (4 A, 
activated) was stirred for 12 h at room temperature. Lutidine (210 Ill, 190 mg, 1.8 
mmol) was added in one portion and then acetyl chloride (90 Ill, 100 mg, 1.3 mmol) 
was added dropwise over 5 min at room temperature. The mixture was allowed to stir 
for 2 h, filtered through a pad of eelite and the solvent evaporated in vacuo to give a 
yellow residue. The residue was purified by chromatography on silica using ethyl 
acetate - petroleum (b.p. 40-60°C) (2:3) as eluant to give l-amino-(N-acetyl, N-6'-
methylhept-l',6'-dien-2'-yl)-3,7-dimethyloct-2,6-diene (329) (110 mg, 31 %) as a 
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colourless oil, eluted first, OH (360 MHz, CDCI3) 5.17 (lH, app. td, J 6.9 Hz and 1.1 
Hz, C=CHCH2N), 5.03 (2H, m, C=CHCH2 and C=CHH), 4.87 (IH, 5, C=ClU/), 4.72 
(lH, s, C=CHH), 4.67 (lH, s, C=CHH), 4.04 (2H, d, J 6.9 Hz, CHCH2N), 2.15-1.96 
(8H, m, CHCH2CH2C and CH2CH2CH2), 2.04 (3H, s, COCH3), 1.70 (3H, s, CCH3). 
1.65 (3H. d. J 1.1 Hz, CH=CCH3), 1.62 (3H. s. CCH3), 1.60 (2H. m, CH2CH2CH2). 
1.57 (3H. 5, CCH3); Oe (67.8 MHz. CDCl3) 169.4 (5), 148.6 (s). 144.8 (s). 138.5 (s), 
131.4 (s), 123.9 (d). 119.9 (d), 113.3 (t), 110.5 (t). 43.3 (t), 39.5 (t), 37.2 (t), 33.9 (t), 
26.3 (t), 25.6 (q), 4.7 (t), 22.2 (q), 21.8 (q) 17.6 (q), 16.1 (q); 'Umax (liquid film)/cm-l 
2966 (m), 2931 (m), 1655 (s), 1438 (m), 1588 (s), 1276 (w), 1107 (w), 977 (w), 888 
(m); mlz (EI) 303.2552 (M+, C20H33NO requires 303.2562), and l-amillo-(N -acetyl,_ 
N-6'-methylhept-2',6'-dien-2'-yl)-3,7-dimethyloct-2.6-diene (330) (82 mg, 23 %) as a 
colourless oil, eluted second, OH (360 MHz, CDCI3) 5.32 OH, t, J 7.2 Hz, 
C=CHCH2), 5.19 (lH, t, J 7.0 Hz, C=CHCH2), 5.08 (lH, t, J 5.3 Hz, C=CHCH2), 
4.72 (2H, m, C=CH2), 4.04 (2H, d, J 7.0 Hz, C=CHCH2N), 2.19 (2H, m, CH=CCH2), 
2.11-1.99 (6H, m, CHCH2CH2C, CHCH2CH2C), 2.00 (3H, s, COCH3), 1.80 (3H, s, 
CCH3), 1.73 (3H, s, CCH3), 1.68 (3H, s, CCH3), 1.63 (3H, s, CCH3), 1.60 (3H, s, 
CCH3); Oe (67.8 MHz, CDCI3) 169.7 (5), 144.6 (s), 138.7 (5), 136.1 (s), 131.5(s), 
130.3 Cd), 124.0 (d), 119.9 (d), 110.6 (t), 43.5 (t), 39.6 (0, 36.8 (t). 26.4 (t), 25.8 (t), 
25.7 (q), 22.5 (q), 22.2 (q), 21.7 (q), 17.7 (q), 16.1 (q); 'Umax (liquid film)/cm-l 2966 
(s), 1650 (s), 1445 (s), 1398 (5), 1283 (m), 1228 (m), 887 (m); mh (EI) 303.2547 (M+, 
C20H33NO requires 303.2562) 
3-(Ethyl carboxy)-4-iminohex-2-one.tin tetrachloride complex (331)129 
o NH.SnCI4 
m ~ ~
331 
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Tin tetrachloride (13 cm3, 29 g, 110 mmol) was added dropwise over 20 min at room 
temperature to a solution of ethyl acetoacetate (26 cm3, 26 g, 200 mmol) and 
propanonitrile (14 cm3, 11 g, 200 mmol) in chlorobenzene (200 cm3) and left to stir at 
room temperature for a further 30 min. The solution was warmed to 80°C for 4 hand 
then allowed to cool to room temperature over 30 min. Hexane (200 cm3) was added 
and the precipitated solid was filtered under nitrogen, washed with hexane (50 cm3) 
and dried under vacuum (P20S) to leave the tin complex (331) (43 g, 86 %) as a pale 
yellow solid. OH (400 MHz, DMSO) 8.27 (tH, br, NH), 4.12 (2H, q, J 7.0 Hz, 
OCH2CH3), 2.38 (2H, q, J 7.5 Hz, C(=NH)CH2CH3), 2.11 (3H, s, COCH), 1.23 
(3H, t, J 7.0 Hz, OCH2CH3), 1.11 (3H, t, J 7.5 Hz, C(=NH)CH2CH); eSc (100.6 
MHz, DMSO) 172.3 (s), 172.3 (s), 169.7 (s), 60.0 (t), 28.2 (t), 14.5 (q), 14.4 (q), 13.8 
(q). 
Ethyl3-oxopentanoate (333) 129 
o 0 
E t O ~ ~
333 
A solution of 3-(ethyl carboxy)-4-iminohex-2-one.tin tetrachloride complex (331) (45 
g, 100 mmol) in chloroform (80 cm3) was added in one portion at room temperature 
to 10 % aqueous hydrochloric acid (90 cm3) and the mixture was stirred vigerously 
for 2 h at room temperature. Water (80 cm3) was added and the layers were 
separated, the acidic aqueous layer was extracted with chloroform (2x100 em3) and 
the organics were combined, dried (MgS04) and reduced in vacuo. The resulting 
residue was purified by distillation (10 mmHg) to leave the ketoester (333) (12 g, 83 
%) as a colourless oil. b.p. 84°C/IO mmHg; OH (400 MHz, CDCI3) 4.20 (2H, q, J 7.0 
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Hz, OCH2CH3), 3.45 (2H, s, COCH2C(h), 2.58 (2H, q, J 7.5 Hz, COCH2CH3), 1.28 
(3H, t, J 7.0 Hz, OCH2CH3), 1.09 (3H, t, J 7.5 Hz, COCfhCH3); Be (100.6 MHz, 
CDCI3) 203.4 (s), 167.3 (s), 61.3 (t), 49.0 (t), 36.3 (t), 14.1 (q), 7.6 (q); umax (liquid 
film)/cm- 1 2980 (m), 1743 (s), 1719 (s), 1413 (mi, 1314 (m), 1251 (m), 1160 (m), 
1026 (m). 
5-( Ethyl carboxy)-2-methyloct-l-en-6-one (332) 
Ethyl 3-oxopentanoate (333) (7.3 g, 50 mmol) was added dropwise over 10 min to a 
stirred slurry of sodium hydride (1.9 g, 48 mmol, 60 wt.% in oil) in tetrahydrofuran 
(50 cm3) as O°C and left to stir at O°C for 30 min. The resulting clear solution was 
transfered via cannula, dropwise over 5 min, to a stirred solution of l-iodo-3-
methylbut-3-ene (4.9 g, 25 mmol) in tetrahydrofuran (50 cm3) at O°C. The resulting 
solution was heated at reflux for 4 hours, cooled to room temperature and water (100 
cm3) was added. The mixture was reduced in vacuo and the resulting aqueous layer 
was extracted with ether (3x100 cm3) and the combined organics were washed with 
brine (50 cm3), dried (MgS04) and the solvent was removed ill vacuo. The residue 
was purified by chromatography on silica using ethyl acetate - petroleum (b.p. 40-
60°C) (1:9) as eluant to leave the ketoester (332) (3.4 g, 87 %) as a colourless mobile 
oil. BH (400 MHz, CDCI3) 4.74 (lH, s, C=CHH), 4.68 (lH, s, C=CHH), 4.18 (2H, t, J 
7.1 Hz, OCH2CH3), 3.45 (1H, m, CH2CH(C02Et)CO), 2.61 (1H, dq, J 18.4 Hz and 
7.0 Hz, COCHHCH3), 2.49 (lH, dq, J 18.4 Hz and 7.0 Hz, COCHHCH3), 2.01 (4H, 
m, CH2CH2), 1.72 (3H, s, CH2=C(CH2)CH3), 1.27 (3H, t, J 7.1 Hz, OeH2CHj), 1.07 
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(3H, t, J 7.0 Hz, COCH2CH3); Oc (100.6 MHz, CDCI3) 205.8 (s). 169.9 (s), 144.3 (s), 
111.2 (t). 61.3 (t), 58.0 (d), 35.4 (t), 35.4 (t), 26.0 (t), 22.l (cO: 14.1 (q), 7.7 (q); 'Umax 
(liquid fiIm)/cm- 1 2977 (m). 2931 (m), 1741 (s), 1718 (s), 1445 (m). 1359 (m). 1255 
(m), 1214 (m), 1118 (m), 1032 (m), 891 (w); Found %: C. 67.7; H, 9.7 (C12H2003 
requires C, 67.9; H, 9.5); mlz (EI) 194.l305 (M-HzO+, C12HlSOZ requires 194.l307). 
7-Methyloct-7-en-3-one (334) 
334 
A stirred mixture of 5-(ethyl carboxy)-2-methyloct-l-en-6-one (332) (1.3 g, 5.9 
mmol) and 50% aqueous w/v sodium hydroxide (6 cm3) were heated at reflux for 4 h 
and then cooled to room temperature and acidified to pH 1 with hydrochloric acid (2 
moldm-3). The aqueous mixture was extracted with ether (3x20 cm3) and the 
combined organics were dried (MgS04) and reduced in vacuo to leave the ketone 
(334) (700 mg, 85 %) as a mobile colourless oil. OH (400 MHz, CDCI3) 4.73 (lH, s, 
C=CHH), 4.67 (lH. s. C=CHH), 2.42 (4H, m, CH2COCH2), 2.01 (2H, t, J 7.0 Hz, 
CH2CMe=CH2), 1.71 (5H, m, CH2=CCH3 and CH2CH2CH2). 1.05 (3H, t, J 7.0 Hz, 
COCH2CH3); Oe (67.8 MHz. CDC}3) 211.7 (s). 145.1 (s), 110.5 (t). 41.6 (t), 37.1 (q), 
36.0 (t), 22.2 (q). 21.5 (t). 7.9 (q); 'Umax (liquid fiIm)/cm- i 2971 (m), 2931 (m), 1718 
(s). 1459 (m). 1405 (w), 1373 (m), 1123 (m), 877 (m); mlz (EI) 140.1207 (M+, 
C9H160 requires 140.1201). 
160 
3-Amino-(N-acetyl, N-prop-2 '-en-} '-yl)-7-methyloct-2-ene (335a) and 3-amillo-(N-
acetyl, N-prop-2'-en-l '-yl)-7-methyloct-3-ene (335b) 
335a 335b 
A mixture of7-methyl-7-en-3-one (334) (170 mg, 1.2 mmol) and l-aminoprop-2-ene 
(90 J.d, 68 mg, 1.2 mmol) in benzene (20 cm3) with molecular sieves (4.1., activated) 
was stirred at room temperature for 12 h. Lutidine (120 J.ll, 190 mg, 1.8 mmol) was 
added in one portion followed by acetyl chloride (93 /-tl, 100 mg, 1.3 mmol), added 
dropwise over 5 min at room temperature. The mixture was left to stir for 2 h, filtered 
through a pad of celite and the solvent evaporated in vacuo to leave a yellow residue. 
The residue was purified by chromatography on silica using ethyl acetate - petroleum 
(b.p. 40-60°C) (2:5) as eluant to leave the enamides (335) (140 mg, 52 %) as an 
inseperable (3:2) mixture of C-2 and C-3 double bond isomers. Both isomers: OB 
(360 MHz, CDC}3) 5.76 (1H, m, CH2CH=CH2), 5.30 (0.6H, q, J 7.1 Hz, 
NC=CHCH3), 5.20 (OAH, t, J 7.4 Hz, NC=CHCH2), 5.04 (2H, m, CH2CH=CH2), 
4.69 (lH. app. s, C=CHH), 4.63 (IH, app. s, C=CHH), 3.95 (2H. br., NCH2CH). 2.18 
(0.8H, q, J 7.4 Hz, NCCH2CH3), 2.14-2.02 (2.4H, m), 1.98 (3H. s, NCOCHj). 1.66 
(3H, s, CCH3). 1.67-1.62 (1.8H, m), 1.49 (2H, m). 1.20 (0.8H, m), 0.96 (1.2H, m): Oe 
(90.6 MHz, CDCI3) 170.1 (5), 170.0 (s), 144.7 (s). 144.4 (s). 140.7 (s). 140.2 (s), 
133.6 (d), 133.5 (d), 129.6 (d), 124.9 (d), 117.0 (t), 116.9 (t). 110.6 (t), 110.4 (t), 48.7 
(t), 48.5 (t), 37.6 (t), 37.0 (t), 28.7 (t), 25.2 (t), 24.8 (t), 22.3 (t). 22.1 (q), 22.0 (q), 
21.9 (q), 21.8 (q), 12.8 (q), 11.7 (q): u max (liquid film)/cm- 1 2934 (m), 1652 (s), 1437 
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(w), 1388 (s), 1276 (w), 1219 (w), 1071 (w), 982 (w), 920 (w); mlz (EI) 221.1781 
(M+, C14H23NO requires 221.1780). 
3.4 STABILISED ENAMIDE STUDIES 
Ethyl2-oxohexanoate (342)130 
E ~ ~ ~
o 
342 
A solution of I-bromobutane (660 /-ll, 840 mg, 6.2 mmol) in tetrahydrofuran (4 cm3) 
was added dropwise over 15 min to a stirred mixture of magnesium (160 mg, 6.7 
mmol) and iodine (1 crystal) in tetrahydrofuran (4 cm3) maitaining a temperature of 
50·C. The solution was then allowed to cool to room temperature over 30 min and 
transfered via cannula, over 20 min, to a stirred solution of diethyl oxalate (1.6 cm3• 
1.8 g, 12.2 mmol) at -78·C. The solution was allowed to come to room temperature 
over 2 h and then acidified to pH 1 with hydrochloric acid (2 moldm-3) and diluted 
with diehloromethane (10 em3) and water (10 cm3). The layers were separated and 
the aqueous layer was extracted with diehloromethane (2xlO cm3), dried (MgS04) 
and reduced in vacuo to leave a colourless residue which was then purified by 
chromatography on silica using ether - petroleum (b.p. 40-60·C) (1:9) as eluant to 
leave the a-keto ester (342) (420 mg, 44 %) as a colourless mobile oil. 8H (360 MHz. 
CDCI3) 4.32 (2H, q, J 7.2 Hz, OCH2CH3), 2.84 (2H, t, J 7.3 Hz, COCH2CH2), 1.62 
(2H, app. quin., J 7.5, CH2CR2CH2), 1.37 (5H, m, CH2CR2CH), 0.93 (3H, t, J 7.2 
Hz, OCH2CR3); Oc (90.6 MHz, CDCI3) 194.8 (s), 161.3 (s), 62.3 (t), 39.0 (t), 25.0 (t). 
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22.1 (t), 14.0 (q), 13.7 (q); umax (liquid film)/cm- 1 2961 (s), 2874 (s), 1728 (s), 1466 
(m), 1402 (m), 1369 (m), 1275 (s), 1246 (s), 1145 (m), 1I2! (s), 1055 (s), 1017 (m), 
857 (w), 756 (w), 731 (w), 677 (w). 
Ethyl 2-amino-(N-acetyl, N-prop-2'-en-l'-yl)-hex-2(E)-enoate (3438) and ethyl 2-
amino-(N-acetyl, N-prop-2' -en-l' -yl)-hex-2(Z)-enoate (343b) 
0y 
~ N r r
o OEl 
3438 
E t O ~ ~
y N ~ ~
o 
343b 
A mixture of ethyl 2-oxohexanoate (342) (250 mg, 1.6 mmol), l-aminoprop-2-ene 
(120 J!l, 90 mg, 1.6 mmol) and molecular sieves (4 A) in benzene (45 cm3) was stirred 
at room temperature overnight and then N,N-diethylaniline (350 J,tl, 350 mg, 2.4 
mmol) was added in one portion, followed by acetyl bromide (140 J,tl, 230 mg, 1.9 
mmol) also in one portion. The mixture was stirred at room temperature for a further 
2 h and then filtered through celite, reduced in vacuo to leave a brown oil which was 
purified by chromatography on silica using ethyl acetate - petroleum (b.p. 40-60°C) 
(3:7) as eluant to leave the enamides (342) (300 mg, 77 %) as a colourless mobile 
oily (3: 1) mixture of E and Z isomers. The mixture was seperated by chromatography 
on silica using ethyl acetate - petroleum (b.p. 40-60°C) (2:8) as eluant to leave a (I: 1) 
mixture of the E and Z isomers (230 mg, 58 %) eluted first and the E ellamide (342a) 
(64 mg, 17 %) eluted second. OH (360 MHz, CDCI3) 6.17 (1H, t, J 7.6 Hz, 
C=CHCH2), 5.77 (lH, m, CH2=CHCH2), 5.12 (2H, m, CH2=CHCH2), 4.23 (2H, q, J 
7.2 Hz, C02CH2CH3), 4.05 (2H, d, J 6.6 Hz, CH2=CHCH2N), 2.61 (2H, app. q, J 7.6 
Hz, C=CHCH2CH2), 1.96 (3H, s, NCOCH 3), 1.50 (2H, app. hexet, J 7.4 Hz, 
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CH2CH2CH3), 1.30 (3H, t, J 7.2 Hz, C02CH2CH3), 0.96 (3H, t, J 7.4 Hz, 
CH2CH2CH3); Oc (90.6 MHz, CDCI3) 170.5 (s), 164.2 (s), 148.9 (d), 133.1 (d), 131.5 
(s), 188.2 (t), 61.1 (t), 50.5 (t), 30.4 (t), 22.1 (t), 22.0 (q), 14.1 (q), 13.8 (q); \)max 
(liquid film)!cm- l 2962 (s), 1722 (s), 1667 (s), 1392 (s), 1192 (s), 1140 (m), 1030 (m), 
922 (w); mlz (EI) 239.1522 (M+, Cl3H21N03 requires 239.1521). 
Ethyl 2-oxohept-6-enoate (344) 
EtO 
o 
344 
A solution of I-bromopent-4-ene (460 J.d, 580 mg, 4.0 mmol) in tetrahydrofuran (4 
cm3) was added over 10 min to a stirred mixture of magnesium (110 mg, 4.4 mmol) 
and iodine (1 crystal) in tetrahydrofuran (4 cm3) maintaining a temperature of 50·C. 
After 10 min the resulting brown solution was transfered via cannula to a solution of 
diethyloxalate (1.1 cm3, 1.2 g, 8.0 mmol) in tetrahydrofuran (4 cm3) at -10·C and the 
resulting solution was allowed to warm to room temperature overnight. The solution 
was acidified to pH 1 with hydrochloric acid (2 moldm-3) and diluted with 
dichloromethane (10 cm3) and water (10 cm3). The layers were separated and the 
aqueous layer was extracted with dichloromethane (2x 10 cm3), dried (MgS04) and 
reduced in vacuo to leave a colourless residue which was then purified by 
chromatography on silica using ether - petroleum (b.p. 40-60·C) (1 :9) as eluant to 
leave a mixture of the a-keto ester and diethyloxalate as a colourless mobile oil. The 
mixture was . separated by bulb to bulb distilation (1.0 mmHg) to give the a-keto ester 
(344) (250 mg, 37 %) as a colourless mobile oil. OH (360 MHz, CDCl3) 5.78 OH, m, 
CH2CH=CH2), 5.01 (2H, m, CH2CH=CH2), 4.32 (2H, q, J 7.2 Hz, OCH2CH3), 2.85 
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(2H, t, J 7.2 Hz, 02CCOCH2), 2.11 (2H, app. q, J 7.4 Hz, CH2=CHCH2), 1.75 (2H, 
app. quin., J 7.3 Hz, CH2CH2CH2), 1.37 (3H, t, J 7.2 Hz, oeH2CH3); Oc (90.6 MHz, 
CDCI3) 194.4 (s), 161.1 (s), 137.4 (d), 115.5 (t), 62.3 (t), 38.3 (t), 32.7 (t), 22.0 (t), 
13.9 (q); U max (liquid film)/cm- 1 2980 (m), 2938 (in), 1728 (s), 1446 (w), 1401 (w), 
1369 (w), 1268 (s), 1185 (s). 1072 (s), 1043 (s). 915 (s), 861 (w); mlz (EI) 170.0939 
(M+, C9H1403 requires 170.0943). 
l-amino-(N-acetyl, N-ethyl hept-2 ',6'-dienoat-2'-yl)-3, 7-dimethyloct-2,6-dielle (345) 
0 y O ~ ~
~ N ~ ~
o ~ ~
345 
A mixture of ethyl 2-oxohept-6-enoate (344) (110 mg, 0.65 mmol), geranylamine 
(328) (60 J.d. 50 mg, 0.32 mmol) and molecular sieves (4 A) in benzene (12 cm3) was 
stirred at room temperature for 38 h and then diethylanaline (76 J.ll, 72 mg, 0.48 
mmol) was added in one portion, followed by acetyl bromide (26 ).ll, 43 mg, 0.35 
mmol) also in one portion. The mixture was stirred at room temperature for a further 
3 h and then filtered through celite, reduced ill vacuo to leave a brown oil which was 
purified by chromatography on silica using ethyl acetate - petroleum (b.p. 40-60·C) 
(3:7) as eluant to leave the enamide (345) (81 mg, 73 %) as a colourless mobile oily 
(1:1) mixture of C-2' E and Z isomers. OH (360 MHz, CDCI3) 6.94 (0.5H, t, J 7.4, 
02CC=CHCH2), 6.12 (0.5H, t, J 7.4, 02CC=CHCH2), 5.77 (lH, m, CH2CH=CH2), 
5.03 (4H, m, C=CH, C=CH, CH2CH=CH2), 4.22 (2H, q, J 7.2 Hz, OCH2CH3), 4.07 
(2H, d, J 7.3 Hz, CHCH2N), 2.71 (1H, q. J 7.4 Hz. CH2CH=CC02). 2.03 (7H. m. 
CHCH2CH2CH=CC02, CHCH2CH2C), 1.92 (1.5H. s. COCH3), 1.1.87 (1.5H, s, 
COCH3), 1.66 (3H, s, CCH3). 1.57 (6H, s, C(CH)z). 1.28 (3H. t. J 7.2 Hz, 
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OCH2CH3); oe (90.6 MHz, CDCI3) 170.4 (s), 164.2 (s), 164.1 (s), 147.5 (d), 143.7 
(d), 139.9 (s), 137.0 (d), 136.5 (d), 132.6 (s), 131.6 (s), 123.8'(d), 123.7 (d), 118.8 (d), 
118.6 (d), 116.1 (t), 115.7 (t), 61.3 (t), 61.0 (t), 44.6 (t), 44.4 (t), 39.6 (t), 39.5 (t), 32.6 
I • 
(t), 32.8 (t), 27.6 (t), 27.5 (t), 26.4 (t), 26.3 (t), 25.6 (q), 22.1 (q), 21.5 (q), 17.6 (q), 
16.1 (q), 14.2 (q), 14.1 (q); Umax (liquid film)/cm- 1 2977 (m), 2925 (s), 2855 (w), 
1720 (5), 1668 (5), 1444 (m), 1386 (s), 1265 (s), 1202 (s), 1094 (w), 1042 (w), 993 
(w), 914 (w); mJz (EI) 347.2455 (M+, C21H33N03 requires 347.2460). 
2-Methylhepta-l,6-dien-3-o1 (347) 117 
~ ~
OH 
347 
A solution of I-bromobut-3-ene (4.5 cm3, 6.0 g, 44 mmol) in ether (30 cm3) was 
added dropwise over 20 min, whilst maintaining a steady reflux, to a mixture of 
magnesium turnings (1.3 g, 53 mmol) and iodine (1 crystal) in ether (10 cm3). The 
resulting solution was left to cool to room temperature and then a solution of 2-
methylprop-2-enal (3.9 cm3, 3.3 g, 47 mmol) in ether (40 cm3) was added dropwise 
over 45 min, whilst maintaining a steady reflux. The mixture was then refluxed for a 
further 2 h, cooled to room temperature and hydrochloriC acid (80 cm3, 2 moldm-3) 
was added. The layers were separated and the aqueous was extracted with ether (2x80 
cm3), the organics were combined and washed with saturated sodium hydrogen 
carbonate (60 cm3) and brine (40 cm3), dried (NaS04) and reduced ill vacuo to leave 
an oily residue. The residue was purified by chromatography on silica, using ethyl 
acetate - petroleum (b.p. 40-60·C) (1:12) as eluant, to leave the allylic alcohol (347) 
(3.2 g, 60 %) as a colourless oil. OH (360 MHz, CDC}3) 5.84 (1H, m, CH2CH=CH2), 
5.07-4.85 (4H, m, C=CH2 and CH=CH2), 4.09 (1H, t, J 6.5 Hz, CCH(OH)CH2), 2.12 
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(2H, m, CH2CH2CH), 1.73 (3H, s, CCH3), 1.65 (2H, m, CH(OH)CH2CH2); oe (90.6 
MHz, CDCI3) 147.4 (s), 138.3 (d), 114.8 (t), 111.1 (t), 75.3 (tl), 34.0 (t), 29.8 (t), 17.5 
(q); Umax (liquid film)/cm- 1 3382 (s), 3076 (s), 2976 (s), 2940 (s), 1642 (m), 1447 
(m), 1374 (m), 1304 (w), 1119 (w), 1062 (m), 905 (s). 
Ethyl 4-methylnona-4,S-dienoate (349) 117 
OEt 
o 
349 
A stirred solution of 2-methylhepta-l,6-dien-3-ol (347) (3.2 g, 25 mmol) and 
propanoic acid (4 drops) in triethyl orthoacetate (46 cm3) was heated to 140·C for 4 h. 
The solution was reduced in vacuo at 60·C to leave an oil which was purified by 
distillation (0.25 mmHg) to leave the E diene (349) (4.4 g, 90%) as a colourless oil. 
b.p. 54-55·C/0.25 mmHg; OH (360 MHz, CDCI3) 5.82 (lH, m, CH2CH=CH2), 5.17 
(lH, m, C=CHCH2), 4.97 (2H, m, CH=CH2), 4.l2 (2H, q, J 7.2 Hz, OCH2CH3), 2.39 
(4H, m, 02CCH2CH2C), 2.08 (4H, m, CHCH2CH2CH), 1.62 (3H, s, CCH3), 1.26 
(3H, t, J 7.2 Hz, OCH2CH); oe (90.6 MHz, CDC)3) 173.2 (s), 138.3 (d), 133.6 (s), 
124.4 (d), 114.4 (t), 60.0 (t), 34.5 (t), 33.7 (t), 33.1 (t), 27.2 (t), 15.8 (q), 14.1 (q); 
Umax (liquid film)/cm- 1 3076 (w), 2978 (s), 2922 (m), 1737 (s), 1640 (w), 1445 (w), 
1371 (w), 1343 (w), 1293 (w), 1251 (m), 1157 (s), 1096 (w), 1042 (m), 911 (m), 857 
(w). 
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4-Methylnona-4,8-dien-l-ol (348) 117 
OH 
348 
A solution of ethyl 4-methylnona-4,8-dienoate (349) (4.3 g, 22 mmol) in 
tetrahydrofuran (140 cm3) was transferred via cannula to a stirred slurry of lithium 
aluminium hydride (2.1 g, 55 mmol) in tetrahydrofuran (45 cm3) at room temperature. 
The resulting mixture was left to stir at room temperature for 12 h, then water (2.5 
cm3), a 10% w/v solution of sodium hydroxide (5.1 cm3) and then water (7.7 cm3) 
were added. The resulting thick suspension was filtered and the solid was washed 
with ether (100 cm3). The washings were combined and reduced in vacuo to leave an 
oil which was then purified by chromatography on silica, using ethyl acetate • 
petroleum (b.p. 40-60°C) (1:4) as eluant, to give the E-hydroxydiene (348) (2.9 g, 85 
%) as a colourless oil. OH (360 MHz, CDC)3) 5.82 (1H, m, CH2CH=CH2), 5.17 (1H, 
m, C=CHCH2), 4.96 (2H, m, CH=CH2), 3.62 (2H, t, J 6.6 Hz, CH2CH20H), 2.07 
(6H, m, CH2C(Me)=CHCH2CH2CH), 1.66 (2H, app. quin., J 6.6 Hz, CH2CH2CH2), 
1.61 (3H, s, CCH3); Oc (90.6 MHz, CDC}3) 138.6 (d), 135.0 (s), 124.2 (d), 114.4 (t), 
62.6 (t), 35.8 (t), 33.9 (t), 30.5 (t), 27.3 (t), 15.8 (q); 'l>max (liquid film)/cm- 1 3343 (b), 
3076 (m), 2936 (s), 1712 (m), 1640 (m), 1441 (m), 1383 (m), 1269 (m), 1166 (w), 
1059 (m), 1013 (m), 910 (s). 
4-Methyl-l- para-toluenesulfonyloxynona-4,8-diene (350a) 
OTs 
350a 
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para-Toluenesulfonyl chloride (2.5 g, 13 mmol) was added if} one portion to a stirred 
solution of 4-methylnona-4,8-dien-l-01 (348) (1.8 g, 12 mmol) in pyridine (20 cm3) at 
O°C and the resulting solution was then allowed to warm to room temperature over 2 
h. The mixture was diluted with ether (30 cm3) and then washed with water (20 em3), 
saturated aqueous copper (II) sulfate (50 cm3), water (20 cm3) andbrine (10 cm3). 
The organic layer was dried (Na2S04), reduced in vacuo and the residue was then 
purified by chromatography on silica, using ether - petroleum (b.p. 40-60°C) (1:9) as 
eluant, to give the E-tosylated diene (350a) (2.9 g, 80 %) as a colourless oil. SH (360 
MHz, CDCI3) 7.81 (2H, Ar-H), 7.35 (2H, Ar-H), 5.79 (lH, m, CH2CH=CH2), 5.02 
(3H, m, C=CHCH2 and CH=CH2), 4.00 (2H, t, J 6.6 Hz, TsOCH2CH2), 2.46 (3H, 5, 
Ar-CH3), 2.04 (6H, m, CH2C(Me)=CHCH2CH2CH), 1.74 (2H, app. quin., J 6.6 Hz, 
CH2CH2CH2), 1.54 (3H, s, CCH3); Oc (90.6 MHz, CDCI3) 144.6 (Ar-s), 138.4 (d), 
133.3 (5), 133.2 (Ar-s), 129.8 (Ar-d), 127.8 (Ar-d), 125.1 (d), 114.5 (t), 70.1 (t), 35.0 
(t), 33.7 (t), 27.3 (t), 26.9 (t), 21.6 (q), 15.7 (q); 'Umax (liquid film)/cm- 1 3072 (w), 
2921 (s), 2852 (m), 1921 (w), 1732 (w), 1639 (m), 1598 (m), 1494 (w), 1447 (m), 
1362 (5), 1306 (w), 1291 (w), 1210 (w), 1188 (s), 1098 (5), 1019 (m), 967 (5), 925 (5), 
832 (s), 815 (s), 792 (w), 734 (5), 644 (5); Found %: C, 66.0; H, 7.8 (C17H2403S 
requires C, 66.2; H, 7.8); mlz (FAB) 309.1506 (M+H+, C17H2S03S requires 
309.1524). 
9-Bromo-6-methylllolla-l,5-dielle (3S0b) 
Br 
350b 
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Lithium bromide (2.8 g, 33 mmol) was added in one portion to a stirred solution of 4· 
methyl-l-para-toluenesulfonyloxynona-4,8-diene (350a) (2.9 g, 9.3 mmol) in acetone 
(25 cm3) at room temperature. The mixture was then heated at reflux for 4 h then 
cooled to room temperature and partitioned/between ether (250 cm3) and water (150 
cm3). The layers were then separated and the aqueous layer was washed with ether 
(250 cm3), the combined organics were dried (Na2S04) and reduced in vacuo to leave 
an oily residue. The residue was then purified by chromatography on silica, using 
pentane as eluant, to give the E-bromo diene (350b) (1.8 g, 91 %) as a colourless oil. 
OH (360 MHz, CDCI3) 5.82 (lH, m, CH2CH=CH2), 5.20 (lH, m, C=CHCH2), 4.98 
(2H, m, CH=CH 2), 3.38 (2H, t, J 7.1 Hz, BrCH 2CH3), 2.11 (6H, m, 
CH2C(Me)=CHCH2CH2CH), 1.95 (2H, app. quin., J 7.1 Hz, CH2CH2CH2), 1.61 
(3H, s, CCH3); Oc (90.6 MHz, CDCI3) 138.4 (d), 133.3 (s), 125.2 (d), 114.5 (t), 37.7 
(t), 33.8 (t), 33.2 (t), 30.8 (t), 27.3 (t), 15.8 (q); Umax (liquid film)/cm- 1 3073 (m), 
2924 (s), 2359 (s), 2340 (m), 1638 (m), 1437 (m), 1382 (w), 1245 (m), 993 (m), 912 
(s); Found %: C, 55.5; H, 8.1; Br, 36.9 (ClOH17Br requires C, 55.3; H, 7.9; Br, 36.8); 
mlz (El) 216.0513 (M+, ClOH17Br requires 216.0514). 
Ethyl 6-methyl-2-oxoundeca-6,lO-dienoate (346) 
OEt 
o 
346 
A solution of I-bromo-4-methylnona-4,8-diene (350) (600 mg. 2.8 mmol) in 
tetrahydrofuran (2 cm3) was added dropwise over 10 min. maintaining a temperature 
of 40·C. to a stirred mixture of magnesium (74 mg) and iodine (1 crystal) in 
tetrahydrofuran (2 cm3). The mixture was left to cool to room temperature over 10 
min and then transfered via cannula over 10 min to a stirred solution of diethyl 
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oxalate (750 Ill, 810 mg, 5.5 mmol) in tetrahydrofuran (2 cm3) at O°C. The mixture 
was left to warm to room temperature over 4 h, acidified to' pH 1 with hydrochloric 
acid (2 cm3, 2 moldm-3) and diluted with water (S cm3). The mixture was extracted 
I • 
with dichloromethane (3xl0 cm3) mid the combined organics dried (MgS04) and 
reduced in vacuo to leave a colourless oil. The residue was then purified by 
chromatography on silica, using ethyl acetate-petroleum (b.p. 40-60°C) (1: 19) as 
eluant, to leave the a-ketoester (346) (330 mg, 52 %) as a colourless oil. OH (360 
MHz, CDCI3) 5.81 (IH, m, CH2CH=CH2), 5.14 (IH, m, C=CHCH2), 4.98 (2H, m, 
CH=CH2), 4.31 (2H, q, J 7.1 Hz, OCH2CH3), 2.79 (2H, t, J 7.1 Hz, CH2COC02), 
2.09 (4H, m, CHCH2CH2CH), 2.03 (2H, t. J 7.1 Hz. CH2C(Me», 1.78 (2H. app. 
quin., J 7.1 Hz, CH2CH2CH2), 1.59 (3H, s, CCH]), 1.37 (3H, t, J 7.1 Hz, OCH2CH]); 
Oe (90.6 MHz, CDCI3) 194.4 (s), 161.0 (s), 138.3 (d). 134.0 (s), 125.0 (d), 114.3 (t), 
62.1 (t), 38.S (t). 38.2 (t), 33.7 (t). 27.2 (t), 20.8 (t). 15.S (q), 13.8 (q); umax (liquid 
film)/cm- 1 3076 (w), 2933 (s), 1730 (s). 1640 (w). 1446 (m). 1370 (w). 1267 (m), 
1076 (m), 1044 (m), 912 (m); mlz (EI) 220.14S1 (M-H20+. C14H2002 requires 
220.1463). 
Ethyl 2-amino-(N-acetyl, N -methylS '-metl,ylhept-5 '-en-7 'yloate )-6-methylundeca-
2,6,lO-trienoate (351) 
OEt 0 
N ~ O M . .
oA 
351 
Triflouroacetic acid (430 Ill, 630 mg, 5.5 mmol) was added in one portion to stirred 
methyl 7-amino-(N-tert-butylcarboxylate)-S-methylhept-S-enoate (274b) (150 mg. 
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0.55 mmol) at room temperature and the oil was left to stir for 5 min. Toluene (10 
cm3) was added and the solution was reduced in vacuo to leave a colourless oil. 
Triethylamine (77 J.lI, 56 mg, 0.55 mmol) was added in one portion to a stirred 
solution of the oil in benzene (15 cm3) and stirred at room temperature for 5 min. 
Molecular sieves (4 A, activated) were added to the solution, followed by ethyl 6-
methyl-2-oxoundeca-6,1O-dienoate (346) (140 mg, 0.61 mmol) and left to stir at room 
temperature for 12 h. N,N-Diethylaniline (130 JlI, 120 mg, 0.83 mmol) was added in 
one portion to the stirred mixture at room temperature and then acetyl bromide (49 J.lI, 
83 mg, 0.66 mmol) was added in one portion and the mixture was left to stir at room 
temperature for 2 h. The mixture was filtered through a pad of celite, washed with 
ethyl acetate (50 cm3) and the solvent removed in vacuo to leave a yellow oil. The oil 
was purified by chromatography on silica, using ethyl acetate - petroleum (b.p. 40-
60°C) (1:2) as eluant, to give the enamide (351) (130 mg, 54 %) as a colourless oily 
mixture of 2 and 5' E:Z isomers. All isomers: ~ H H (360 MHz, CDCI3) 6.95 (0.5H, t, J 
7.5 Hz, C(C02Et)=CHCH2), 6.13 (0.5H, t, J 7.5 Hz, C(C02Et)=CHCH2), 5.81 (1H, 
m, CH2CH=CH2), 5.17 (2H, m, C(Me)=CHCH2 and C(Me)=CHCH2), 4.99 (2H, m, 
CH2CH=CH2), 4.24 (2H, q, J 7.1 Hz, OCH2CH3), 4.07 (2H, d, J 7.4 Hz, 
C=CHCH2N), 3.67 (3H, s, C02C H 3), 2.74 (lH, apparent q, J 7.6 Hz, 
C(C02Et)=CHCH2), 2.27 (3H, m, C(C02Et)=CHCH2Clh and Me02CCH2), 2.19-
1.95 (8H, m, CH2C(Me)=CH and CH2C(Me)=CHCH2CH2CH), 2.09 (3H, S, 
NCOCH3), 1.70 (2H, m, CH2CH2CH2), 1.62 (6H, m, C(CH3)=CH and C(CH3)=CH), 
1.31 (3H, T, J 7.1 HZ, OCH2CH3); Oc (90.6 MHz, CDCI3) 173.8 (s), 170.5 (s), 164.2 
(s), 148.1 (d), 144.3 (d), 138.8 (s), 138.4 (d), 133.9 (s), 133.4 (s), 131.4 (s), 125.4 (d), 
125.1 (d), 120.6 (d), 119.8 (d), 114.6 (t), 61.4 (t), 61.1 (t), 51.5 (q), 44.7 (t), 44.5 (1), 
44.2 (t), 38.9 (t), 38.4 (t), 37.6 (t), 33.8 (t), 33.5 (t), 30.9 (t), 29.7 (t), 27.3 (l), 27.0 (t), 
26.7 (t), 23.3 (t), 23.2 (t), 23.1 (t), 22.8 (t), 22.0 (q), 21.5 (q), 15.9 (q), 15.8 (q), 14.2 
(q); umax (liquid film)/cm- 1 2931 (s), 1721 (s), 1666 (s), 1435 (s), 1392 (s), 1251 (s), 
172 
1197 (s), 1096 (m), 1032 (m), 912 (w), 864 (w), 781 (w); mlz (EI) 433.2820 (M+, 
C2SH39NOS requires 433.2828). 
I 
Ethyl 2-amino-(N -acetyl, N-phenyl S'-methylhept-S'-en-7'-ylselenoate)-6-
methyiundeca-2,6,lO-trienoate (338) 
OEt 
N ~ s e P h h
O ~ ~
338 
A solution of lithium hydroxide (18 mg, 0.44 mmol) in water (4 cm3) was added in 
one portion to a stirred solution of ethyl 2-amino-(N-acetyl, N-methyl 5'-methylhept-
5'-en-7' -yloate )-6-methylundeca-2,6, lO-trienoate (351) (130 mg, 0.29 mmol) in 
tetrahydrofuran (4 cm3) at room temperature. The resulting mixture was stirred at 
room temperature for 2 h, the solution was acidified to pH 1 with hydrochloric acid 
(10 drops, 2.0 moldm-3) and then extracted with dichloromethane (3x30 cm3). The 
combined organic extracts were dried (Na2S04) and then the solvent was removed in 
vacuo to leave a colourless oil. 
Tributylphosphine (110 ,.tI, 89 mg, 0.44 mmol) was added in one portion to a stirred 
solution of the oil in dichloromethane (2 cm3) and the solution was left stirring at -
30°C for 5 min. N-Phenylselenophthalimide (130 mg, 0.44 mmol) was then added in 
one portion to the mixture solution at -30°C and left to stir for 5 min. Water (2 em3) 
and brine (2 cm3) were added in one portion and the mixture was allowed to warm to 
room temperature. The layers were separated and the aqueous layer was extracted 
with dichloromethane (3x30 cm3) and the combined organics were dried (Na2S04) 
and reduced in vacuo. The resulting pale yellow semi solid was purified by 
chromatography on silica. using ethyl acetate - petroleum (b.p. 40-60°C) (1 :2) as 
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eluant, to leave a yellow oil which was titurated with pentane to give the se/eny/ ester 
(338) (100 mg, 63 %) as a pale yellow oily mixture of 2 and 5' E:Z isomers. All 
isomers: DH (360 MHz, CDCI3) 7.51 (2H, m, Ar-H), 7.38 (3H, m, Ar-H), 6.95 (O.5H, 
t, J 7.5 Hz, C ( C ~ E t ) = C H C H 2 ) , , 6.13 (O.5H, t, J 7.5 Hz, C(C02Et)=CHCH2), 5.80 
(lH, m, CH2CH=CH2), 5.17 (2H, m, C(Me)=CHCH2 and C(Me)=CHCH2), 4.97 (2H, 
m, CH2CH=CH2), 4.23 (2H, q, J 7.1 Hz, OCH2CH3), 4.07 (2H, d, J 7.4 Hz, 
C=CHCH2N), 2.74 (IH, apparent q, J 7.6 Hz, C(C02Et)=CHCH2), 2.66 (2H, m, 
CH2COSePh), 2.27 (lH, m, C(C02Et)=CHCH2), 2.19-1.95 (9H, m, NCOCHj and 
CH2C(Me)=CHCH2CH2CH), 1.94 (2H, m, CH 2C(Me)=CH), 1.78 (2H, m, 
CH2CH2CH2), 1.61 (6H, m, C(CH3)=CH and C(CHj)=CH), 1.30 (3H, t, J 7.1 HZ, 
OCH2CH3); DC (90.6 MHz, CDCl3) 200.0 (s), 170.5 (s), 164.2 (s), 148.0 (d), 144.3 
(d), 138.4 (d), 135.7 (d), 134.1 (d), 133.9 (s), 133.4 (s), 131.4 (s), 129.3 (d), 128.8 (d), 
126.3 (s), 125.4 (d), 123.4 (d), 121.0 (d), 120.1 (d), 114.6 (t), 61.4 (t), 61.0 (t), 46.9 
(d), 44.7 (t), 44.6 (t), 44.2 (t), 38.5 (t), 38.3 (t), 37.6 (t), 33.7 (t), 30.6 (t), 29.6 (t), 27.3 
(t), 26.9 (t), 26.8 (t), 26.7 (t), 23.4 (t), 23.2 (t), 23.1 (t), 23.1 (q), 22.0 (q), 21.5 (q), 
15.9 (q), 15.8 (q), 15.7 (q), 14.2 (q); umax (liquid film)/cm- 1 2926 (m), 1722 (s), 1667 
(s), 1439 (s), 1398 (s), 1266 (m), 1195 (s), 1096 (w), 1022 (w), 914 (w); m/z (FAB) 
560.2274 (M+H+, C3oli42N04 sOSe requires 560.2279), 558.2271 (M+H+, 
C30H42N0478Se requires 558.2287). 
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Ethyl 4-acetyl-3, 7-dimethyl-l1-oxo-3-pent-4-enyl-l ,2,3,4,5,8,9,10,11,11 a-
decahydro-4-aza-cyclopentacyclodecene-3a-carboanoate (354) 
354 
A solution of tributyltin hydride (76 ~ l , , 82 mg, 0.28 mmol) and AIBN (5 mg) in 
degassed benzene (5 em3) was added dropwise over 8 h to a refluxing solution of the 
selenyl ester (338) (126 mg, 0.23 mmol) and AIBN (5 mg) in benzene (67 em3). The 
solution was refluxed for a further 4 h, allowed to cool to room temperature and 
reduced in vacuo to leave an oily residue. The residue was purified by 
chromatography on silica, using ethyl acetate - petroleum (b.p. 40-60°C) (3:7) to ethyl 
acetate - petroleum (b.p. 40-60°C) (7:3) as eluant, to the bicyclic compound (354) (34 
mg, 35 %) as a colourless oil. OH (360 MHz, CDC)3' 328 K) 5.83 (lH, m, 
CH2CH=CH2), 5.14 (1H, m, C=CHCH2), 4.98 (2H, m, CH2CH=CH2), 4.20 (2H, q. J 
7.2 Hz, C02CH2CH3), 3.85 (1H, app. t, J 10.1 Hz, COCHCHH), 3.70 (lH. app. t, J 
10.1 Hz. COCHCHH). 2.91 (lH. t. J 10.1 Hz. COCH). 2.48 (2H, m, COCHH, CHH). 
2.34 (lH, m, COCHH) , 2.08 (3H. s. NCOCH3), 2.09-1.87 (10H, m, CH2N, CH2, 
CH2, CHH, CHH, CH2). 1.58 (3H, s, CH3). 1.44-1.30 (2H, m, CHH, CHH), 1.28 (3H, 
t, J 7.2 Hz. C02CH2CH3), 1.20 (3H, s, CH3), 1.10 (1H, m, CHH); Oc (90.6 MHz, 
CDCI3) 209.6 (s), 170.0 (s), 168.9 (s), 138.7 (d), 134.7 (s), 124.4 (d), 114.4 (t), 76.3 
(s), 61.0 (t), 58.1 (d), 51.3 (s), 49.8 (t), 40.0 (t), 37.2 (t), 33.9 (t), 31.5 (q), 29.9 (t), 
27.4 (t), 24.3 (t), 23.4 (q), 22.3 (t), 18.7 (q). 15.9 (q), 14.2 (q); mlz (EI) 403.2735 
(M+H+, C24H37N04 requires 403.2723). 
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5. APPENDIX 
187 
5.1 CRYSTALDATA 
The following eight pages contain the crystallographic data from the X-ray study on 
the tricyclic compound 291. 
291 
188 
TRINCO #458 
for PJO/GP 
T = 1 5 0 K ~ ~ 50% 
-00 
'" 
File. trinco.pll 
Table 1. Crystal data and structure refinement for TRINCO at 150.0(2)K. 
Empirical formula C16 H25 N 02 
Formula weight 263.37 
Crystal description colourless block 
Crystal size 0.60 x 0.50 x 0.40 mm 
Crystal system 
Space group 
Unit cell dimensions 
Triclinic 
P-1 
a = 5.884(2) A 
b = 9.265(3) A 
c = 13.687(6) A 
Volume 706.2(5) AA3 
Reflections for cell refinement 40 
Range in theta 14 to 16 deg. 
Z 2 
Density (calculated) 1.239 Mg/mA3 
Absorption coefficient 0 . 080 mmA_1 
F(OOO) 288 
alpha = 77.23(3) deg. 
beta ~ ~ 83.17(4) deg. 
gamma = 76.63(3) deg. 
Diffractometer type Stoe Stadi-4 four-circle 
Wavelength 0.71073 A 
Scan type omega/theta 
Reflections collected 2464 
Theta range for data collection 2.50 to 24.98 deg. 
Index ranges -6<=h<=6, -10<=k<=10, 0<=1<=16 
Independent reflections 2464 
Observed reflections 2071 [I>2sigma(I)] 
Decay correction variation +/-2.3% 
Structure solution by direct methods 
Hydrogen atom location in calculated positions 
Hydrogen atom treatment riding model 
Data / restraints / parameters 2464/0/174 (least-squares on FA2) 
Final R indices [I>2sigma(I)] R1 = 0.0438, wR2 = 0.0951 
Final R indices (all data) R1 = 0.0563, wR2 = 0.1062 
Goodness-of-fit on FA2 1.153 
Extinction coefficient 0.024(4) 
Final maximum delta/sigma 0.001 
Weighting scheme 
calc w=1/[\sA2 A(Fo A2 A)+(0.035P)A2 A+0.446P] where P=(Fo A 2 A +2Fc A 2 A )/3 
Largest diff. peak and hole o . 2 8 and - 0 . 21 e. A A - 3 
19l 
Table 2. Atomic coordinates ( x 1 0 ~ 4 ) ) and equivalent isotropic 
displacement parameters (AA 2 x 10 A3) for TRINCO. U(eq) is defined 
as one third of the trace of the o r t h o g o n a l i z e ~ ~ Uij tensor. 
x y z U(eq) 
C1 -3687 (3) 11361(2) 1710(1) 23 (1) 
C2 -4270(4) 12651(2) 2288 (2) 28 (1) 
C3 -5783 (3) 12215(2) 3244(2) 27 (1) 
C4 -5199(3) 10545(2) 3678(1) 20 (1) 
04 -6642(2) 9904(1) 4192(1) 26 (1) 
C5 -2722 (3) 9721(2) 3439(1) 19 (1) 
C6 -2376(3) 8042(2) 3944(1) 20 (1) 
N7 -309(2) 7149 (2) 3489 (1) 19 (1) 
C8 -412(3) 7134(2) 2425(1) 19 (1) 
C9 -2234(3) 8497(2) 1946(1) 18(1) 
CI0 -2033 (3) 9957(2) 2271(1) 18 (1) 
C10M 473(3) 10206(2) 2069 (1) 24 (1) 
Cl1 -2047(3) 8554(2) 814 (1) 24 (1) 
C12 -2476(4) 7090(2) 604 (2) 29(1) 
C13 -812(4) 5698(2) 1141 (1) 29(1) 
C14 -914(3) 5666(2) 2262 (1) 24 (1) 
C15 1688(3) 6471(2) 3946 (1) 20 (1) 
C16 1760(3) 6528(2) 5035 (1) 26 (1) 
017 3402(2) 5804(2) 3490 (1) 29 (1) 
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Table 3. Bond lengths [A], angles and torsions [deg] 
for TRINCO. 
CI-C2 1. 52S (3) 
CI-CI0 1. 543 (2) 
C2-C3 1.524(3) 
C3-C4 1.504(3) 
C4-04 1.215(2) 
C4-C5 1.515 (2) 
C5-C6 1.533(2) 
C5-CI0 1.5S1(2) 
C6-N7 1.461(2) 
N7-C15 1.352 (2) 
N7-CS 1.468(2) 
CS-C14 1.524(2) 
C8-C9 1.533 (2) 
C9-C11 1. 530 (2) 
C9-CI0 1.547(2) 
CI0-C10M 1.529(2) 
CI1-C12 1.52S(3) 
C12-C13 1.526(3) 
C13-C14 1.523(3) 
C15-017 1.233 (2) 
C15-C16 1.50S(3) 
C2-C1-C10 111.73(15) 
C3-C2-Cl 109.63(15) 
C4-C3-C2 112.37(15) 
04-C4-C3 121.44(17) 
04-C4-C5 122.35(16) 
C3-C4-C5 116.21(16) 
C4-C5-C6 110.30(15) 
C4-CS-C10 112.32(14) 
C6-C5-C10 112.30(14) 
N7-C6-C5 110.96(14) 
C15-N7-C6 125.04(15) 
C15-N7-C8 119.49(14) 
C6-N7-CS 115.23(14) 
N7-CS-C14 113.00(14) 
N7-CS-C9 110.11(14) 
C14-C8-C9 110.4S(15) 
C11-C9-C8 108.19(14) 
C11-C9-C10 116.14 (14) 
C8-C9-C10 111.02(14) 
CI0M-C10-C1 108.56(15) 
C10M-C10-C9 110.95(14) 
C1-C10-C9 111.37(14) 
C10M-C10-C5 109.30(14) 
C1-C10-CS 110.1S(14) 
C9-CI0-C5 106.46(14) 
C12-CII-C9 110.30(15) 
C13 -C12 -C11 111. 80 (16) 
C14 -C13 -C12 111.42(16) 
C13-C14-CS 109.53(15) 
017-C1S-N7 120.93(16) 
017-C15-C16 120.69(16) 
N7-C15-C16 118.37(16) 
CI0-C1-C2-C3 -6S.4(2) 
CI-C2-C3-C4 33.0(2) 
C2-C3-C4-04 -153.6S(lS) 
C2-C3-C4-CS 26.5(2) 
04-C4-C5-C6 -0.8(2) 
C3-C4-C5-C6 179.04(15) 
04-C4-C5-C10 12S.34(18) 
C3-C4-CS-C10 -S4.9(2) 
C4-CS-C6-N7 162.S3(14) 
C10-CS-C6-N7 36.4(2) 
CS-C6-N7-C1S 111.18 (18) 
CS-C6-N7-C8 -63.09(19) 
C1S -N7 -C8 -C14 82.1(2) 
C6-N7-C8-C14 -103.29(17) 
C1S-N7-C8-C9 -lS3.84(15) 
C6-N7-C8-C9 20.8(2) 
N7 -C8 -C9 -Cll 172.44(14) 
C14 -C8 -C9 -Cll -62.06(18) 
N7-C8-C9-C10 43.89(19) 
C14-C8-C9-C10 169.40(14) 
C2-C1-C10-C10M -80.68(18) 
C2-C1-C10-C9 lS6.88(lS) 
C2-C1-C10-CS 39.0(2) 
Cll-C9 -C10 -C10M -70.99(19) 
C8-C9-C10-C10M S3.1S(19) 
Cll-C9 -C10 -C1 SO.1(2) 
C8-C9-C10-C1 174.20(14) 
C11-C9-C10-C5 170.19(14) 
C8-C9-Cl0-CS -6S.67(17) 
C4-C5-C10-C10M 138.49(lS) 
C6-C5-C10-C10M -96.49(17) 
C4-C5-C10-C1 19.29(19) 
C6-C5-C10-C1 144.30 (lS) 
C4-CS-Cl0-C9 -101.61(16) 
C6-CS-C10-C9 23.41(18) 
C8-C9-Cll-C12 S9.06(19) 
C10-C9-Cll-C12 -175.3S(lS) 
C9-Cll-C12-C13 -55.9(2) 
C11-C12-C13-C14 S4.0(2) 
C12 -C13 -C14 -C8 -5S.5(2) 
N7 -C8 -C14 -C13 -175.84(15) 
C9-C8-C14-C13 60.30(19) 
C6-N7-C15-017 -176.05(16) 
C8-N7-C15-017 -2.0(2) 
C6-N7-C15-C16 4.9 (3) 
C8-N7-C15-C16 178.91(15) 
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Table 4. 
Cl 
C2 
C3 
C4 
04 
CS 
C6 
N7 
C8 
C9 
C10 
C10M 
Cll 
C12 
C13 
C14 
C1S 
C16 
017 
Anisotropic displacement parameters (AA2 x 10 A3) for TRINCO. 
The anisotropic displacement factor exponent takes the form: 
-2 pi A2 [ h A2 a*A 2 U11 + ••• + 2 h k a* b* U12 ] 
U11 U22 U33 U23 U13 U12 
26 (1) 18 (1) 22 (1) -1 (1) -1 (1) -4 (1) 
35 (1) 15(1) 31(1) - 3 (1) -1 (1) -4 (1) 
30 (1) 18 (1) 31 (1) -9 (1) -1 (1) -1 (1) 
25(1) 20 (1) 18(1) - 8 (1) -1 (1) -4 (1) 
24(1) 26 (1) 26(1) -6 (1) 4 (1) -4 (1) 
20 (1) 19 (1) 18 (1) -5 (1) -2 (1) -3 (1) 
21 (1) 18 (1) 16(1) -3 (1) 2 (1) 1(1) 
20 (1) 20 (1) 16(1) -4 (1) 0(1) 1 (1) 
19(1) 19 (1) 16(1) -4 (1) 1 (1) 0(1) 
19(1) 17 (1) 18 (1) -4 (1) -1 (1) -2(1) 
20 (1) 18 (1) 17(1) -4 (1) 1 (1) -4(1) 
24 (1) 26 (1) 23 (1) - 5 (1) 1 (1) -8(1) 
29 (1) 23 (1) 18(1) -4 (1) -4 (1) -1(1) 
38(1) 29 (1) 23 (1) -10(1) -6 (1) -5(1) 
42 (1) 23 (1) 25 (1) -11 (1) 1 (1) - 5 (1) 
32 (1) 16 (1) 23(1) -5 (1) 1 (1) 0(1) 
22(1) 15 (1) 22 (1) - 2 (1) -2 (1) - 3 (1) 
29 (1) 23 (1) 24 (1) -2 (1) -7 (1) -3 (1) 
22 (1) 30 (1) 30 (1) -8 (1) - 3 (1) 5(1) 
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Table 5. 
H1A 
H1B 
H2A 
H2B 
H3A 
H3B 
H5 
H6A 
H6B 
H8 
H9 
H10A 
H10B 
Hl0e 
H11A 
HIIB 
H12A 
H12B 
H13A 
H13B 
H14A 
H14B 
H16A 
H16D 
H16B 
Hydrogen coordinates ( x 10 A 4) and isotropic 
displacement parameters (AA2 x 10 A3) for TRINCO. 
x y z U(eq) 
-2936 11712 1040 2 -: 
-5154 11080 1610 27 
- 2806 12857 2461 33 
-5118 13582 1863 33 
-5561 12778 3749 32 
-7451 12516 3093 32 
-1646 10167 3740 22 
-2195 7928 4669 24 
-3777 7661 3876 24 
1152 7238 2077 23 
-3812 8293 2212 22 
905 10353 1345 36 
1545 9320 2419 36 
575 11106 2312 36 
-3215 9426 488 28 
-469 8695 526 28 
-4113 7009 829 35 
-2264 7123 -128 35 
-1236 4772 1036 35 
808 5704 847 35 
258 4793 2583 29 
-2485 5549 2573 29 
3261 5932 5280 38 
478 6109 5432 38 
1588 7581 5099 38 
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5.2 MOLECULAR MODELS 
The following four pages contain conformations for the global energy minimum of 
the four tricyclic structures 261,292,291 and 293 respectively. 
261 292 
291 293 
197 
261 
198 
292 
(' 
199 
291 
200 
293 
201 
